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Tuberous sclerosis complex 1 (TSC1) and -2 (TSC2) proteins form a 
functional complex to negatively regulate the mechanistic target of rapamycin 
(mTOR), a serine/threonine protein kinase that regulates cell proliferation, protein 
synthesis and autophagy. It has been demonstrated earlier that cells deficient of 
TSC proteins are known to have constitutively higher level of mTORC1 activity 
and susceptible to cell death induced by various stress factors. However, the exact 
function of the TSC proteins in cell stress responses has not well explored. 
Therefore, the main objective of this study is to investigate the roles of TSC 
proteins in cell death by focusing on the involvement of autophagy and JNK 
signaling pathway, with the following aims: 1) elucidation of the role of TSC to 
autophagy in response to starvation and 2) examination of the role of TSC in 
oxidative stress-mediated JNK signaling.  
In the first part of our study, we found that TSC-null mouse embryonic 
fibroblasts (MEFs) were indeed more sensitive in response to various cell death 
stimuli, such as starvation, hypoxia and oxidative stress. The TSC2-deficient cells 
possessed a lower basal and inducible autophagy level, mainly due to the 
hyperactivation of the mTORC1 activity. Suppression of autophagy through 
pharmacological inhibition or genetic knockdown of Atg7 sensitised the TSC2 
wild-type (TSC2WT) cells significantly, but not the TSC2-null MEFs. In contrast, 
ablation of mTORC1 activity via raptor knockdown or by pharmacological 
inhibitors in TSC2-deficient cells activated the autophagy process while 
simultaneously rescued the cells from starvation-mediated cell death. Notably, we 
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have also demonstrated that nutrients supplementation, which activated the Akt-
mTORC1 signaling, enhanced cell death in TSC2-null cells but significantly 
reduced cell death in the TSC2WT cells. Taken together, our data demonstrate 
that constitutively-activated mTORC1 in TSC2-deficient cells suppresses 
autophagy and thus contributes to the hypersensitivity of TSC-null cells to 
apoptosis when stimulated with various cell death stimuli. 
In the second part of our study, we systematically examined the changes 
of c-Jun N-terminal kinase (JNK) in the TSC-deficient cells in response to 
oxidative stress. We first demonstrated that TSC-null MEFs had a significantly 
lower level of JNK activation induced by H2O2 while the reconstitution of TSC2 
protein expression restored the impaired JNK activation in TSC2-deficient cells. 
Importantly, neither the mTOR activity, nor the upstream JNK signaling kinases 
such as MKK4, MKK7 and ASK1 were directly involved in the defective JNK 
activation in the TSC2-null cells. Notably, the TSC2-deficient cells exhibited a 
significantly reduced activation of tyrosine phosphorylation in response to 
oxidative stress and one key finding from our study was that the TSC may be 
involved in stabilizing the JNK phosphatase, MAPK phosphatase (MKP-1) 
activity. Finally, the impairment of JNK signaling in TSC2-deficient cells appears 
to promote necrotic cell death in these cells. Thus, our data demonstrates a novel 
function of TSC in mediating the cell death through JNK-MKP1 signaling in 
response to oxidative stress. In summary, data from our study demonstrate that 
TSC protein plays vital roles in the regulation of autophagy and cell death in 
response to stress. 
  xi 
 
LIST OF TABLES 
 
Table 2.1 Primers sequence of genes for mRNA analysis  64 






















  xii 
 
LIST OF FIGURES 
 
Figure 1.1 The autophagy machinery.  4 
Figure 1.2 Autophagy has multiple roles in tumourigenesis, 
depending on the different stages of tumour 
development.  
14 
Figure 1.3 Intrinsic and extrinsic apoptosis. 22 
Figure 1.4 The necroptosis signaling.  29 
Figure 1.5 The mTOR signaling.  36 
Figure 1.6 mTORC1 signaling and diseases.  45 
Figure 1.7 The MAPK signaling cascades.  50 
Figure 2.1 Map of expression for vector pLenti4/TO/V5-TSC2. 70 
Figure 3.1 Statistical quantifications for the susceptibility of TSC 
cells induced by starvation and hypoxia stimuli.  
79 
Figure 3.2 TSC-null cells are more sensitive to cell death induced 




 MEFs are more sensitive to cell death induced 
by oxidative stress and TNFα stimuli.  
81 
Figure 3.4 Basal autophagy level is lower in TSC2
-/-
 cells.  83 
Figure 3.5 Lower inducible autophagy levels in TSC2
-/-
 cells. 84 
Figure 3.6 Autophagy inhibition with CQ sensitizes starved cells 
to death.  
86 
Figure 3.7 Atg7 knockdown inhibits autophagy.  87 
Figure 3.8 Autophagy inhibition with Atg7 knockdown sensitizes 
starved cells to death.  
88 
Figure 3.9 Raptor siRNA knockdown in TSC2
-/-
 cells increases 
autophagy.  
90 
Figure 3.10 Autophagy induction through raptor knockdown 







  xiii 
 
Figure 3.11 Effect of IGF-1+Leu (insulin growth factor-1 and 





Figure 3.12 Nutrients supplementation further sensitizes TSC2
-/-
 
cells to cell death.  
94 
Figure 3.13 The involvement of TSC in the regulation of autophagy 




 cells are impaired in oxidative stress-induced 




 MEFs have weakened JNK signaling activation 









 MEFs have reduced JNK activation induced by 
other stimuli. 
108 
Figure 4.5 TSC2 knockdown impairs JNK phosphorylation.  110 
Figure 4.6 Overexpression of TSC2 restores JNK activation.  110 
Figure 4.7 Reconstitution of TSC2 increases activation of 
oxidative stress-induced JNK activation.  
111 
Figure 4.8 JNK activation is restored in TSC2-reconstituted stable 
cell line.  
112 
Figure 4.9 Inhibition of autophagy with chloroquine does not 
inhibit JNK signaling.  
114 
Figure 4.10 Inhibition of autophagy with wortmannin alters JNK 
signaling.  
115 
Figure 4.11 Autophagy-deficient Atg7-null cells do not show JNK 
impairment.  
115 
Figure 4.12 JNK impairment in TSC2
-/-
 cells is not due to PI3K-
Akt-mTORC1 pathway.  
118 
Figure 4.13 Raptor knockdown does not affect JNK signaling.  119 
  xiv 
 
Figure 4.14 Upstream of MAPK signaling (MAP3K-MAP2K) is 









Figure 4.16 Tyrosine phosphatase inhibitors restored JNK 
activation in the TSC2
-/-
 cells.  
124 
Figure 4.17 Tyrosine phosphatase inhibitor significantly 
upregulates tyrosine phosphorylation in TSC2-null 
(EV) cells.  
126 
Figure 4.18 Immunoprecipitated phospho-tyrosine is lower in 
TSC2
-/-
 cells transfected with constitutive active 
JNKK2-JNK1 fusion protein. 
126 
Figure 4.19 MKP-1 mRNA level is higher in TSC2
-/-
 cells.  127 
Figure 4.20 TSC2 binds to MKP-1. 128 
Figure 4.21 H2O2-induced cell death in TSC2
-/-
 MEFs. 129 
Figure 4.22 H2O2 induces apoptotic and necrotic cell deaths in 
TSC2
-/-
 MEFs.  
131 
Figure 4.23 The regulation of TSC1/TSC2 complex in oxidative 
stress and cell death.  
138 
Figure 5.1 TSC as a key stress modulator in control of mTORC1, 
JNK, autophagy and cell fate in response to various 












  xv 
 
LIST OF ABBREVIATIONS 
 
4EBP1 eukaryotic translation-initiation factor 4E-binding protein 
AgRP agouti-related peptide  
AIF apoptosis-inducing factor  
AMPK adenosine monophosphate-activated protein kinase 
AP-1 activator protein 1 
APAF-1 apoptosis protease-activating factor-1 
ARE AU-rich element 
ASK1  apoptosis signal regulating kinases 1 
Atg autophagy related 
ATM Ataxia-telangiectasia mutated  
Bad Bcl-2-associated death promoter protein 
Bcl B-cell lymphoma 
Bcl-xL Bcl-extra large  
Beclin 1 Bcl-2-interacting protein 
BH Bcl-2 homology 
Bif-1 Bax-interacting factor 1  
BNIP3 Bcl-2/adenovirus E1B 19 kD protein-interacting protein 3 
BRCA1 breast cancer 1 
BSA bovine serum albumin 
C/EBPβ CCAAT/enhancer binding protein beta 
cAMP cyclic adenosine monophosphate 
Caspase cysteinyl aspartate-specific protease 
CD cluster of differentiation 
CD95L cluster of differentiation 95 ligand  
cDNA complementary DNA 
cFLIP cellular form of the caspase-8 inhibitor FLIP  
cIAP1 cellular inhibitor of apoptosis 1 
CMA chaperone-mediated autophagy 
CO2 carbon dioxide 
COP coatomer protein 
CQ chloroquine diphosphate 
CREB cAMP response element-binding protein 
C-terminus carboxy-terminus 
CUL3 cullin3  
CYLD Cylindromatosis 
cyt c cytochrome c 
DAP1 death-associated protein-1  
DAPk death-associated protein kinase  
DEPTOR DEP domain containing mTOR-interacting protein 
DIABLO direct inhibitor of apoptosis-binding protein with low pi 
DIF differentiation factor 
DISC death-inducing signaling complex 
DMEM Dulbecco's Modified Eagle's Medium 
DNA deoxyribonucleic acid 
  xvi 
 
dNTP deoxyribonucleotide triphosphate 
DR death receptor 
DRAM damage-regulated autophagy modulator  
Drp1 dynamin-related protein 1 
EBSS Earles’s balanced salt solution 
EDTA ethylenediaminetetraacetic acid 
EGF epidermal growth factor  
eIF4 eukaryotic translation initiation factor 4 
ER endoplasmic reticulum 
ERK extracellular signal-regulated kinases 
ESCRT endosomal sorting complex required for transport 
ETC electron transport chain 
EV empty vector 
FADD Fas-associated death domain 
FAK focal adhesion kinase 
Fas apoptosis stimulating fragment  
FasL Fas ligand 
FBS fetal bovine serum 
FFA free fatty acids 
FIP200 FAK-family-interacting protein of 200kD 
FLICE FADD-like IL-1β-converting enzyme 
FLIP FLICE-inhibitory protein 
FRB FKBP12-rapamycin binding 
GAP GTPase Activating Protein 
GAPDH glyceraldehyde-3-phosphate dehydrogenase 
GDP Guanosine diphosphate 
GPCR G protein-coupled receptors 
GSK3β glycogen synthase kinase 3β  
GTP Guanosine triposphate 
H2O2 hydrogen peroxide 
HDAC6 histone deacetylase 6 
HEPES 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
HIF1 hypoxia-inducible factor-1  
HIV human immunodeficiency virus 
HMGB1 high-mobility group box 1  
HOPS homotypic fusion and vacuole protein sorting 
Hsp70 heat-shock protein 70  
HSV-1 herpes simplex virus type 1  
hVps34 human vacuolar protein sorting protein  
IFN Interferon 
IGF-1 insulin-like growth factor-1 
IKK IκB kinase 
IL Interleukin 
IMS intermembrane space 
IP immunoprecipitation 
IRE1α inositol requiring 1α 
  xvii 
 
IRS-1 insulin receptor substrate-1 
IκB NF-κB inhibitory protein 
JNK c-Jun N-terminal kinases 
JNKK2 JNK kinase/MKK7 
KLHDC10 Kelch domain containing 10  
LAM Lymphangioleiomyomatosis 
LAMP-2 lysosomal-associated membrane protein 2  
LC3 microtubule-associated protein light chain 3 
LE longer exposure 
LIR LC3-interacting region  
Lys63-Ub lysine63-linked polyubiquitination  
MAPK mitogen activated protein kinase 
MAPKK MAPK kinase/MEK/MKK 
MAPKKK MAPKK kinase/MEK kinase/MAP3K  
Mcl-1 myeloid cell leukemia sequence-1 
MEF mouse embryonic fibroblast 
MHC major histocompatibility complex  
miR micro RNA 
MKPs map kinase phosphatases 
MLK mixed lineage kinase 
mLST8 mammalian lethal with sec-13 protein 8 
mn-SOD mitochondrial superoxide dismutase  
MOMP mitochondrial outer membrane permeabilization 
mRNA messenger RNA 
mSin1 mammalian stress-activated map kinase-interacting protein 1 
mTORC mechanistic/mamalian target of rapamycin complex 
MTT 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide  
N2 Nitrogen 
NaCl sodium chloride 
NaN3 sodium azide 
NBR1 neighbour of BRCA1 gene 1 
Nec-1 necrostatin-1 
NF-IL6 nuclear factor for the IL-6 gene 
NF-κB  nuclear factor kappa B 
NLR NOD-like receptors 
NOD nucleotide oligomerization domain 
Nox1 NADPH oxidase 1 




 superoxide anion 
OATL1 ornithine aminotransferase-like 1 
p- phosphorylation of 
PARP poly(ADP-ribose) polymerase 
PBS phosphate buffered saline 
PCD programmed cell death 
PCR polymerase chain reaction 
  xviii 
 
PDK1 phosphatidylinositol-dependent kinase 1 
PE Phosphatidylethanolamine 
PGAM5 phosphoglycerate mutase 5  
PGC1α PPAR-γ coactivator 1α  
PI propidium iodide 
PI3K phosphoinositide-3 kinase 
PIKK PI3K-related protein kinase 
PINK1 PTEN-induced putative kinase 1 
PK protein kinase 
Pol 1 Polymerase I 
PP5 protein phosphatase 5 
PPAR-γ peroxisome proliferator-activated receptor gamma 
PRAS40 proline-rich Akt substrate of 40 kD 
Protor protein observed with rictor-1 
PtdIns(4,5)P2 phosphatidylinositol-4,5-bisphosphate 
PtdIns3P Phosphatidylinositol 3-phosphate 
PTEN Phosphatase and tensin homolog 
PTPs protein tyrosine phosphatases  
PVDF polyvinylidene difluoride 
qPCR quantitative PCR 
RAB7A Ras-related GTP-binding protein 7A  
Rag Ras-related GTPase 
Raptor regulatory associated protein of mTOR 
RB1CC1 Retinoblastoma1-inducible coiled-coil 1 
REDD1 regulation of DNA damage response 1  
RFK riboflavin kinase  
Rheb Ras homolog enriched in brain 
Rictor rapamycin-insensitive companion of mTOR 
RIP receptor interacting protein 
RNA ribonucleic acid 
Romo1 ROS modulator 1  
ROS  reactive oxygen species 
RSK p90 ribosomal S6 kinase 
RTK receptor tyrosine kinase 
RT-PCR reverse transcriptase polymerase chain reaction 
Rubicon RUN domain and cys-rich domain containing Beclin 1 
interacting protein 
S.O.C  Super Optimal broth with Catabolite repression  
S6K p70 S6 kinase 
SD standard deviation 
SDS  sodium dodecyl sulfate 
SDS-PAGE  SDS polyacrylamide gel electrophoresis 
SE shorter exposure 
SEGA subependymal giant cell astrocytomas 
SGK1 serum- and glucocorticoid-induced protein kinase 1 
siRNA short interference RNA 
  xix 
 
SMAC second mitochondria-derived activator of caspase  
SNARE soluble N-ethylmaleimide-sensitive factor attachment protein 
receptor 
SNP sodium nitroprusside 
SREBP sterol regulatory element binding proteins 
SRF serum response factor  
STK11 serine/threonine kinase 11 
TAK1 TGF-β-activated kinase 1 
tBid truncated BH3 interacting domain death agonist 
TBST Tris Buffered Saline with Tween 20 
TCA tricarboxylic acid 
TE Tris and EDTA  
TECPR1 tectonin beta-propeller repeat containing 1 
Tel2 telomere maintenance 2 
TFEB transcription factor EB 
TGF-β transforming growth factor beta  
Th T helper  
TIF-1A transcriptional intermendiatery factor 1 Alpha 
TLR Toll-like receptors 
TM turn motif 
TNF tumour necrosis factor 
TNFR TNF receptor 
TOR target of rapamycin 
TRADD TNFα receptor-associated death domain 
TRAF TNFα receptor-associated factor 
TRAIL  TNF-related apoptosis-inducing ligand 
TRAILR TRAIL receptor 
TRIF Toll/IL-1 receptor domain-containing adaptor inducing IFN-β  
Tris 2-Amino-2-hydroxymethyl-propane-1,3-diol 
TSC tuberous sclerosis complex 
Tti1 Tel two interacting protein 1 
ULK Unc-51-like kinase 
UV Ultraviolet 
UVRAG UV irradiation resistance-associated gene  
WIPI2 WD repeat domain phosphoinositide-interacting protein 2  
WT wild type 
XIAP X-linked inhibitor of apoptosis protein  
YY 1 Ying-Yang 1  





  xx 
 




Ng S, Wu YT, Chen B, Zhou J, and Shen HM (2011). Impaired autophagy due to 
constitutive mTOR activation sensitizes TSC2-null cells to cell death under stress. 
Autophagy, 2011 Oct;7 (10):1173-86. 
 
Zhou J, Ng S, Huang Q, Wu YT, Li Z, Yao SQ, and Shen HM (2013). AMPK 
mediates a pro-survival autophagy downstream of PARP-1 activation in response 
to DNA alkylating agents. FEBS Lett, 2013 Jan;587 (2):170-7. 
 
TSC2 protein promotes oxidative stress-mediated JNK activation via disruption of 

























1.1.1 Overview of Autophagy 
Autophagy is a major intracellular degradation system in which 
cytoplasmic materials are delivered to the lysosome for degradation, and 
subsequently recycled to form new building blocks for cellular renewal and 
maintaining homeostasis (Mizushima and Komatsu, 2011). In mammalian cells, 
there are three classes of autophagy, namely macroautophagy, microautophagy 
and chaperone-mediated autophagy (CMA). Macroautophagy (referred as 
autophagy thereafter in this thesis) involves the formation of an omegasome and 
an isolation membrane that sequesters a small portion of the cytoplasm to form 
the double-membrane vesicles known as autophagosomes. This autophagosome 
then fuses with lysosome to form autolysosome for cellular degradation. 
Meanwhile, microautophagy takes place by the engulfment of components in 
cytoplasm through the inward invagination of the lysosomal membrane. In CMA, 
substrate proteins are stationed directly across the lysosomal membrane 
(Mizushima and Komatsu, 2011). The molecular machinery of autophagy will be 
discussed in detail below. 
1.1.2 Autophagic process and its machinery 
 Autophagy is a dynamic, catabolic process that is evolutionary conserved 
throughout the unicellular and multicellular eukaryotes (Lebovitz et al., 2012; 
Yang and Klionsky, 2010b). The most common stimulus of autophagy is nutrients 
starvation, such as amino acid starvation in mammalian cells and nitrogen 
starvation in yeasts as well as in plants (Mizushima, 2007). Meanwhile, 
3 
rapamycin and other mechanistic target of rapamycin complex (mTOR) kinase 
inhibitors have been used to upregulate autophagy under nutrient-rich conditions 
(Mizushima et al., 2011). The autophagy machinery studies was first discovered 
in yeasts Saccharomyces cerevisiae (Tsukada and Ohsumi, 1993). In mammalian 
cells, the mechanistic process of autophagy can be divided into four stages, which 
are i) induction, ii) nucleation, iii) elongation/expansion and finally, iv) 
maturation of the autophagosome to form autolysosome (Lebovitz et al., 2012). 
Figure 1.1 illustrates the autophagic process and its machinery. 
1.1.2.1 Induction 
The first significant event in autophagy is the induction or initiation of the 
membrane of an autophagosome to form the phagophore or isolation membrane. 
This double-membrane structure formed has the ability to grow and expand 
through selective engulfment of proteins and organelles while extending its 
membrane (Tooze and Yoshimori, 2010). Though it still remains interesting to 
study the origin of this membrane, recent evidence has proposed that endoplasmic 
reticulum (ER) (Hayashi-Nishino et al., 2009; Yla-Anttila et al., 2009) and 
mitochondria (Hailey et al., 2010) are the sources.  
The induction process is initiated by the activation of Unc-51-like kinases 
(ULK) complex, comprising of ULK1 and ULK2, Atg13, the scaffold focal 
adhesion kinase (FAK)-family-interacting protein of 200 kD (FIP200, also known 
as Retinoblastoma1-inducible coiled-coil 1, RB1CC1) and Atg101 (an Atg13-
binding protein) (Chen and Klionsky, 2011). ULK is the mammalian homolog of 




























(Mizushima et al., 2011). The major homolog of Atg1 could be ULK1 (Chan et 
al., 2007) as ULK2 could have a redundant function (Kundu et al., 2008; 
Mizushima et al., 2011).  
In contrast to yeasts’ Atg1 complex disassembly upon starvation, the 
ULK1-Atg13-FIP200-Atg101 complex is constitutively formed in the cytosol of 
mammalian cells but is inactivated by mTORC1 (Hosokawa et al., 2009; Jung et 
al., 2009). mTORC1 is a major cell regulator that will be described later in this 
chapter (please refer to Section 1.3). During nutrients availability, mTORC1 
phosphorylates ULK1, ULK2 as well as Atg13 and there is a direct interaction of 
raptor (a regulatory subunit of mTORC1) to ULK1 (Ganley et al., 2009; 
Hosokawa et al., 2009; Jung et al., 2009). Under starvation conditions, the 
mTORC1 is inactivated and dissociates from this complex, thereby leading to 
partial dephosphorylation and activation of the ULK1 complex (Hosokawa et al., 
2009). The activated ULK1 phosphorylates and thereby activates FIP200, causing 
a stable ULK1-Atg13-FIP200-Atg101 complex that initiates the induction of 
autophagy machinery (Ganley et al., 2009; Hosokawa et al., 2009; Jung et al., 
2009). The ULK complex is also additionally regulated by cAMP-dependent 
protein kinase A (Stephan et al., 2009) and the more recent discovery of 
adenosine monophosphate-activated protein kinase (AMPK) signaling (Egan et 
al., 2011; Kim et al., 2011; Lee et al., 2010c; Shang et al., 2011).  
1.1.2.2 Nucleation 
In autophagy, the activation of Class III phosphoinositide 3-kinases 
(PI3K) complex is the key positive regulator for the nucleation step of 
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autophagosome formation. In mammalian cells there are three classes of PI3K. 
Depending on substrate specificity preference and sequence homology, PI3Ks are 
categorised into respective three classes of class I, II and III that regulate diverse 
roles of cellular processes (Domin and Waterfield, 1997; Vanhaesebroeck et al., 
2012). Class I PI3K has substrate specificity to phosphatidylinositol-4,5-
bisphosphate (PtdIns(4,5)P2) to form PtdIns(3,4,5)P3, while Class II PI3K utilises 
PtdIns and PtdIns4P as a substrate to produce PtdIns(3,4)P2 and convert 
PtdIns(4,5)P2 to PtdIns(3,4,5)P3. Meanwhile, Class III PI3K (PI3KC3) contains 
the catalytic member human vacuolar protein sorting protein (hVps34) that 
specifically uses PtdIns as a substrate to generate PtdIns3P for nascent 
autophagosome formation (Mizushima et al., 2011; Vanhaesebroeck et al., 2010).  
The Class III PI3K complex includes hVps34, Beclin 1 (a homolog of 
yeast Atg6) (Furuya et al., 2005; Zeng et al., 2006), p150 (Petiot et al., 2000), 
Atg14-like protein (Atg14L or also known as Barkor) (Matsunaga et al., 2009; 
Zhong et al., 2009), ultraviolet irradiation resistance-associated gene (UVRAG) 
(Liang et al., 2008), Ambra1 (Fimia et al., 2007) and Bax-interacting factor 1 
(Bif-1) (Takahashi et al., 2007). There are two complexes formed for Class III 
PI3K that positively regulates autophagosome formation, which are i) Beclin 1-
Ambra1-Atg14L-p150-PI3KC3 or 2) UVRAG-Bif1-Beclin 1-p150-PI3KC3 
(Janku et al., 2011). In contrast, the RUN domain and cysteine-rich domain 
containing Beclin 1 interacting protein (Rubicon) interacts with UVRAG–Beclin 
1–hVps34–p150 complex to inhibit autophagosome maturation by reducing 
hVps34 activity (Matsunaga et al., 2009; Zhong et al., 2009).  
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Class I and III PI3K are known to play negative and positive roles of 
autophagy, respectively (Baehrecke, 2005). However, one recent report has 
shown that Class IA PI3K p110-beta subunit is a positive regulator of autophagy 
by affiliating with the autophagy-promoting Vps34–Vps15–Beclin 1–Atg14L 
complex to promote the generation of cellular PtdIns3P (Dou et al., 2010), which 
is required for the generation of autophagosome (Noda et al., 2010).  
In addition to the functions of PI3K, the Atg9-Atg2-Atg18 cycling 
complex is also thought to deliver lipids from source to growing autophagosome 
(Simonsen and Tooze, 2009). Atg9 is an interesting protein among all other Atgs 
proteins needed for autophagosome formation because it is the only known 
transmembrane protein that spans the membrane six times (Noda et al., 2000). 
However the functions of Atg9 has yet to be fully understood (Mizushima et al., 
2011). 
1.1.2.3 Elongation/expansion 
The isolation membrane extends to sequester the targeted cytosolic 
components and organelles and finally closes to form the structure termed as 
autophagosome (Tooze and Yoshimori, 2010). For the formation of 
autophagosome, the PtdIns3P-containing membranes recruit two distinct 
ubiquitin-like protein conjugation systems: 1) Atg12-Atg5-Atg16L system, and 2) 
the microtubule-associated protein light chain 3 (LC3, is the mammalian Atg8 
homolog)-phosphatidylethanolamine (PE) conjugation system. Atg7 and Atg10 
(which are ubiquitin-activating enzymes, E1- and E2-like enzymes, respectively) 
are required to catalyse the conjugation of Atg12 to Atg5. This Atg12-Atg5 
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conjugate then associates with Atg16L (E3-like ligase enzyme) through 
oligomerization to form a large multimeric Atg16L complex. On the other hand, 
Atg7 and another E2-like enzyme, Atg3 mediate the ubiquitin-like conjugation of 
LC3-I to membrane lipid, PE. Following this step, the lipidated form of LC3 
(termed as LC3-II) is generated (Mizushima et al., 2011). The LC3‐I is soluble 
and present in the cytosol, while LC3‐II is bound specifically to the membrane. 
LC3-II attaches to both faces of isolation membrane, but will be delipidated from 
the outer membrane to be recycled by Atg4, a cysteine protease that cleaves the 
C-terminus of LC3-II to generate cytosolic LC3-I with a C-terminal glycine 
residue (Mizushima et al., 2011). Meanwhile, the LC3-II in the inner membrane 
will be degraded together during the fusion of autophagosome to a late endosome 
or lysosome by lysosomal proteases (Kimura et al., 2009).  
1.1.2.4 Autophagosome maturation and degradation 
In the final stage of autophagy, autophagosome fuses with late endosome 
and lysosome to form autolysosome, a process involving rather complicated 
mechanisms and membrane trafficking proteins such as lysosomal-associated 
membrane protein 2 (LAMP2) (Fortunato et al., 2009) and the small GTPase Ras-
related GTP-binding protein 7A (RAB7A) (Jager et al., 2004). These proteins 
mediate the docking and fusion of autophagosomes with lysosomes to form 
autolysosomes (Jager et al., 2004). UVRAG is also involved in controlling 
autophagosome maturation by activating RAB7A (Liang et al., 2008).  
Presently, numerous studies have also been performed to uncover the 
mechanisms underlying the autophagosome maturation process. These studies 
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have defined other essential players such as the soluble N-ethylmaleimide-
sensitive factor attachment protein receptor (SNARE) proteins (Abeliovich et al., 
1999; Darsow et al., 1997; Fraldi et al., 2010; Ishihara et al., 2001; Moreau et al., 
2011; Nair et al., 2011), endosomal coatomer protein (COP) (Ishihara et al., 2001; 
Razi et al., 2009), endosomal sorting complex required for transport (ESCRT) III 
complex (Lee et al., 2007d; Rusten et al., 2007), homotypic fusion and vacuole 
protein sorting (HOPS) complex (Nickerson et al., 2009), and heat-shock protein 
70 (Hsp70) chaperone (Leu et al., 2009).  
More recently, the discovery of histone deacetylase 6 (HDAC6) (Lee et 
al., 2010d), ornithine aminotransferase-like 1 (OATL1) (Itoh et al., 2011) and 
tectonin beta-propeller repeat containing 1 (TECPR1) (Chen et al., 2012) has 
contributed more in understanding the underlying mechanism involving the fusion 
between autophagosome and lysosome.  
1.1.3 Biological functions of autophagy  
Notably, autophagy essentially plays numerous functional roles for 
maintaining proper cellular functions, such as in energy recycling for cell survival 
and in cellular degradation (Mizushima, 2007). However, autophagy regulation 
seems to be rather complex, as it may be beneficial to the cells as well as 
detrimental, such that observed in cancer development, which will be discussed in 
the following section. The roles of autophagy in cell survival and cell death will 
be further discussed in Section 1.2 in this chapter. 
1.1.3.1 Autophagy in maintaining energy homeostasis  
Notably, the pro-survival function of autophagy has been observed in 
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numerous models. One important pro-survival role of autophagy is through the 
recycling of cellular products components to continuously maintain the amino 
acid level. This is especially important during starvation as an adaptive response 
to support the survival of cells under stressed conditions (Mizushima, 2007). 
Autophagy is required for survival, at least in maintaining the amino acid pool as 
knockout of Atg3 (Sou et al., 2008), Atg5 (Kuma et al., 2004), and Atg7 (Komatsu 
et al., 2005) in mice ensues in neonatal lethality. Previously, it has also been 
shown that autophagy is essential to maintain survival during starvation 
conditions in Saccharomyces cerevisiae (Tsukada and Ohsumi, 1993), 
Dictyostelium discoideum (Otto et al., 2003), Drosophila melanogaster (Scott et 
al., 2004), Caenorhabditis elegans (Kang et al., 2007), Spodoptera litura (Wu et 
al., 2011), zebrafish (Yabu et al., 2012) and also in plants (Honig et al., 2012). 
Through the tricarboxylic acid (TCA) cycle, amino acids can be utilised as an 
energy source (Newsholme et al., 1985).  
Autophagy is also found to be involved in regulating other types of 
nutrients such as lipids. Lipophagy, a process for the degradation of liver lipid 
droplets by autophagy, contributes to the production of free fatty acids that are 
oxidised in the mitochondria (Singh et al., 2009). This relatively new type of 
autophagy, named as macrolipophagy, is constitutively active at basal levels in 
most cell types that functions in controlling the size and number of lipid droplets 
under basal conditions (Cuervo and Macian, 2012; Singh et al., 2009). During 
conditions such as energy scarcity or to prevent mass accumulation of lipids, 
macrolipophagy is activated (Singh et al., 2009). It is interesting to note that the 
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stimulatory effects of lipids such as free fatty acids (FFA) on autophagy in the 
hypothalamic neurons triggers the secretion of agouti-related peptide (AgRP) to 
elicit restoration of cellular energetic balance (Kaushik et al., 2011).  
In addition to amino acids and lipids, studies have showed that autophagy 
is also essential in glycogen breakdown to maintain cellular energy levels 
(Kotoulas et al., 2006; Raben et al., 2008). Nevertheless, the contributions of 
autophagy in glucose production as compared to the extent of the classical 
cytosolic degradation of glycogen will require more investigations. 
1.1.3.2 Autophagy in cellular degradation 
Autophagy is a constitutively active process that functions at low levels 
under cell basal conditions (Mizushima and Komatsu, 2011). Autophagy clears 
unwanted proteins and cellular organelles to maintain the quality and condition of 
cells through the constitutive turnover of cytoplasmic contents (Mizushima, 
2007). Basal autophagy is essential to maintain the tissue and cellular 
homeostasis. For examples, hepatomegaly and hepatic failure were seen in liver 
specific Atg7
-/-
 mice (Komatsu et al., 2005) while neurodegeneration along with 
progressive motor deficits were observed in neural cell-specific Atg5 and Atg7 
knockout mice (Hara et al., 2006; Komatsu et al., 2006). However, it is possible 
that only a small amount of autophagy is adequate for quality control as induced 
autophagy is not observed in the brain during starvation (Mizushima et al., 2004; 
Nixon et al., 2005).  
Multiple health complications have been linked to defects in cellular 
degradation processes. Most neurodegenerative diseases are characterised by the 
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formation of protein inclusions inside neurons. One important example is 
neurodegenerative diseases, as an incremental amount of autophagic vacuoles and 
protein aggregates have been demonstrated in Alzheimer’s diseases (Lee et al., 
2010b; Nixon et al., 2008), Parkinson’s disease (Anglade et al., 1997), 
amyotrophic lateral sclerosis (Kabuta et al., 2006), and Huntington’s disease 
(Petersen et al., 2001; Ravikumar et al., 2002). More recently, in an axotomy 
model, autophagy is also seen to be cytoprotective in retinal ganglion cells as 
autophagy increases the number of surviving cell (Rodriguez-Muela et al., 2012). 
Meanwhile, unnecessary organelles such as peroxisomes is selectively degraded 
through microautophagy in yeasts (Sakai et al., 1998) and macroautophagy in 
mammals (Iwata et al., 2006); as well as mitochondrial degradation through 
mitophagy (Kim et al., 2007a). Recently, in C. elegans, paternal mitochondria are 
found to be degraded by fertilization-induced autophagy (Al Rawi et al., 2011; 
Sato and Sato, 2011). Autophagy is also implicated in cardiomyopathy (Kashio et 
al., 1991) and metabolic diseases such as diabetes and obesity as reviewed 
recently (Rubinsztein et al., 2012). 
In addition, the selective degradation is also mediated by autophagy. 
Interactions of cellular cargos with a molecular tag (for example polyubiquitin), 
adaptor proteins [such as p62 and neighbour of breast cancer 1 (BRCA1) gene 1, 
(NBR1)] and LC3 further target them to autophagosomes (Levine et al., 2011). 
Both p62 and NBR1 proteins have been identified as a LC3-interacting proteins, 
depending on LC3-interacting region (LIR) and ubiquitin-binding protein that are 
selectively trapped by LC3 and degraded in the autophagosome (Bjorkoy et al., 
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2005; Komatsu et al., 2007; Lamark et al., 2009; Pankiv et al., 2007). A long term 
inhibition of autophagy causes p62 and NBR1 accumulation and subsequently 
compromises the ubiquitin-proteasome degradation system (Korolchuk et al., 
2009; Lamark et al., 2009).  
Autophagy also removes damaged organelles, including mitochondria and 
ER. Mitophagy, a process whereby the mitochondria is selectively removed by 
autophagy during the loss of mitochondrial potential (Wang and Klionsky, 2011). 
For example, specific autophagy receptor such as Bcl-2/adenovirus E1B 19 kD 
protein-interacting protein 3-like (BNIP3L or also known as Nix) mediates 
mitochondria elimination during reticulocyte maturation (Schweers et al., 2007). 
The ubiquitination process is also important for organelle removal, such as those 
conferred by Parkin, an E3 ubiquitin ligase. Parkin localizes at depolarised 
mitochondria to induce mitophagy, along with phosphatase and tensin homolog 
(PTEN)-induced putative kinase 1 (PINK1) (Kim et al., 2008b; Vives-Bauza et 
al., 2010). Interestingly, PINK1 also interacts with Beclin 1 under basal and 
starvation conditions to promote autophagy (Michiorri et al., 2010).  
1.1.3.3 Autophagy in cancer  
While the involvement of autophagy in cancer has been extensively 
studied, its exact role in cancer development remains to be fully elucidated. The 
common understanding is that autophagy plays a dual role in cancer: autophagy 
favors a tumour suppressive role in the early stage of carcinogenesis, while it also 
protects cells during cellular and metabolic stress that favors tumour progression 
(Mathew et al., 2007). Autophagy acts as an intracellular cell quality controller 
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that prevents malignant transformation and cancer initiation, while paradoxically, 
its pro-survival role during stressed conditions enables the established tumours to 
adapt and survive (Mathew et al., 2007). Thus, the development of cancer 
involves a complicated processes with multiple stages (Hanahan and Weinberg, 
2011). Moreover, in part of its dual role in cancer, the strategy for modulating 
autophagy in cancer treatments increases in its complexity (Dalby et al., 2010). 
Figure 1.2 briefly illustrates the roles of autophagy in tumourigenesis. 
 
 
Figure 1.2 Autophagy has multiple roles in tumourigenesis, depending on the 
different stages of tumour development. Adapted from Liu and Ryan (2012).  
 
Previously, it has been suggested that in the early stages of tumour 
development, cancer cells undergo a higher rate of protein synthesis than protein 
degradation (Cuervo, 2004; Kondo et al., 2005). Several oncogenes have been 
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reported to inhibit autophagy especially through mTOR activation (Maiuri et al., 
2009), in agreement with the hypothesis that catabolic processes are often 
suppressed in tumours to support cell mass production. Moreover, autophagy 
reduced the mutation rate and restrains oncogenesis through the elimination of 
damaged organelles that produce genotoxic stresses, such as free radicals 
(Edinger and Thompson, 2003; Kondo et al., 2005). Therefore, defective 
autophagy during early stages of cancer formation supports tumour growth 
through increased rate of protein synthesis and genotoxic stresses (Kondo et al., 
2005).  
The initial evidence that linked tumour suppression to autophagy comes 
from the deletion of Beclin 1 in various breast cancer cell lines (Aita et al., 1999). 
Meanwhile, re-expressing Beclin 1 protein restores autophagy and represses 
tumourigenesis in human MCF7 breast carcinoma cells (Liang et al., 1999). 
Notably, Beclin 1 knockout mice died early during embryogenesis (Yue et al., 
2003), while the autophagy defective heterozygous Beclin 1-deficient mice 
develop higher incidence of lymphoma, hepatocellular carcinoma and lung cancer 
(Qu et al., 2003; Yue et al., 2003). In addition, autophagy defective mice with 
systemic mosaic deletion of Atg5 and liver-specific Atg7 deficient mice develop 
benign liver adenomas (Takamura et al., 2011). These suggest that autophagy is 
important in suppressing tumour growth, at least at the early stage of tumour 
growth (Kondo et al., 2005). Moreover, impaired autophagy regulation in 
apoptosis-defective tumours stimulates angiogenesis, necrotic cell death and 
inflammation in promoting tumour growth (Degenhardt et al., 2006).  
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Mounting evidence has also indicated that autophagy is required for 
tumour progression, such as seen in pancreatic cancer cells (Yang et al., 2011) 
and Ras-expressing cell lines (Guo et al., 2011). Despite the suppression of 
autophagy in the early stage of tumour growth, autophagy seemed to be 
upregulated in the later stages of tumour development to protect cells (Kondo et 
al., 2005). During cancer advancement, cells have to survive in limited nutrients 
and oxygen (hypoxia) conditions as blood supply is reduced due to poor 
vasculature (Hockel and Vaupel, 2001; Ogier-Denis and Codogno, 2003; Shankar 
et al., 1996). These results in metabolic stress in cancer cells and subsequently 
activate autophagy (Shay and Celeste Simon, 2012). This is in line with 
autophagy’s pro-survival role in sustaining cells that are deprived of serum, amino 
acids or growth factors (Boya et al., 2005; Lum et al., 2005). For example, one 
early study on human colon cancer cells found that these cells are able to sustain 
under nutrients scarcity and also have high autophagy levels (Houri et al., 1995). 
Moreover, specific lines of tumour cells are also found to be unusually tolerant to 
nutrients deprivation (Izuishi et al., 2000). 
Under limited oxygen supply, hypoxia is able to activate autophagy 
through hypoxia-inducible factor-1 α (HIF1α)-independent effects (DeYoung et 
al., 2008). The activated HIF1α induces ER stress, and subsequently activated 
autophagy eliminates excess ER and reduce mitochondrial mass for adaptations to 
hypoxic conditions (Glick et al., 2010; Janku et al., 2011). Also, autophagy is able 
to protect cells from anoikis upon detachment from the extracellular matrix, 
suggesting a possible role of autophagy in metastasis and in supporting tumour 
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progression (Fung et al., 2008). Moreover, autophagy level is elevated in many 
solid-tumours (Mathew et al., 2009), highlighting the importance of autophagy as 
a pro-survival strategy for cells. In support of this hypothesis, the poor outcome of 
radiation therapy or chemotherapy-resistance of tumour cells is usually linked to 
elevated level of autophagy. For example, chemotherapy-induced cytotoxicity that 
activates autophagy releases high-mobility group box 1 (HMGB1), which confers 
for the resistance of leukemia cell lines to chemotherapy (Liu et al., 2011). 
1.1.3.4 Autophagy in immunity 
Remarkably, selective autophagy is an essential defensive system against 
microorganisms via selective delivery of microorganisms to degradative 
lysosomes (known as xenophagy) or delivery of foreign materials of the microbes 
such as nucleic acids and antigens to endolysosomal compartments for the 
activation of innate and adaptive immunity (Levine et al., 2011). The p62 and 
ubiquitin mechanisms are utilised to selectively remove infections by intracellular 
bacteria such as Salmonella typhimurium (Zheng et al., 2009) and Listeria 
monocytogenes to autophagosomes (Yoshikawa et al., 2009). Autophagy is also 
utilised during human immunodeficiency virus (HIV) replication (Killian, 2012), 
implicating a significant therapeutic benefit against microorganisms invasion. The 
HIV protein Nef interacts with Beclin 1 to inhibit autophagosome maturation, 
which subsequently protects HIV from degradation (Kyei et al., 2009). Moreover, 
the ICP34.5, a herpes simplex virus type 1 (HSV-1)-encoded neurovirulence 
protein, binds to Beclin 1 to inhibit its autophagy function during immune 
invasion (Orvedahl et al., 2007). The Toll-like receptors (TLR) and nucleotide 
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oligomerization domain (NOD)-like receptors (NLR) are also involved in the 
regulation of autophagy process, in addition to their mediation of pro-
inflammatory cytokine production (Shi and Kehrl, 2008; Travassos et al., 2010). 
Moreover, other immune system signals such as T helper 1 (Th1) cytokines 
interferon (IFN)-γ and tumour necrosis factor-α (TNFα) as well as CD40 
signaling stimulates autophagy, while Th2 cytokines such as interleukin (IL)-4 
and IL-13 inhibit autophagy (Harris et al., 2007).  
Autophagy is also involved in mediating adaptive immunity. For example, 
it is essential in regulating the survival and differentiation of T-and B-cells as well 
as in Paneth cell homeostasis (Bell et al., 2008; Cadwell et al., 2008; Miller et al., 
2008; Pua et al., 2009). Autophagy also helps to coordinate in the antigen 
presentation of major histocompatibility complex (MHC) class I and class II 
during infections by foreign particles (Crotzer and Blum, 2010; English et al., 
2009; Lee et al., 2010a). Meanwhile, autophagy facilitates the delivery of 
cytoplasmic viral nucleic acids to endosomal TLR to stimulate the production of 
type 1 IFN and IFN-dependent immune responses (Lee et al., 2007c). 
Furthermore, immunization in cells induced with autophagy enhances the 
competency of cross-priming in antigen-specific CD8
+
 T cells (Uhl et al., 2009). 
In addition, autophagy is also crucial in the modulation of self-tolerance and 
specific T-cell selection (Nedjic et al., 2008).  
1.1.3.5 Autophagy in differentiation and development 
Autophagy also plays an essential role in cellular differentiation and 
development, enabling extensive cellular and tissue remodeling through 
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degradation process (Mizushima and Levine, 2010). Earlier studies have shown 
that autophagy is required for spores formation in starved yeasts (Tsukada and 
Ohsumi, 1993) and dauer formation in Caenorhabditis elegans during starvation 
(Melendez et al., 2003); chick retina development (Mellen et al., 2008), clearance 
of apoptotic cells in embryonic development (Qu et al., 2007), Leishmania major 
differentiation (Besteiro et al., 2007), proliferation and differentiation in intestinal 
protozoan parasite (Picazarri et al., 2008), and also recently through GATA-1, the 
main regulator of hematopoiesis that directly activates gene transcription of LC3 
(Kang et al., 2012) as well as in encystations of Acanthamoeba castellanii (Song 
et al., 2012). Moreover, autophagy also plays a major role of differentiation and 
development in liver, brain, intestines, heart, lung, skeletal muscle, kidney, 
pancreas, and bone as reviewed recently (Mizushima and Komatsu, 2011). 
1.1.3.6 Autophagy and ageing  
As autophagy is able to renew cells, therefore its ability to prevent ageing 
and promote longer lifespan is much correlated. At present, numerous reports 
have showed the anti-ageing effects by TOR suppression (Lamming et al., 2012; 
Powers et al., 2006; Tatar et al., 2003; Vellai et al., 2003), calorie restriction, 
activation of sirtuin (Bordone and Guarente, 2005; Yuan et al., 2012), or 
reduction of insulin-receptor pathway (Lewis et al., 2010). In agreement that 
autophagy slows down ageing process, a reduction of formation and elimination 
of autophagosomes is often seen in ageing cells (Terman, 1995). Therefore, 
declining autophagy level increases the accumulation of detrimental protein 
aggregates and impaired organelles, resulting in an increase of reactive oxygen 
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species (ROS), incremental risks in DNA mutations as well as weakened 
biological processes that lead to disrupted autophagic processes and finally 
promote ageing (Cuervo et al., 2005). 
It is interesting to learn that autophagy plays numerous roles in the 
physiological state, including cell death, in which will be discussed shortly. Thus, 
autophagy can be modulated in response to various conditions seen in diseased 
states such as starvation, hypoxia or other types of metabolic stress (Wilkinson 
and Ryan, 2010) and serves as an important target for numerous therapeutic 
benefits.  
1.2 Cell death 
Cell death was first observed as early as in 1842 (Vogt, 1842), forgotten 
but subsequently revived by a review written by Glucksmann in 1951 
(Glucksmann, 1951). The “programmed cell death” (PCD) is the most common 
term used in the study of cell death (Vaux, 2002), and was first coined by 
Lockshin and Williams (1965) to study developmental cell death in insects. 
Thereafter, cell death is recognised an important mechanism to remove damaged, 
unhealthy and unneeded cells to regulate normal physiological developments, 
tissue homeostasis, and acts as a defense system against immunity, inflammation 
and tumourigenesis (Fuchs and Steller, 2011; Takeda et al., 2007). There are three 
types of cell death, which are apoptosis, necrosis and autophagic cell death 
(Clarke, 1990), which will be discussed in more details below. 
1.2.1 Apoptosis 
Apoptosis (also known as type I cell death) was first termed by Kerr et al., 
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(1972) to morphologically define this form of cell death. Apoptosis is 
characterised by the shrinkage of cell, nuclear condensation and fragmentation, 
followed by engulfment of nearby phagocytes (Kerr et al., 1972). In addition, the 
presence of phosphatidylserine residues on the outer plasma membrane (Martin et 
al., 1995) and activation of caspases (Villa et al., 1997) also serve as the hall 
marks of apoptosis. Apoptosis occurs either through extrinsic or intrinsic 
mitochondrial pathway, in which death executing signals involves the activation 
of cell surface receptors by an extracellular death signal or through death signals 
that arise within the cell, respectively (D'Amelio et al., 2010; Krammer et al., 
2007). The Cysteinyl ASPartate-specific proteASE (caspases) are cysteine 
proteases synthesised in cells as inactive zymogens that cleave target substrates at 
specific sites of aspartate residues to inactivate pro-survival proteins and to trigger 
apoptosis (D'Amelio et al., 2010; Shi, 2004; Venderova and Park, 2012). 
Therefore, activation of caspase is often used as an apoptosis marker (Venderova 
and Park, 2012). Caspases are divided into two types; one being the apoptosis-
initiator caspases comprising caspase -8 and -9, while the other is the executioner 
caspases, which are of caspase-3,-6 and -7. Inactive initiator caspase monomers 
are activated with dimerization formation while executioner caspases exists in 
inactive dimers. Executioner caspases are activated after cleavage by initiator 
caspases to form enzymatically active dimers (Tait and Green, 2010). Figure 1.3 
describes the regulation of both intrinsic and extrinsic apoptosis. 
Extrinsic pathway is triggered by the binding of death ligands to specific 
trimeric cell surface receptors named as death receptors. For example, tumour  
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Figure 1.3 Intrinsic and extrinsic apoptosis (Tait and Green, 2010).  
 
necrosis factor (TNF) α (TNFα), TNF (ligand) superfamily member 10 
(TNFSF10) or also known as TNF-related apoptosis inducing ligand, TRAIL), 
FAS/CD95 ligand (FASL/CD95L) bind to respective death receptors such as 
TNFα receptor 1 (TNFR1), TRAIL receptor (TRAILR) 1 and 2, and FAS/CD95 
(Galluzzi et al., 2012). Following receptor trimerization and the clustering of 
intracellular cytoplasmic death domains, numerous adaptor molecules will then be 
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recruited to form the death-inducing signaling complex (DISC) (Fulda and 
Debatin, 2006; Long and Ryan, 2012). In the Fas, TRAILR1 and TRAILR2 
pathways, FAS-associated death domain (FADD) and procaspase-8 are associated 
with the DISC. Meanwhile, the DISC downstream of TNFR1 signaling includes 
additional molecules comprising TNFR-associated death domain (TRADD) and 
TNFR-associated factor 2 (TRAF2) (Fulda and Debatin, 2006; Long and Ryan, 
2012). Subsequently, the formation of DISC leads to caspase-8 oligomerization 
and activation followed by death signals that are induced through a series of 
effector caspases-3, -6 and/or -7 cascade or through mitochondrial outer 
membrane permeabilization (MOMP) pathway (Long and Ryan, 2012). Upon 
MOMP, the release of various proteins from the mitochondrial intermembrane 
space (IMS) subsequently promote caspase activation and apoptosis (Tait and 
Green, 2010). Meanwhile, the release of second mitochondria-derived activator of 
caspase (SMAC; also known as DIABLO) and Omi (also known as HTRA2) from 
the mitochondria neutralizes the caspase inhibitory function of X-linked inhibitor 
of apoptosis protein (XIAP) (Tait and Green, 2010). 
Intracellular stress conditions such as oxidative stress, DNA damage, 
excessive cytosolic Ca
2+
 and ER stress are able to trigger intrinsic apoptotic 
pathway (Galluzzi et al., 2012). These stress stimulates MOMP to cause leakage 
of mitochondrial proteins through i) irreversible loss of mitochondrial 
transmembrane potential with cessation of ATP production in mitochondria, ii) 
toxic protein discharge from mitochondria IMS into the cytosol and iii) inhibition 
of respiratory chain. Intrinsic pathway has been recently reviewed to be 
24 
differentiated into two subgroups, which are caspase-dependent and caspase-
independent intrinsic apoptosis based on the magnitude of cytoprotection due to 
caspase inhibition (Galluzzi et al., 2012). Subsequent to stimulated mitochondrial 
outer membrane permeabilization (MOMP), cytochrome c (cyt c) released from 
the mitochondria will promote apoptosis protease-activating factor-1 (APAF-1) 
and ATP/dATP to assemble the apoptosome that aids the proteolytic maturation 
of caspase-9 from procaspase-9. Mature caspase-9 remains associated to 
apoptosome while involved in recruiting and activating executioner caspase-3 
and/or caspase-7. Both extrinsic and intrinsic signaling converge at caspase-3 and 
together with other effector caspases (for example, caspase-7 and caspase-6), to 
cleave specific substrates and eventually cell death (D'Amelio et al., 2010).  
1.2.1.1 Autophagy and apoptosis 
 At present, the role of autophagy and apoptosis seemed complex, as it is 
generally known for its pro-survival role, while paradoxically, it also able to 
mediate apoptosis under certain circumstances. For example, the critical pro-
survival role of autophagy has been demonstrated in various studies that utilize 
Atg-knockout mice including mice deficient of Atg3, Atg5, Atg7, Atg9 and 
Atg16L. These mice, which are defective in autophagy, subsequently die on the 
day one of birth due to starvation despite the normal appearance at birth (Komatsu 
et al., 2005; Kuma et al., 2004; Saitoh et al., 2009; Saitoh et al., 2008; Sou et al., 
2008). Moreover, mice of neuron-specific Atg5 or Atg7 knockouts suffer from 
apoptotic neuronal deaths as well as neurodegeneration, while T-cell specific of 
Atg5 deficiency observes an increase apoptosis in peripheral T-cells during T-cell 
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activation (Hara et al., 2006; Komatsu et al., 2006; Pua et al., 2009). 
Despite the much understood role of autophagy in protecting cell death, 
the pro-death function of autophagy has also been implicated in several studies. 
For example, the overexpression of Atg1 lead to high levels of autophagy and 
caspase-dependent cell death in Drasophila (Scott et al., 2007). Moreover, during 
Drasophila development, autophagy contributes to cell death in several different 
tissues types including salivary gland, midgut, and in reproductive cells (Berry 
and Baehrecke, 2007; Denton et al., 2009; Hou et al., 2008; Nezis et al., 2010). 
Also, in a model of HIV infection, HIV-1 envelope glycoproteins-mediated 
autophagy is required to trigger CD4
+
 T cell apoptosis in which apoptosis was 
blocked when autophagy was inhibited (Espert et al., 2006). 
The pro-death function of autophagy in apoptosis seemed to be regulated 
by Atg genes. For example, fragments of typical Atg proteins formed from 
proteolytic cleavage such as truncated Atg5, Atg4D and Beclin 1 are found to 
localize at mitochondria to trigger the release of pro-apoptotic factors from 
mitochondria and subsequently stimulate apoptosis (Betin and Lane, 2009; 
Wirawan et al., 2010; Yousefi et al., 2006). Moreover, Atg5 binds to FADD to 
trigger IFN-γ-induced cell death (Pyo et al., 2005) while Atg7 participates in 
lysosome-dysfunction-induced apoptosis in neural cells (Walls et al., 2010). In 
addition, Beclin 1 enhances apoptosis in response to obatoclax, a Bcl-2 inhibitor 
while in the same study; Atg5 downregulation reduces cell death, despite the 
unaltered appearance of cleaved caspase-3 (Heidari et al., 2010). The conjugation 
of Atg12-Atg3 could also sensitize cells downstream of mitochondrial signaling 
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(Radoshevich et al., 2010).  
In the crosstalk between apoptosis and autophagy, the interaction of the 
proteins involved in these two signaling phenomena is crucial in determining the 
final cell fate. For example, Bcl-2 and B-cell lymphoma-extra large (Bcl-xL), are 
members of the anti-apoptotic Bcl-2 family that inhibit the autophagic activity by 
binding to Beclin 1 via the Bcl-2 homology (BH)-3 domain of Beclin 1 (Levine et 
al., 2008; Liang et al., 1998). However, the binding of Beclin 1 to Bcl-2 does not 
affect the anti-apoptotic role of Bcl-2 (Ciechomska et al., 2009). Meanwhile, the 
interaction of Ambra1 with Bcl-2 at the mitochondria is also able to inhibit 
autophagy by preventing Ambra1 from enhancing Beclin 1 activity (Strappazzon 
et al., 2011). Also, FLICE-inhibitory protein (FLIP) is able to suppress autophagy 
via binding to Atg3 and thus attenuate LC3 lipidation (Lee et al., 2009). 
In contrast to the earlier studies, pro-apoptotic proteins seem to stimulate 
autophagy as well. For example, several BH3-only proteins such as Bcl-2-
associated death promoter protein (Bad), truncated BH3 interacting domain death 
agonist (tBid), and BNIP3 compete with Beclin 1 for Bcl-2 binding, and thus 
abolish the Bcl-2-Beclin 1 interaction (Lamparska-Przybysz et al., 2005; Luo and 
Rubinsztein, 2010; Mazure and Pouyssegur, 2009). In addition, the 
phosphorylation by death-associated protein kinase (DAPk) promotes Beclin 1 
release from binding to Bcl-xL (Zalckvar et al., 2009) as well as c-Jun N-terminal 
kinase (JNK) phosphorylation of Bcl-2 to relief the sequestered Beclin 1 from 
Bcl-2 protein (Wei et al., 2008). It is also interesting to note that caspases, such as 
caspase-9, promotes autophagic flux possibly by regulating lysosomal pH and 
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cathepsin activity (Jeong et al., 2011).  
Meanwhile, other apoptotic proteins seem to stimulate autophagy as well. 
For example, several BH3-only proteins such as Bcl-2-associated death promoter 
protein (Bad), truncated BH3 interacting domain death agonist (tBid), and BNIP3 
compete with Beclin 1 for Bcl-2 binding, and thus abolish the Bcl-2-Beclin 1 
interaction (Lamparska-Przybysz et al., 2005; Luo and Rubinsztein, 2010; Mazure 
and Pouyssegur, 2009). In addition, the phosphorylation by death-associated 
protein kinase (DAPk) promotes Beclin 1 release from binding to Bcl-xL 
(Zalckvar et al., 2009) as well as c-Jun N-terminal kinase (JNK) phosphorylation 
of Bcl-2 to relief the sequestered Beclin 1 from Bcl-2 protein (Wei et al., 2008). 
Another interesting finding is the involvements of p53 in apoptosis and 
autophagy, as p53 is a well-known pro-apoptotic tumour suppressor and its 
contrasting roles in autophagy. The cytoplasmic p53 suppresses autophagy 
possibly through ER stress signaling, as inactivation of inositol requiring 1α 
(IRE1α) prevents the activation of autophagy following p53 neutralisation 
(Tasdemir et al., 2008). Meanwhile, nuclear p53 stimulates autophagy through the 
transactivation of damage-regulated autophagy modulator (DRAM), a p53 target 
gene that is activated during DNA damage and is involved in encoding lysosomal 
protein (Crighton et al., 2006). Moreover, p53 has additional role in inhibiting 
mTORC1 through AMPK signaling (Feng et al., 2005), which subsequently 
induces autophagy. On the other hand, the p62 protein is also implicated in the 
regulation of autophagy and apoptosis. Cullin3 (CUL3), an E3 ligase, initially 
mediates the polyubiquitination of caspase-8. Subsequently, p62 promotes the 
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aggregation of CUL3-modified caspase-8 within p62-dependent foci to enhance 
apoptosis (Jin et al., 2009).  
1.2.2 Necrosis 
Necrosis (also known as type III cell death) was earlier known as a form 
of unregulated, accidental cell death that do not resemble the morphological traits 
of either apoptosis or autophagy, before known lately that it is also a regulated 
process of death (Galluzzi et al., 2012). Necrosis is also described as an “ordered 
cellular explosion”, which is morphologically characterised by an early onset of 
plasma membrane permeabilisation, swelling and the final rupture of the cells will 
causes the release of intracellular structures to the surroundings. In contrast to 
apoptotic cells, the nuclei of necrotic cells remain intact (Vandenabeele et al., 
2010). This process can be stimulated by alkylating DNA damage agents, 
excitotoxins, ligation of death receptors and caspase inhibition (Cho et al., 2009; 
Galluzzi et al., 2012; He et al., 2009; Zhang et al., 2009a).  
Receptor interacting protein kinase-1 (RIP1) and -3 (RIP3) interactions are 
known to be critical regulators of necrosis in which RIP3 is recruited to RIP1, 
thus forming a complex for induction of necrotic cell death (Cho et al., 2009; He 
et al., 2009; Zhang et al., 2009a). More recently, the understanding of 
programmed necrosis regulation has improved tremendously since the discovery 
of necrostatin-1 as a potent inhibitor for necroptosis, a term used specifically for 
programmed necrosis (Degterev et al., 2005). Figure 1.4 describes the necroptosis 
signaling. Meanwhile, another form of necrotic cell death that is much being in 
focus recently is the poly-(ADP-ribose) polymerase (PARP)-mediated cell death.
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Figure 1.4 The necroptosis signaling (Han et al., 2011). 
 
The TNFR1 is a receptor that regulates cell survival, inflammation, 
apoptosis and necrosis depending on the subsequent downstream signals 
coordination. Bound TNF causes TNFR1 to undergo conformational changes that 
enable the recruitments of numerous signaling molecules such as TRADD, 
TRAF2, cellular inhibitor of apoptosis 1 (cIAP1), and RIP1 to form a complex 
termed as complex I, in which RIP1 is heavily ubiquitinated by E3 ligases at 
lysine63-linked polyubiquitination (Lys63-Ub) by cIAP ligases. This complex 
formation is responsible for nuclear factor kappa B (NF-κB) activation for cell 
survival (Chan and Baehrecke, 2012) and mitogen-activated protein kinases 
(MAPK) (Han et al., 2011). TRAF5 is also involved in interacting with TRAF2 to 
mediate the downstream NF-κB activation (Aizawa et al., 1997). Deubiquitination 
of RIP1 by cylindromatosis (CYLD) or inhibition of cIAP proteins promotes the 
conversion of complex I to complex II and inhibits NF-κB activation (Han et al., 
2011; Wright et al., 2007). Uninhibited and active caspase-8 will mediate the 
cleavage of RIP1 and RIP3 to generate caspase cascade and apoptosis (Lin et al., 
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1999). Meanwhile, in the presence of cellular form of the caspase-8 inhibitor 
FLIP (cFLIP)-long form (cFLIPL), the activity of caspase-8 is inhibited, thus 
promoting RIP1 and RIP3 interaction to form necrosome (also known as complex 
Iib) (Han et al., 2011). In the event of caspase-8 inactivation, FADD or caspase-8 
depletion, or induction of RIP3 signaling, the inhibition on RIP1-RIP3 is freed to 
form necrosome and subsequently induces necroptosis in TNF-treated cells (Han 
et al., 2011). 
More recently, the identification of additional complexes involved in the 
regulation of necroptosis has shed more light into this area. For example, upon 
necroptosis induction by TNFα and ROS, the mitochondrial protein phosphatase 
phosphoglycerate mutase 5 (PGAM5) is responsible for activating the GTPase 
activity of the mitochondrial fission factor dynamin-related protein 1 (Drp1) to 
cause mitochondrial fragmentation, which is an essential step for necrosis 
induction (Wang et al., 2012). In addition, an adaptor protein Toll/IL-1 receptor 
domain-containing adaptor inducing IFN-β (TRIF/TICAM-1) forms a complex 
with RIP3 upon TLR3/TLR4 activation as it is required for TLR3/TLR4-induced 
necrosis in innate immunity, indicating an important role of programmed necrosis 
during microbial invasion in mammals (He et al., 2011). Moreover, RIP3 is also 
found to phosphorylate mixed lineage kinase domain-like (MLKL) protein, in 
which the phosphorylations are critical for downstream RIP3 regulation in 
necrosis (Sun et al., 2012). 
Meanwhile, the PARP-mediated necrosis is another form of necrotic cell 
death that is activated during DNA damage, due to DNA strand breaks in 
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response to oxidative stress/ROS or DNA-damaging agent such as DNA 
alkylating agents (Zong et al., 2004). PARP consists of a family of nuclear 
enzymes that regulate chromatin structure, transcription, and gene transcription, 
which are controlled through poly(ADP-ribosyl)ation (Jagtap and Szabo, 2005; 
Krishnakumar and Kraus, 2010; Shen and Codogno, 2012). The necrotic cell 
death is triggered by PARP in the event of DNA damage; causing rapid ATP 
depletion, translocation of apoptosis-inducing factor (AIF) from mitochondria to 
the nucleus and eventually, necrosis (Ha and Snyder, 1999; Yu et al., 2002). 
The discovery of necroptosis as an additional or alternate programmed 
pathway in cell death is particularly significant as it can possibly be linked to 
tumour suppression; as necrosis is often observed in chemotherapy treatments and 
apoptosis-deficient tumour cells (Long and Ryan, 2012). 
1.2.2.1 Autophagy and necrosis 
 Similarly to apoptosis, the regulation of autophagy in necrosis seems to be 
rather complex as well. The pro-survival and pro-death roles of autophagy are 
also associated with necroptosis. Firstly, autophagy protects apoptosis-deficient 
cells from necrotic cell death following ischemia (Degenhardt et al., 2006). In the 
event of autophagy impairment in apoptosis-deficient cells, necrotic cell death 
ensues and necrotic inflammation and tumour growth are upregulated 
(Degenhardt et al., 2006). Also, autophagy is able to inhibit necroptosis in various 
cell lines, such as in L929 cells or human cancer cells that are stimulated with 
TNFα or starvation (Farkas et al., 2011; Ye et al., 2011).   
 In contrast, autophagy-dependent necroptosis characteristics are observed 
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in acute lymphoblastic leukemia cells when the cells are stimulated with a 
combination of glucocorticoid dexamethasone and rapamycin, indicating that in 
such system, autophagy promotes necroptosis (Bonapace et al., 2010). Moreover, 
in C. elegans, the inactivation of Atg genes seems to reduce necrotic cell death 
(Samara et al., 2008). Meanwhile, the role of pan-caspase inhibitors such as 
zVAD-fmk (zVAD) in inducing necroptosis or autophagic cell death in L929 cells 
has been controversial (Wu et al., 2009; Yu et al., 2004). In fact, zVAD is found 
to trigger necroptosis in the L929 cells, which are deficient in apoptotic 
machinery due to the suppression of autophagy mediated by zVAD (Wu et al., 
2008).  
 On the other hand, in the PARP-mediated necrosis, a number of studies 
have indicated that PARP-activation is coupled with autophagy to regulate a pro-
survival role during DNA damage induction (Albert et al., 2007; Huang and Shen, 
2009; Hwang et al., 2010; Munoz-Gamez et al., 2009). The possible mechanism 
in which PARP activates autophagy lies on the AMPK activation under ATP 
depletion conditions, as AMPK is readily activated when ATP levels are low 
(Hardie, 2007). AMPK plays a vital role in autophagy, as AMPK phosphorylates 
ULK1 directly to initiate autophagy (Egan et al., 2011; Kim et al., 2011; Lee et 
al., 2010c; Shang et al., 2011). Meanwhile, PARP also mediates the AIF nuclear 
translocation during ATP depletion, and therefore the dual-role of PARP in 
deciding the final cell fate lies on the forces that balances the outcome, depending 
on the extent of the DNA damage and the functional role of PARP (Shen and 
Codogno, 2012). 
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 Despite the contradicting roles of autophagy in necrotic-mediated cell 
death, the molecular link between autophagy and necrosis remains to be further 
investigated. 
1.2.3 Autophagic cell death 
The term “autophagic cell death”, also known as type II cell death, has 
been used widely to morphologically define instant cell death that is accompanied 
by enormous cytoplasmic vacuolization along with increased autophagic flux 
(Kroemer et al., 2009). Recently, this type of cell death is redefined as cell death 
that can be suppressed when autophagic pathways are pharmacologically or 
genetically inhibited, increased autophagic flux or an increased degradation of 
autophagic substrates such as p62 (Galluzzi et al., 2012). In fact, the autophagic 
cell death term should be used when the cell death is caused by autophagy and not 
cell death with autophagy, as autophagy may be present as an attempt for the cells 
to prolong survival (Shen and Codogno, 2011). In line with this, Shen and 
Codogno (2011) have proposed that the following criteria should be met for the 
definition of cell death by autophagy: i) cell death that occur is independent of 
apoptosis, ii) observation of increased autophagic flux instead of autophagic 
markers in the dying cells and, iii) suppression of autophagy enhances cell 
survival (Shen and Codogno, 2011). 
Autophagic cell death has been observed in Drosophila salivary glands 
(Berry and Baehrecke, 2007), and recent studies have showed the involvement of 
trol, a novel gene CG11880, and the cop9 signalsome component cop9 
signalsome 6, are required for Drosophila larval salivary gland degradation 
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although neither of these are required for autophagy (McPhee et al., 2012). 
Autophagy has also been showed to be required for the removal of Drosophila 
larval midgut (Denton et al., 2010; Denton et al., 2009; Lee et al., 2002). 
Although the midgut PCD requires autophagy for removal, however the loss of 
autophagy seems to delay PCD but does not abolish it. Therefore, much still need 
to be investigated about the role of autophagy in metamorphosis (Denton et al., 
2010).  
Moreover, the contrasting roles of Ras expression in promoting cell 
growth with increasing autophagy (Guo et al., 2011) or in causing autophagic cell 
death (Elgendy et al., 2011) has further showed the complexity of autophagy in 
regulating cell death and cell survival. In amoeba Dictyostelium discoideum, a 
distinct role of autophagy is seen under starvation and cell death conditions in 
which Atg1 is required for the pro-survival role during starvation, but is also 
required for autophagic cell death during exposure to differentiation factor (DIF-
1) under starvation conditions (Luciani et al., 2011). Meanwhile, the development 
of vascular system through secondary cell wall thickening and cell death of the 
xylem cells to form the tracheary elements in Arabidopsis requires autophagic cell 
death (Kwon et al., 2010). At present, the more supporting evidence of autophagic 
cell death comes from the studies of hippocampal neural (HCN) stem cells, 
following insulin withdrawal treatment in which Atg7 knockdown blocks cell 
death, while it is also independent of caspase activation (Yu et al., 2008). 
Nevertheless, cell death by autophagy is still relatively uncommon at 
present (Denton et al., 2009). Despite the pro-death role of autophagy observed 
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under various cellular settings, autophagy seems to be essential for various 
functional roles in cellular processes when elicited, instead of contributing 
negatively in the cellular regulatory functions. However, it is also important to 
distinguish carefully among the numerous literature cited in the literature, whether 
autophagy is the cause of cell death or precede for the cells to survive longer. As 
autophagy is essentially regulated by the mTOR signaling, the mTOR pathway 
will be discussed next. 
1.3 mTOR pathway  
1.3.1 Overview of the TSC1-TSC2 and mTOR signaling pathway 
 The TOR is a serine/threonine kinase that belongs to the phosphoinositide 
3-kinase (PI3K)-related protein kinases (PIKK) family which enable organisms to 
mediate genetic, metabolic, and environmental stresses (Zoncu et al., 2011). The 
breakthrough of TOR as the target of the immunosuppressant rapamycin, a 
lipophilic macrolide found in soil bacterium, Streptomyces hygroscopicus in 
Easter Island (Vezina et al., 1975) has led to a substantial amount of studies 
targeting this pathway subsequently. Figure 1.5 describes the main components in 
the mTOR signaling. 
The mTOR functions as the catalytic subunit that binds to different 
accessory proteins to form multiprotein mTOR Complex 1 (mTORC1) and 
mTOR Complex 2 (mTORC2) respectively (Chi, 2012). mTORC1 comprises of 
six while mTORC2 has seven distinguished protein complexes respectively 




Figure 1.5 The mTOR signaling. 
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Both complexes have the catalytic mTOR, mammalian lethal with sec-13 
protein 8 (mLST8, or GβL) (Jacinto et al., 2004; Kim et al., 2003), DEP domain 
containing mTOR-interacting protein (DEPTOR) (Peterson et al., 2009), and 
Tti/Tel2 complex (Kaizuka et al., 2010). Meanwhile, mTORC1 has a scaffolding 
protein of regulatory associated protein of mTOR (raptor) which is sensitive to 
rapamycin (Hara et al., 2002; Kim et al., 2002) and proline-rich Akt substrate of 
40 kD (PRAS40) (Sancak et al., 2007; Thedieck et al., 2007; Vander Haar et al., 
2007; Wang et al., 2007b), while mTORC2 has a different scaffold protein that is 
insensitive to rapamycin, unless under prolonged treatment, which is known as 
rapamycin-insensitive companion of mTOR (rictor) (Jacinto et al., 2004; 
Sarbassov et al., 2004), mammalian stress-activated map kinase-interacting 
protein 1 (mSin1) (Frias et al., 2006; Jacinto et al., 2006) and protein observed 
with rictor 1 and 2 (protor 1/2) (Pearce et al., 2007; Thedieck et al., 2007; Woo et 
al., 2007). 
The much more studied mTORC1 is a major regulator for at least five 
types of cellular signals including amino acids, growth factors, energy, stress and 
oxygen that in turn, controls protein synthesis, lipogenesis, energy metabolism, 
autophagy as well as lysosome biogenesis (Laplante and Sabatini, 2012). The 
TSC1-TSC2 (tuberous sclerosis complex-1, and -2; which are also known as 
hamartin and tuberin, respectively) forms a functional protein complex that 
negatively regulates mTOR through the GTPase Activating Protein (GAP) 
domain in TSC2 by converting active GTP-bound Rheb to inactive GDP-bound 
Rheb (Inoki et al., 2003a; Tee et al., 2003; Zhang et al., 2003b). Numerous signals 
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converge at TSC1-TSC2 complex to regulate mTORC1 activity. Growth factors 
such as insulin and insulin-like growth factor 1 (IGF-1) activates PI3K and Ras 
pathways. Activation of mTORC1 occurs through the inactivation and 
phosphorylation of TSC1-TSC2 complex by effector kinases such as protein 
kinase B (PKB/Akt) (Inoki et al., 2002; Manning et al., 2002; Potter et al., 2002) 
via a negative feedback loop of insulin receptor substrate-1 (IRS-1) proteins 
(Harrington et al., 2004), extracellular-signal- regulated kinase 1/2 (ERK1/2) (Ma 
et al., 2005) and ribosomal S6 kinase 1 (RSK1) (Roux et al., 2004). 
In contrast, mTORC1 activity is inhibited with the phosphorylation of 
TSC1-TSC2 complex under low energy conditions and hypoxia by AMPK, which 
occurs when there is an increase in AMP/ATP ratio (Inoki et al., 2003b). Hypoxia 
is also able to induce the transcriptional regulation of DNA damage response 1 
(REDD1) to activate TSC2 and downregulate mTORC1 (DeYoung et al., 2008; 
Liu et al., 2009; Zou et al., 2011). Others, such as DNA damage inducers are able 
to stimulate the TSC2 and phosphatase and tensin homolog deleted on 
chromosome 10 (PTEN) expressions (Feng et al., 2005), in which PTEN 
deactivates Akt while activating AMPK through Sestrin1/2 thus leading to 
mTORC1 inhibition through p53-dependent transcription (Budanov and Karin, 
2008). TNFα is also able to activate IκB kinase β (IKKβ) that suppreses TSC1 
through phosphorylation, leading to mTORC1 activation (Lee et al., 2007b). 
mTORC1 is also activated by another major regulator of cell growth, 
proliferation, differentiation, cell polarity and development through the canonical 
Wnt pathway. Activated Wnt inactivates glycogen synthase kinase 3β (GSK3β) 
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that usually phosphorylates and promotes TSC2 activity under normal conditions 
(Inoki et al., 2006). There are also inputs on mTORC1 directly which are 
independent of TSC1-TSC2 regulation. For example, Akt deactivating 
phosphorylation on PRAS40, which binds to raptor to inhibit mTORC1 activity 
through insulin stimulation (Sancak et al., 2007; Thedieck et al., 2007; Vander 
Haar et al., 2007) and AMPK inhibition of mTORC1 during energy stress through 
direct phosphorylation on raptor to induce its binding to 14-3-3 (Gwinn et al., 
2008). 
Amino acid signaling activates mTORC1 activity independent of TSC1-
TSC2 (Smith et al., 2005), by utilizing Ras-related GTPases (Rag) (Kim et al., 
2008a; Sancak et al., 2008). There are four Rag proteins in mammals, comprising 
Rag A or Rag B that forms heterodimers with Rag C or Rag D. When Rag A/B is 
bound to GTP, the complementary Rag C/D bound will be loaded with GDP. 
Amino acids promote the Rag A/B with GTP through an unknown mechanism, 
but allow the heterodimer to interact with raptor (Sancak et al., 2008), thus 
resulting in mTORC1 recruitment to the lysosomal surface through Ragulator. 
This multicomplex subunit Ragulator scaffolds Rag GTPases to the lysosomal 
surface and is essential for mTORC1 activation by amino acids (Sancak et al., 
2010). 
1.3.2 mTOR signaling components and functions  
1.3.2.1 mTORC1 function in protein synthesis  
The activation of mTORC1 results in promotion of its downstream 
substrates S6 kinase (S6K) and eukaryotic translation initiation factor 4E (eIF4E)-
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binding protein 1 (4EBP1) that subsequently control protein synthesis (Ma and 
Blenis, 2009). The role of mTORC1 in protein synthesis is extensive, such as its 
vital role in regulating the three classes of nuclear RNA polymerases for ribosome 
biogenesis (Mayer and Grummt, 2006).The mTORC1-dependent phosphorylation 
at threonine 389 (T389) of S6K activates its kinase activity in promoting the 
downstream substrates that are involved in mRNA maturation and protein 
translation.  
In contrast, multisite phosphorylation of 4EBP1 by mTORC1 removes its 
binding to the translation initiation factor eIF4E that subsequently activates cap-
dependent translation (Ma and Blenis, 2009). The 4EBP1 phosphorylation 
releases eIF4E to form eIF4F complex that is required for cap-binding initiation 
process. An increase of mRNA biogenesis, translational initiation and elongation 
ensue following the activation of S6K1 (Ma and Blenis, 2009). In addition, the 
mTORC1 also stimulates protein synthesis machinery via the activation of 
transcriptional intermediary factor 1 Alpha (TIF-1A) and thus promoting its 
interaction with RNA Polymerase I (Pol I) to form transcription-initiation 
complex (Mayer et al., 2004). In addition, mTORC1 phosphorylates and inhibits 
Maf1, a Pol III repressor to induce transfer RNA transcription (Kantidakis et al., 
2010; Shor et al., 2010).  
1.3.2.2 mTORC1 in autophagy and lysosomal regulation 
An additional essential role of mTORC1 lies on its regulation on 
autophagy. In mammals, mTORC1 suppresses autophagy through 
phosphorylation of ULK1/Atg13/FIP200 complex to initiate autophagy (Ganley et 
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al., 2009; Hosokawa et al., 2009; Jung et al., 2009), a process that has been 
discussed in more details earlier in this chapter (Section 1.1.2.1). Another 
substrate downstream of mTORC1 that is responsible in autophagy regulation 
includes WD repeat domain phosphoinositide-interacting protein 2 (WIPI2), a 
mammalian ortholog of yeast Atg18. WIPI2 is a PI3P-mTORC1 effector that 
positively regulates autophagosomal formation (Polson et al., 2010). Meanwhile, 
activation of another mTORC1 substrate, death-associated protein-1 (DAP1) has 
been identified to be a suppressor of autophagy (Koren et al., 2010). The 
mTORC1 signaling is also found to regulate lysosomes by negatively regulate the 
transcription factor EB (TFEB), as TFEB controls numerous genes involved in the 
autophagosome formation to fusion processes, as well as in lysosomal function 
(Settembre et al., 2011).  
1.3.2.3 mTORC1 in lipid regulation 
The regulation of lipid is also controlled by mTORC1, implying the 
various regulatory roles mediated by mTORC1 in the regulation of cell processes. 
Inactivation of mTORC1 activity causes a reduction in sterol regulatory element 
binding proteins (SREBP) -1 and -2 expressions which significantly reduce 
lipogenic genes expressions (Porstmann et al., 2008; Wang et al., 2011) 
implicating that mTORC1 plays an essential role in lipogenesis. Studies have 
shown that mTORC1 regulation of SREBPs through S6K (Duvel et al., 2010; Li 
et al., 2011) and lipin 1 localization (Peterson et al., 2011). The mTORC1 also 
positively regulate the peroxisome proliferator-activated receptor γ (PPAR-γ) 
expression which is essential in adipogenesis (Kim and Chen, 2004; Zhang et al., 
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2009b).  
1.3.2.4 mTORC1 in cellular energy metabolism  
mTORC1 positively regulates glycolytic processes through increasing the 
expression of HIF1, a transcriptional factor (Brugarolas et al., 2003; Duvel et al., 
2010; Hudson et al., 2002; Laughner et al., 2001). HIF1 was initially identified 
through its adaptive role to hypoxia that regulates expressions of anaerobic 
glycolysis to increase cytosol ATP generation, from the conversion of glucose to 
pyruvate (Semenza et al., 1994). In addition, it was reported earlier that mTOR 
itself is an ATP sensor (Dennis et al., 2001). In addition, mTORC1 controls 
mitochondria biogenesis and oxidative function by regulating the nuclear 
association between PPAR-γ coactivator 1α (PGC1α) and the transcription factor 
Ying-Yang 1 (YY1) (Cunningham et al., 2007), although there were recent 
studies that argued on this study and thus needs further supporting evidences 
(Laplante and Sabatini, 2012). 
1.3.2.5 Functions of mTORC2  
Much limited studies have been performed in mTORC2 as compared to 
mTORC1. mTORC2 was initially discovered to be rapamycin-insensitive that 
controls cell survival/metabolism and cytoskeleton (Jacinto et al., 2004; 
Sarbassov et al., 2004) but later, one of the same pioneering groups and another 
study found that prolonged treatment of rapamycin does inhibit mTORC2 (Phung 
et al., 2006; Sarbassov et al., 2006). mTORC2 has also been implicated in 
promoting protein folding and stability of Akt and conventional protein kinase C 
(PKC) through phosphorylation at the turn motif (TM) I site (Facchinetti et al., 
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2008; Ikenoue et al., 2008) as well as its role in activating the serum- and 
glucocorticoid-induced protein kinase 1 (SGK1) involved in ion transport and 
growth. mTORC2 also plays a role in terminal differentiation in myoblasts though 
rictor (Shu and Houghton, 2009). A recent study has linked mTORC2 to 
ribosomes as binding of ribosomes-mTORC2 increases after insulin activation 
(Zinzalla et al., 2011).  
1.3.3 TSC impairment and implications in pathological diseases 
mTORC1 is hyperactivated in the event that TSC1 or TSC2 protein is loss, 
which is due to the mutation in either of its gene, TSC1 or TSC2 respectively. 
Consequently, tumour formation is promoted in TSC disease. TSC, which is also 
known as Bourneville disease, was initially described by a French neurologist, 
Désiré-Magloire Bourneville in year 1880 (Bourneville, 1880). This autosominal 
dominant disease is a genetic disorder characterised by the formation of 
hamartomas in numerous organs, including brain (subependymal giant cell 
astrocytomas [SEGA] and tubers), kidney (angiomyolipomas and cysts), lung 
(lymphangioleiomyomatosis [LAM]), skin (facial angiofibromas), heart 
(rhabdomyomas), and retina due to the mutation found in the tumour suppressor 
genes, TSC1 or TSC2 (Gomez, 1991; van Slegtenhorst et al., 1997).  
In an older report, TSC disease has an estimated prevalence of 1 in 5800 
people (Osborne et al., 1991) and a global prevalence reaching 1 million 
individuals (Budde and Gaedeke, 2012). Sporadic mutations of TSC genes takes 
place in about 70-80% cases (De Vries and Bolton, 2000), with phenotypes of 
TSC2 mutation being more common and severe comparing to TSC1 (Sancak et al., 
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2005). An implication of two-hit mechanism is present as numerous lesions in 
TSC patients displayed the loss of both alleles of either TSC1 or TSC2 (Au et al., 
1999; Green et al., 1994; Henske et al., 1997; Verhoef et al., 1999), although there 
are also cases of haploinsufficiency for TSC disease pathogenesis (Henske et al., 
1996; Niida et al., 2001).  
The manifestations of TSC disease were recorded as early as 1900. Benign 
tumours caused by TSC such as lesions in brains are associated with epilepsy, 
cognitive retardation, facial angiofibroma, autism, hydrocephalus, and seizures. 
Other appearances involving kidneys, eyes, heart and lungs that were present 
were then subsequently reported (Budde and Gaedeke, 2012). There is currently 
no approved systemic therapies to treat the abnormal biochemistry in TSC 
disease, such as targeting the upregulated mTORC1 activity (Budde and Gaedeke, 
2012), despite the numerous clinical implications of TSC disease, possibly due to 
the perception that this is a rare disease. However, there are current clinical trials 
in phase II utilizing sirolimus, an mTORC1 inhibitor, to treat patient with TSC- or 
LAM-associated angiomyolipomas as well as everolimus to treat SEGAs, with 
promising results (Budde and Gaedeke, 2012). 
1.3.4 Implications of mTOR dysregulation 
mTORC1 hyperactivation also leads to numerous other complications. 
Figure 1.6 describes various diseases, including cancer, that are associated with 
mTORC1 signaling, implying that this signaling plays highly important roles in 
the pathological functions of cellular processes.  
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Figure 1.6 mTORC1 signaling and diseases (Efeyan et al., 2012). 
 
Several known tumour suppressor genes such as p53, PTEN, LKB1, TSC1 
and TSC2 inhibit mTOR activation. In contrast, mTOR activating upstream 
signaling such as class I PI3K/Akt and ERK1/2 block autophagy and are often 
hyperactivated in cancers. Thus, autophagy defects may contribute to 
tumourigenesis (Levine, 2007).  
1.4 Oxidative stress and MAPK signaling pathways 
1.4.1 Oxidative stress  
Oxidative stress refers to the outcome of an imbalance state due to higher 
accumulated ROS with insufficient antioxidant defenses (Halliwell, 1993). ROS 
is a group of chemical species produced when incomplete reduction of oxygen 
takes place, in which it includes superoxide anion (O
2-
), hydrogen peroxide 
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(H2O2) and the hydroxyl radical (HO•) (D'Autreaux and Toledano, 2007). These 
species are generated as byproducts from normal cellular processes and atypical 
metabolic processes in all aerobic organisms. Accumulation of these free radicals 
can lead to disruption of cellular functions and integrity, such as glutathione 
depletion, lipid peroxidation, membrane damage and DNA strand breaks 
(Halliwell, 1993). Cancer-prone inflammatory diseases patients of ulcerative 
colitis, haemochromatosis and viral hepatitis are linked to free-radical stress 
(Hussain et al., 2003). Also, there is a frequent pro-oxidative shift in systematic 
thiol/disulfide redox state in cancer cells, which are termed as “mitochondrial 
oxidative stress” or “inflammatory oxidative condition” (Singh et al., 2007). 
A major source of ROS in the cells is generated at the mitochondrial 
electron transport chain (ETC) (Chance et al., 1979; Loschen et al., 1971), mainly 
found through the leakage of electrons that passes the ETC to molecular oxygen 
(O2) to form superoxide molecules. These superoxides are then rapidly converted 
to H2O2 spontaneously or by the mitochondrial superoxide dismutase (Mn-SOD) 
(Alvarez et al., 1987; Boveris and Cadenas, 1975; Loschen et al., 1974). 
Environmental stimuli such as growth factors, ionizing radiation, ultraviolet (UV) 
radiation, inflammatory cytokines, oxidizing chemicals, chemotherapeutics, 
hyperoxia, toxins and transition metals are also able to produce ROS as well as 
cytosolic enzymes such as nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidases that produces superoxides from oxygen (Cui et al., 2012). 
ROS has been implicated in activating MAPK signaling in numerous studies 
(McCubrey et al., 2006). 
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1.4.2 MAPK signaling pathway 
The MAPK is a major signaling controlling embryogenesis, 
differentiation, cell proliferation, death and migration (Kyriakis and Avruch, 
2001). MAPK are driven by phosphorylation of three-tier cascades, composing of 
a i) MAPK, ii) MAPK kinase (MAP2K, MAPKK, MKK or MEK) and a iii) 
MAPKK kinase or MEK kinase (MAP3K, MAPKKK or MEKK). The stimulation 
of a MAPK requires the activation of two protein kinases from upstream signaling 
(Chang and Karin, 2001; Pearson et al., 2001). These comprised of dual 
specificity, evolutionary conserved enzymes that are able to phosphorylate 
hydroxyl side chains of serine/threonine and tyrosine residues at Thr-X-Tyr motif 
that is catalysed by MKKs (Pearson et al., 2001; Wagner and Nebreda, 2009).  
The well-characterised mammalian MAPK family is comprised of JNK, 
p38 MAPK (p38), and ERK1/2. These members are regulated differently by 
upstream MAPK cascades (Rodriguez-Berriguete et al., 2012). The mammalian 
MAPK pathways can be activated by various extracellular stimuli through diverse 
receptor families. These include cytokines or tyrosine kinase receptors that are 
activated by hormones and growth factors, respectively; vasoactive peptides that 
stimulate G protein-coupled receptors (GPCR), transforming growth factor beta 
(TGF)-β-related polypeptides that act through serine/threonine kinase receptors, 
inflammatory cytokines of the TNF family, as well as environmental stress such 
as osmotic shock, ionizing radiation and ischemic injury (Kyriakis and Avruch, 
2001). 
Depending on cell types, the MAPK cascade may be involved in different 
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cellular response. The MAPK in turn, is deactivated by a variety of MAPK 
phosphatases (MKPs) with different substrate selectivity (Keyse, 2000; Patterson 
et al., 2009). Thus, a sustained MAPK activation could involve either the 
activation by an upstream kinase or inhibition by MKPs. The MKPs are divided 
based on the subcellular localization, in which the MKPs in the first group are 
encoded by early genes and localised in nucleus; while the second group is 
encoded by late genes and could reside in the cytoplasm or both cytoplasm and 
nuclear compartments (Liu et al., 2007). The JNK and p38 signaling are activated 
by pro-inflammatory cytokines such as TNFα, IL-6 and IL-1 or anti-inflammatory 
epidermal growth factor (EGF) and TGF-β cytokines, as well as other cellular 
stresses comprising genotoxic, osmotic, hypoxic, and oxidative stress (Rodriguez-
Berriguete et al., 2012). JNK is activated by upstream MAPKK of MKK4 (also 
known as JNKK1, SEK1or MEK4) (Derijard et al., 1995; Sanchez et al., 1994) 
and MKK7 (JNKK2, SEK2 or MEK7) (Tournier et al., 1999; Yao et al., 1997).  
The higher MAPKKK tier consists of apoptosis signal-regulating kinases-
1 and 2 (ASK1 or MAPKKK5; ASK2 or MAPKKK6) (Nishitoh et al., 1998; 
Wang et al., 1998), MAPKKK1 (also known as MEKK1) (Xu and Cobb, 1997; 
Xu et al., 1996), mixed-lineage kinases (MLK) (Kyriakis and Avruch, 2001) and 
TGF-β-activated kinase 1 (TAK1) (Moriguchi et al., 1996; Ninomiya-Tsuji et al., 
1999). Rac and Cdc42, both are small Rho-GTPases, activate the JNK and p38 
MAPK signaling but not the ERK pathway (Coso et al., 1995; Khosravi-Far et al., 
1995; Minden et al., 1995; Olson et al., 1995). Different MAPKKs such as MKK3 
and MKK6 activate p38, but the upstream may be activated by the same 
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MAPKKKs (such as ASK1 and TAK1) as in JNK signaling (Rodriguez-
Berriguete et al., 2012). Meanwhile, ERK1 or ERK2 (ERK1/2) is activated by 
MKK1/MKK2, in which the upstream involves a Raf isoform such as A-Raf, B-
Raf, or Raf-1 (also known as C-Raf) as well as TRAF-2 and TRAF-6 (Rodriguez-
Berriguete et al., 2012. The small Ras-like GTPase, Pak activates the Raf-1 
kinase; and Ras is activated by the receptor tyrosine kinase (RTK) signaling axis 
(King et al., 1998; Marshall, 1995).  
Activated MAPK signaling then regulates gene expression through a 
number of mechanisms. For example, MAPK promotes gene transcription histone 
acetylation to modulate the chromatin structure (Cheung et al., 2000). MAPKs 
also enhance numerous transcription factors, such as activator protein 1 (AP-1) 
(Whitmarsh and Davis, 1996), cAMP response element-binding protein (CREB) 
(Arthur and Cohen, 2000; Arthur et al., 2004; Eliopoulos et al., 2002; Wong et al., 
2004), serum response factor (SRF) (Posern and Treisman, 2006), and 
CCAAT/enhancer binding protein beta (C/EBPβ or also known as NF-IL6) 
(Nakajima et al., 1993). MAPKs are also involved in regulating gene expression 
by altering the transport, stability, and translation of mRNAs with AU-rich 
element (ARE), AUUUA (Carballo et al., 1998; Mahtani et al., 2001; Stoecklin et 
al., 2004). Moreover, MAPKs are also able to modulate microRNAs (miR) 
expressions, such as miR-21 (Huang et al., 2009b), miR-125a (Monk et al., 2010), 
and miR-155 (O'Connell et al., 2007; Yin et al., 2008).  
In addition, MAPKs are also capable in regulating the stability of proteins 
such as the the acetylation of a key haemopoietic transcription factor, GATA-1 
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for degradation (Hernandez-Hernandez et al., 2006). The downstream signaling 
subsequently activates a range of cellular responses for growth, survival, cell 
differentiation and cell death processes. Figure 1.7 shows a simple representative 
of the MAPK signaling.  
Figure 1.7 The MAPK signaling cascades.  
 
1.4.3 Crosstalk between MAPK and mTOR 
Meanwhile, much study on the crosstalk of these two distinct signaling 
pathways of mTORC1 and MAPK have linked the ERK downstream signaling to 
the mTORC1 activity. Ras activates Raf to promote the activity of MKK1/MKK2, 
and subsequently the phosphorylation of MKK1/2 activates ERK1/2 to stimulate 
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phosphorylation of multiple cytoplasmic substrates such as RSK and nuclear 
substrates such as transcription factors (Roux and Blenis, 2004). Meanwhile, 
different isoforms of S6K and RSK are also formed when Akt is activated, 
through phosphorylation of phosphatidylinositol-dependent kinase 1 (PDK1) that 
activates Akt at T308 (Alessi et al., 1996). An earlier study that linked MAPK to 
mTORC1 pathway is first observed in S6K deficient mice, as phosphorylated S6 
ribosomal proteins are present despite the S6K deficiency in the system, thus 
linking the existence of an S6K-independent pathway (Pende et al., 2004).  
Meanwhile, RSK is also found to be the upstream kinase that activates the 
eukaryotic translation initiation factor 4B (eIF4B) to mediate its activity in 
translation initiation process (Shahbazian et al., 2006). Consistently with earlier 
observations, subsequent study have found that in T cells, the complete blockage 
of S6 protein phosphorylation requires both mTORC1 and ERK signaling and 
RSK is required in an S6K-independent manner to mediate S6 phosphorylation 
(Salmond et al., 2009). mTORC1 is also positively mediated through the raptor 
phosphorylation by RSK and ERK signaling (Carriere et al., 2008; Carriere et al., 
2011). 
On the other hand, the IRS-1 is also negatively regulated by JNK in which 
JNK acts as a negative feedback regulator for insulin action by phosphorylating at 
S307 in IRS-1 (Aguirre et al., 2000; Hilder et al., 2003; Lee et al., 2003). IRS-1 is 
also the upstream regulator of PI3K-Akt-mTORC1 signaling, which is regulated 
by TSC1/TSC2 and mTORC1 through the repression of S6K activity on IRS-1 
(Harrington et al., 2004). Cells that are deficient of TSC complex seem to have 
52 
lower Akt activation due to the suppression of S6K activity towards IRS-1 
(Harrington et al., 2004). Therefore, the convergence of JNK to PI3K-Akt-
mTORC1 signaling exists through the IRS-1 regulation. Moreover, more studies 
have shown that inhibition of insulin and Akt mediated by JNK reduces cell 
survival, increases insulin resistance, promotes obesity as well as diabetes in a 
few models (Gao et al., 2003; Hirosumi et al., 2002; Mamay et al., 2003). 
Nevertheless, the link of TSC1/2-mTORC1 pathway to JNK seems to be elusive 
at present. 
1.4.4 Roles of JNK-mediated ROS signaling in cell death  
1.4.4.1 JNK-mediated ROS in apoptosis signaling 
JNK is well-known to promote cell death, as well as cell survival. 
However, the proposed mechanisms underlying JNK-dependent apoptosis are still 
controversial, depending on stimuli- and cell-types, possibly due to the periodic 
activation of JNK signaling. Prolonged JNK activation at the initial stage seemed 
to promote survival of the cells, indicating a pro-survival row of JNK. 
Meanwhile, a sustained activation of JNK can promote cell death (Weston and 
Davis, 2007), thus indicating that JNK is an important signaling pathway in 
cellular response to stress. 
It has been generally known that ROS are potent inducers of JNK 
activation, as most studies on ROS-induced JNK activation results from the usage 
of H2O2 (Torres, 2003). Enhanced production of ROS is usually observed in cells 
exposed to ultraviolet (UV) radiation (Chan et al., 2003; Ding et al., 2002), 
ionizing radiation (Choi et al., 2007; Morales et al., 1998), cancer 
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chemotherapeutics (Nebbioso et al., 2011; Policastro et al., 2009) and TNFα 
(Deng et al., 2012; Kim et al., 2010). 
 At present, one of the most extensively studied pathway for ROS mediated 
JNK activation is via the TNF signaling, TNFR1 (Shen and Pervaiz, 2006; Takeda 
et al., 2003; Torres, 2003). TNFα stimulation leads to two distinct activation 
pathways: 1) earlier and transient activation of JNK is mediated by TRAF2 (Lamb 
et al., 2003) while the delayed and persistent JNK activation is mediated by ROS 
(Sakon et al., 2003; Ventura et al., 2004). Several studies have showed that the 
accumulation of ROS promotes prolonged JNK activation through JNK 
phosphatases inactivation and subsequently, TNF-mediated cell death (Kamata et 
al., 2005; Kim et al., 2007b; Micheau and Tschopp, 2003). 
In mitochondria, ROS-mediated apoptosis seem to generate from a few 
pathways. One well-known example is through NADPH oxidase 1 (Nox1) 
(Hamanaka and Chandel, 2010). TNF-induced ROS is mainly generated by 
reduced Nox1 and Rac1, which are recruited to complex I by associating with 
TRADD, RIP1 and mitochondrial respiratory complex I (Seki et al., 2012). JNK 
seems to amplify mitochondria mediated ROS production during stimuli, causing 
JNK to translocate to mitochondria upon mitochondria stress, subsequently 
leading to higher amount of ROS produced through complex I formation 
(Chambers and LoGrasso, 2011). One recent example is the role of Apaf-1 in 
mediating ROS-induced apoptosis, in which the deficiency of Apaf-1, an 
important member of the apoptosome, significantly abrogates all UV-induced 
signal deterioration and cell death in mouse embryo fibroblasts (MEFs) (Feng et 
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al., 2012). Meanwhile, the ROS modulator 1 (Romo1) and Bcl-xL are recently 
discovered to be important regulators of TNF-induced ROS (Kim et al., 2010), as 
the complex II components seem to bind to the C-terminus of Romo1 located in 
the mitochondria, allowing the recruitment of Bcl-xL by Romo1. Subsequently, 
MOMP is reduced and ROS is increased and finally leading to apoptosis (Kim et 
al., 2010).  
NF-κB exists as homodimers or heterodimers of the Rel proteins, which 
are characterised by the possession of a Rel homology domain that is required for 
specific binding, dimerization and nuclear localization. NF-κB is normally 
sequestered in the cytoplasm by the inhibitor IκB. Stimulation then leads to the 
activation of IKK, causing IκB to be phosphorylated, ubiquitinated and degraded 
to liberate the NF-κB dimers. This thus enables the freed NF-κB proteins for 
nuclear translocation and binding to specific target genes for transcriptional 
activity (Shen and Pervaiz, 2006). TNF-induced ROS accumulation and 
prolonged JNK activation seem to be suppressed by NF-κB-mediated 
sequestration of ROS and the induction of cFLIP (Chang et al., 2006; Kamata et 
al., 2005; Pham et al., 2004).  
  TNF-mediated activation of JNK1 phosphorylates and stimulates the 
activity of E3 ubiquitin ligase Itch, which is involved in the K48-linked 
ubiquitination of cFLIP to promote apoptosis via activation of caspase-8 and 
caspase- 3 in hepatocytes. The depletion of Itch prevents the ubiquitination and 
degradation of cFLIP that subsequently abrogates liver injury mediated by TNF 
(Chang et al., 2006). Nevertheless, different roles of JNK1 and JNK2 have been 
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proposed, as JNK1 disruption protected hepatocytes from TNF-induced death 
(Chang et al., 2006) while JNK2-deficient hepatocytes have a higher activity of 
TNF-induced JNK1 activity as well as a higher anti-apoptotic Mcl-1 protein level 
(Kodama et al., 2009). JNK1 seems to be pro-apoptotic, but JNK1 might serve to 
be anti-apoptotic via stabilization of Mcl-1 protein in JNK2-deficient cells 
(Kodama et al., 2009).  
 The role of JNK mediated ROS in apoptosis is also essentially mediated 
by the upstream MAPKKK, ASK1. ASK1 activity is first showed to interact with 
thioredoxin, an important cellular redox regulator, in which the reduced form of 
thioredoxin is able to bind to ASK1 to block its kinase activity. ROS stimulated 
oxidizes thioredoxin, thus causing its dissociation from ASK1 and subsequently 
ASK1 is activated through an essential threonine residue in the activation loop 
(Gotoh and Cooper, 1998; Saitoh et al., 1998; Tobiume et al., 2001). Thioredoxin 
also promotes ASK1 ubiquitination and degradation, thereby inhibits ASK-1 
mediated JNK activation and apoptosis (Liu and Min, 2002). Meanwhile, the 
Kelch domain containing 10 (KLHDC10), which is the mammalian ortholog of 
Slim, a kelch protein that inactivates ASK1 in Drasophila, is found to interact 
with protein phosphatase 5 (PP5) to suppress ASK1 activation in response to ROS 
(Sekine et al., 2012). 
 On the other hand, other mediators are also important regulators of the 
JNK signaling in ROS-induced apoptosis. The TRAIL receptors, death receptors 4 
(DR4) and 5 (DR5) are also involved in mediating JNK and ROS signaling, as 
observed in tumour cells studied recently (Park et al., 2012). Upon stimuli, DR4 
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and DR5 recruits riboflavin kinase (RFK) causing the activation of Nox1 at the 
intracellular death domains and this DR4/DR5-RFK complex is subsequently 
stabilised by TRADD to promote apoptosis (Park et al., 2012). Another example 
is the CD95 ligand (CD95L) that acts through the EGF receptor (EGFR) 
signaling; in which activated EGFR enhances the activity of CD95L to promote 
ROS production, JNK activation, FADD and caspase- 8 recruitment followed by 
apoptosis in rat hepatocytes (Reinehr et al., 2005). Meanwhile, the role of MLK3 
in positively regulating ROS-mediated JNK activation and cell death is also seen 
in another study. MLK3 mutant protected cells from JNK activation, reduced 
MOMP release as well as apoptosis, signifying the MAPKKK function in the 
regulation of ROS upstream of mitochondria and JNK signaling (Hong and Kim, 
2007). In addition, another mediator includes the Src kinase activity (Yoshizumi 
et al., 2000), which possibly binds to the docking protein of EGF signaling, Gab1 
in promoting JNK activation (Chen et al., 2001).  
1.4.4.2 JNK-mediated ROS in necrosis 
As compared to oxidative stress mediated apoptosis, the studies on ROS in 
necrosis is much less understood at present. It is generally believed that ROS are 
capable in causing either apoptosis or necrosis, depending to the extent of the 
stimuli, the cell type and the signaling pathway triggered in response to ROS 
(Gardner et al., 1997; Shen and Liu, 2006; Troyano et al., 2003). 
In TNF-induced cell death, the activation of Nox1 is also essential in 
mediating necrotic cell death. Upon stimuli, RIP1 recruits Nox1 to mediate a 
signaling complex consisting TRADD, RIP1, Nox1, and the small GTPase Rac1 
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(Kim et al., 2007b). In that study, RIP1 deficient cells are unable to form the 
signaling complex whereas Nox1 inhibition prevented necrotic cell death in MEFs 
in TNF-induced necrotic signaling, thus signifying an additional role of Nox1 in 
promoting necrosis (Kim et al., 2007b), apart from apoptosis as discussed earlier. 
Meanwhile, MLKL was recently discovered to be an essential player in TNF-
induced necrotic cell death downstream of RIP3. MLKL seems to be required for 
ROS generation as well as the later phase of JNK activation, while MLKL 
inhibition blocks necrosis in human colon adenocarcinoma HT-29 cells (Zhao et 
al., 2012). 
TRAF2 seems to be important in the regulation of ROS-induced necrosis, 
as H2O2-induced JNK activation is significantly impaired in MEFs deficient of 
RIP and TRAF2 (Shen et al., 2004). Moreover, cell death ligands such as FasL 
and TNFα are able to induce caspase-independent or necrotic cell death. This was 
first observed in murine L929 fibrosarcoma cells (Vercammen et al., 1998a; 
Vercammen et al., 1998b). Other studies have also showed similar observation, 
evidenced by the presence of necrotic cell death in other cells such as fibroblasts 
and human T lymphocytes (Lin et al., 2004; Sakon et al., 2003; Ventura et al., 
2004). Moreover, in the MEF cells deficient of NF-κB (p65-/-), TNFα treatment 
enhances ROS production to mediate sustained JNK activation and subsequently, 
necrotic cell death (Kamata et al., 2005; Sakon et al., 2003). Also, JNK may 
mediate PARP-induced necrotic cell death by direct phosphorylation and 
activation of PARP-1, as JNK ablation or inhibition suppresses PARP-1 
activation and caspase-independent cell death (Zhang et al., 2007). More recently, 
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the role of TAK1, a MAPKKK, has been implicated in regulating necroptosis as 
well as apoptosis, as TNFα-induced cell death in TAK1-deficient MEFs do not 
undergo cell death when simultaneous inhibition of caspases and knockdown of 
RIP3 are performed (Lamothe et al., 2012). Nevertheless, the role of JNK in 
ROS-mediated necrosis remains elusive at present.  
1.5 Objectives of the study 
 At present, the role of autophagy and cell death regulation as well as its 
manipulations for therapeutic benefits in the pathogenesis of TSC has yet to be 
fully explored. As it has been previously reported that TSC-deficient cells are 
with constitutively active mTORC1 and hypersensitive to various cell death 
inducers, the main objective of this thesis is to uncover the functional roles of 
TSC in regulation of autophagy and cell death. Thus, to achieve this objective, we 
aimed to conduct the following two aspects of study: 
1. To investigate the role of TSC in the regulation of autophagy in response to 
starvation conditions and, 
2. To study the role of TSC in oxidative stress mediated JNK signaling and cell 
death 
 The present study identifies a novel role of TSC in autophagy and cell 
death as well as its roles in MAPK-JNK signaling, which may be implicated in 
the pathological functions of TSC-related disease. It is thus hoped that results 











































 mouse embryonic 
fibroblasts (MEFs) were generous gifts from Dr. David J. Kwiatkowski (Brigham 
and Women's Hospital, Boston, MA) and were described previously 
(Kwiatkowski et al., 2002; Zhang et al., 2003a), p53
-/-
 MEFs of reconstituted 
TSC2, TSC2
-/-(+/+)
 and pairing TSC2
-/- 
with empty vector (EV) were kind gifts 
from Dr. Huang Jingxiang (National University Hospital, Singapore) and Dr. 
Brendan D. Manning (Harvard School of Public Health, Boston, USA) that was 




 MEFs were generous 
gifts from Dr. Masaaki Komatsu (Tokyo Metropolitan Institute of Medical 
Science, Japan). 293FT cells were purchased from Invitrogen. All cells were 
cultured up to passage-10 in DMEM (Sigma) supplemented with 10% FBS 
(Hyclone), 1% penicillin-streptomycin (Invitrogen) and maintained in a 5% CO2 
incubator at 37 °C.  
2.2 Reagents and antibodies 
All the following antibodies were purchased from Cell Signaling: Akt (#9272), 
phospho-Akt (#9271), p70S6K (#9202), phospho-p70S6K (#9205), caspase 3 
(#9662), PARP-1(#9542), raptor (#2280), TSC2 (#3612), TSC2 (#3990), 4EBP1 
(#9644), phospho-4EBP1 (#2855), phospho-c-Jun (#9261), c-Jun (#9165), TSC1 
(#4963), phospho-MKK3/MKK6 (#9236), phospho-p38 (#9211), phospho-MKK4 
(#4514), phospho-MKK4 (#9151), p38 MAPK (#9212), and phospho-threonine 
(#9386). Anti-p62 (H00008878-M01) was obtained from Abnova while Apg7 
(#3617) was purchased from ProSci. The reagents: rapamycin (#R0395), leucine 
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(#L8912), insulin-like growth factor 1 (IGF-1, #I8779), Earles’s balanced salt 
solution (EBSS #E2888), chloroquine diphosphate (CQ, #C6628), PP242 
(#P0037), sodium nitroprusside (#431451), sodium orthovanadate (#S6508), and 
okadaic acid (#O4511); while anti-LC3 antibody (#L7543), anti-α-tubulin 
(#T6199), anti-β-actin (#A5441), anti-HA (#H3663), and anti-Flag (#F3165) 
antibodies were purchased from Sigma-Aldrich. Necrostatin-1 (#480065) was 
from Merck. Phospho-JNK was from Biosource (#44-682G). Anti-MKP-1 (#SC-
370) and phospho-tyrosine (#SC-7020) were from Santa Cruz. Goat anti-rabbit 
(#31460) or anti-mouse (#31430) horseradish peroxidase-linked antibodies were 
used as secondary antibodies. The phospho-ASK1 was a generous gift by Dr. H. 
Ichijo (University of Tokyo, Japan) described earlier (Tobiume et al., 2002). 
For the preparation of antibodies, 0.5 g of bovine serum albumin (#A9418, 
Sigma) was weighed and dissolved in 10 ml of 1 X Tris Buffered Saline with 
Tween 20 (TBST) to make up a 5% BSA and 0.01% NaN3 final solution. NaN3 
was added to prevent bacterial contamination. All antibodies prepared were stored 
at 4°C. A 1:1000 dilution for all antibodies were used unless indicated as follow; 
1:2000 dilution for p-ASK1 and p-JNK, respectively; 1:5000 dilution for anti-p62, 
anti-actin and anti-tubulin.  
2.3 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) 
assay 
For MTT assay, 5 mg/ml of working solution was prepared in 1 X PBS. Cells 
were plated in 96-well, leaving some wells were unseeded and left as blanks for 
control. After designated treatments, 20 µl of MTT solution was added into 
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control (blanks, with medium only) and treated wells. The plate was incubated for 
2 hours in the incubator (37°C, 5% CO2), for the yellow MTT to be solubilised 
into formazon by the mitochondria of living cells. Medium was then aspirated and 
formazon was resuspended in 200 µl DMSO with 10 seconds shaking. Optical 
density was obtained at 590 nm.  
2.4 Propidium iodide (PI) live exclusion staining for cell viability 
For PI staining, the medium in each well was collected and cells were harvested 
with trypsin after treatments. Then, cell pellets obtained were resuspended in 1X 
phosphate buffer saline (PBS) containing PI at a final concentration of 5 µg/ml 
and incubated for 10 minutes at 37°C. Ten thousand cells from each sample were 
analysed with FACSCalibur flow cytometry (BD Bioscience) using CellQuest 
software. 
2.5 Transient siRNA transfection 
Cells were transfected with 100 nM of either the non-specific control, mouse 





4 siRNA Transfection reagent (Dharmacon) according 
to the manufacturer’s protocol. After 48 hours of siRNA transfection, cells were 
seeded overnight for 70% confluency prior to designated treatments on the next 
day. 
2.6 RNA extraction 
Total RNA was isolated from cell cultured, according to designated treatments 
using RNeasy Mini kit (Qiagen) according to the manufacturer’s protocol. The 
concentration and quality of total RNA was determined using NanoDrop 1000 
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Spectrophotometer (Thermo Scientific). Extracted RNAs were stored at -80°C. 
2.7 Reverse transcriptase polymerase chain reaction (RT-PCR)  
The complementary DNA (cDNA) was synthesised with High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems) according to the manufacturer’s 
protocol. An amount of 0.6 µg RNA was reverse transcribed into cDNA in a 10 µl 
reaction, consisting of RT Buffer, dNTPs, random primers and reverse 
transcriptase that are incubated for 10 minutes at 25°C, 37°C for 2 hours and 
subsequent 85°C for 5 minutes to inactivate the enzyme used (MyCycler
TM
 
Thermal Cycler, Bio-Rad). Products obtained from RT-PCR were diluted 1:5 
times and subsequently used in quantitative real-time PCR (qPCR). 
2.8 Quantitative real-time PCR (qPCR) 
The qPCR was carried out in
 
a thermal cycler (model C1000
TM
, Bio-rad) using 
SsoFast EvaGreen (#1725201AP, Bio-Rad) in a final volume of 10 µl reaction 
containing 2 µl of synthesised cDNA obtained from RT earlier as template, 0.5 
µM of each forward and reverse primers, 5 µl of SsoFast master mix and 
remaining with RNAse-free water (2 µl). GAPDH were used as internal control. 
Three independent experiments were performed. Samples were normalised to the 
levels of GAPDH and subsequently, data was analysed using CFX
TM
 Manager 
software (Bio-Rad). All the MKPs primers (MKP-1, -3, -5, -7) listed in Table 2.1 
were used for qPCR analysis. The MKP primers were generous gifts from Dr. 
Zhang Yongliang (National University of Singapore, Singapore).  
2.9 Plasmids and transient transfection 
The plasmids used in this thesis were kind gifts from the following parties: 
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Table 2.1 Primers sequence of genes for mRNA analysis 
Name Direction      Sequence (5’ to 3’) 
MKP-1 Forward CTTTCTCCAAGGAGGATATGAA 
Reverse  CTTGATGGAGTCTATGAAGTCA 
MKP-3 Forward ATAGATACGCTCAGACCCGTG 
Reverse CTGAAGCCACCTTCCAGGTA 
MKP-5 Forward GCTGTCCACATTAACTGTGCCG 
Reverse TCTCTTCAGGGACTCGAGGA 
MKP-7 Forward ATGGAGTGGCTGAGCCTTTG 
Reverse CGGCTATCAATTAGCAGCACT 
GAPDH Forward GCACAGTCAAGGCCGAGAAT 
Reverse GCCTTCTCCATGGTGGTGAA 
 
pcDNA3-HA-TSC2 (rat) (Dr. Guan Kun-Liang, University of California, San 
Diego, USA) (Inoki et al., 2002), pEF6-TSC2 (human) was from Dr. David J. 
Kwiatkowski (Boston, USA) (Zhang et al., 2003a), pSRα-3HA-JNKK2-JNK1 
construct was from Dr. Lin Anning (University of Chicago, Chicago, USA) and 
Flag-MKP-1 was from Dr. Zhang Yongliang (National University of Singapore, 
Singapore). Overexpression studies were performed according to manufacturer’s 
protocol using Lipofectamine
TM
 2000 (#11668-019, Invitrogen). Cells were 
transfected with recommended amount (µg) of plasmid for 48 hours, and reseeded 
to reach cell confluency of 70% prior to designated treatment after overnight 
incubation. pLenti4-TSC2 construct was also used in the transient transfection in 
subsequent studies. 
2.10 DNA extraction 
The plasmids were extracted using Qiagen Miniprep Plasmid Extraction Kit and 
Qiagen Maxiprep Plasmid Extraction Kits, according to the volume of DNA 
required in the study. For the smaller amount of DNA extraction, the Miniprep kit 
was used while the Maxiprep kit was utilised for larger volumes of DNA 
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extractions. The bacterial plasmid cultured was first centrifuged to obtain the cell 
pellet, while the supernatant was discarded. Bacterial cell pellets were then 
suspended in a series of buffers provided in the respective extraction kits, 
according to the manufacturer’s protocol. 
2.11 Immunoprecipitation 
For immunoprecipitation (IP), cells were lysed in lysis buffer (50 mM HEPES pH 
7.4, 1% NP-40, 150 mM NaCl, 5% glycerol, 1 mM EDTA) freshly supplemented 
with protease inhibitor (Roche) and phosphatase inhibitors (Halt) prior to usage. 
After designated respective treatment, the medium was aspirated and cells were 
washed with 1 X cold PBS. PBS was removed and cells were subsequently 
scraped in 1 ml of IP lysis buffer. Cell extracts were lysed and rotated for 30 
minutes at 4°C and subsequently spun at the highest speed with a microcentrifuge 
for 10 minutes. A partial amount of supernatant was kept as total cell lysates (100 
µl). The remaining supernatant collected was pre-cleared with protein A/G 
agarose beads for 1 hour at 4°C prior to the addition of 1-2 µg of antibodies and 
incubated overnight. On the following day, cell lysates were added with protein 
A/G agarose (#20422, Thermo Scientific), rotated for 2 hours at 4°C, and then 
extensively washed with lysis buffer for 3 times. After spinning down in a 
microcentrifuge, the precipitates obtained were eluted in Laemmli loading buffer, 
boiled for 5 minutes and retained further for SDS-PAGE analysis.  
2.12 Western blotting 
After the indicated time of designated treatments, cells were lysed in M2 lysis 
buffer (20 mM Tris at pH 7, 0.5% NP-40, 250 mM NaCl, 3 mM EDTA, 3 mM 
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EGTA, 2 mM dithiothreitol, 0.5 mM phenylmethylsulfonyl fluoride, 20 mM 
glycerol phosphate, 1 mM sodium vanadate and proteinase inhibitor cocktail). An 
equal amount of protein was resolved by sodium SDS-PAGE and transferred onto 
PVDF membrane (Bio-Rad). After blocking with 5% non-fat milk, the membrane 
was probed with designated first and second antibodies, developed with the 
enhanced chemiluminescence method (Pierce and Merck) and visualised using 
Kodak Image Station 440CF (Kodak) and ImageQuant LAS500 (GE Healthcare). 
Quantification results for the western blots were obtained using Kodak 1D 4.5.1 
software. We further modified the lysis buffer used in subsequent studies (in 
Chapter 4), using sodium dodecyl sulfate (SDS) Laemlli lysis buffer consisting of 
2% SDS, 20% glycerol, 1 M of Tris hydrochloric acid, 2 mM dithiothreitol, Halt 
Phosphatase Inhibitor and Roche Protease Inhibitor. 
2.13 Establishment of TSC2 reconstitution in stable cell line 
For the construction of stable TSC2 into TSC2
-/-
 MEFs, the following steps were 
involved, which were: i) generation of an entry vector, pENTR™/D-TOPO-
TSC2, ii) generation of the destination vector, pLenti4/TO/V5-DEST-TSC2, iii) 
construction of constitutive, stable expression of wild type TSC2 in TSC2
-/-
 MEFs 
using lentivirus infection, followed by iv) effects of reconstituted TSC2 
expression studies using immunoblotting. 
2.13.1 Generation of entry vector pENTR™/D-TOPO-TSC2 
2.13.1.1 PCR amplification of TSC2 DNA 
Prior to DNA amplification from the pEF6-TSC2 plasmid, the primers in Table 
2.2 were first used to verify the full length of TSC2 gene through sequencing.  
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Table 2.2 TSC2 primers used for TSC2 reconstitution 
Name Direction                 Sequence (5’ to 3’) 
start  Forward CACCATGGCCAAACCAACAAGCAAAGAT 
stop  Reverse TCACACAAACTCGGTGAAGTCCTCAC 
731-sequence Forward ACCGCGTCCTCTGTGGACAT  
 1351-sequence Forward GGACCAGAGGCCTGAGTCCT 
 1971-sequence Forward GGGCCGACTCACTGCACCGC 
 2591-sequence Forward AAGCTCACGCACATCTCAGC 
 3211-sequence Forward CTCCAACTTCACGGCTGTCC 
 3831-sequence Forward AGGAGCACCGGGACACAGCC 
 4451-sequence Forward GGCAAGAGAGTAGAGAGGGA 
 5071-sequence Forward CGAGTGCAACCTGGTGTCCC 
 
After verification, the full-length cDNA of TSC2 was isolated using PCR using 
the following cycle for a 20 µl reaction (reaction contained DNA, dNTPs, 
reaction buffer, sterile water, polymerase enzymes and a pair of TSC2 start and 
stop primers as indicated in Table 2.2): i) 94°C for 3 minutes to initialize 
enzymes, ii) 94°C for 45 seconds, iii) 50°C for 45 seconds, iv) 72°C for 1 minute , 
followed by 30 repeating cycles from step (ii) to step (iv) for the series of 
denaturation, annealing and elongation, respectively. Final elongation was 
subsequently performed by heating the samples to 72°C for 7 minutes. Products 
were kept temporarily at 4°C prior to usage. The start codon primer of TSC2 was 
designed to contain the ‘CACC’ in the end of the 5’ forward primer to form base 
pair with the ‘GTCC’ overhang sequence in the pENTR™ TOPO vector (Table 
2.2). 
2.13.1.2 Bacterial plasmid transformation  
The PCR products of TSC2 were first cloned into pENTR™/ D-TOPO vector to 
generate an entry vector (pENTR™/D-TOPO-TSC2), using pENTR™ 
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Directional TOPO Cloning Kit (Invitrogen). The cloning reaction was prepared 
by mixing salt and TOPO vector (both supplied by the kit), with sterile water and 
2 µl of fresh PCR products of TSC2. The reaction was incubated for 5 minutes at 
room temperature followed by placing the tube on ice for 30 minutes of 
incubation. Meanwhile, the following materials were prepared: i) water bath was 
warmed to 42°C, ii) S.O.C medium supplied in the kit was warmed to room 
temperature, iii) two selective kanamycin (50 µg/ml) agar were warmed to 37°C 
and finally, iv) a vial of One Shot Top10 (Invitrogen) Escherichia coli competent 
cells was thawed in ice for bacterial transformation. After the stipulated 
incubation time, the cloning reaction prepared earlier was added into the thawed 
Top10 E. coli cells. The suspension was mixed gently without pipetting, followed 
by 20 minutes incubation on ice. After the incubation time, the cells were heat-
shocked for 30 seconds at 42°C without shaking. The tube was then immediately 
transferred to ice and added with 250 µl of S.O.C. medium and placed on a shaker 
(200 rpm) at 37°C for 1 hour. Subsequently, 50-200 µl of each transformation was 
spread on two different kanamycin selective plates. The plates were incubated 
overnight at 37°C.  
2.13.1.3 PCR colony analysis 
On the following day, about 10 single colonies were picked for PCR colony 
analysis. Basically, the colonies were resuspended individually in 50 µl of PCR 
SuperMix containing TSC2 forward and reverse primers, as well as M13 forward 
and M13 reverse primers that were supplied in the kit. M13 primers were needed 
to aid in the sequencing of intended gene in the entry vector used, as the entry 
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plasmid contains a region of M13 bacteriophage priming site needed for cloning. 
The reaction was first incubated for 10 minutes at 94°C to lyse cells and 
inactivate nucleases. Then, the cycle was amplified for 30 cycles and final 
extension was performed by incubating the products at 72°C for 10 minutes. 
Products was stored at 4°C and subsequently used for agarose gel electrophoresis 
visualization. The same 10 colonies were also streaked on a kanamycin selective 
agar plate to make a patch plate to preserve the colonies for further analysis. 
2.13.2 Generation of destination vector pLenti4/TO/V5-DEST-TSC2 
2.13.2.1 Identification and preservation of positive clone 
Following verification of the 10 single colonies contained in the entry vector 
through agarose gel visualization, the TSC2 DNA from a positive colony was 
extracted and analysed by gene sequencing to verify the correct gene insertion. 
The positive clone was also preserved in a glycerol stock, which was prepared by 
mixing 0.85 ml of culture containing stationary phase of bacterial stock with 0.15 
ml (15%) of sterile glycerol in a cryovial. The glycerol stock was subsequently 
stored in -80°C.  
2.13.2.2 LR Recombination Reaction 
LR recombination reaction was performed to generate the destination vector of 
pLenti4/TO/V5-DEST-TSC2 (Figure 2.1). To prepare the LR recombination 
reaction, purified plasmid containing TSC2 of the entry clone (50-150 ng) was 
added into a mixture of reaction that contained pLenti4/TO/V5-DEST vector 
(Figure 2.1), TE Buffer, Proteinase K, and LR Clonase
TM
 II Enzyme Mix. The 
reaction was incubated for 10 minutes at 37°C. Meanwhile, a vial of One Shot  
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Figure 2.1 Map of expression for vector pLenti4/TO/V5-TSC2. 
 
Stbl3TM competent cell was thawed on ice and the prepared LR reaction was 
subsequently added to the cells. Transformation was performed using ampicillin-
resistant agar plates. Expression clone was propagated, preserved in glycerol 
stock and plasmid extraction was subsequently performed using Qiagen Maxiprep 
Extraction kit. 
2.13.3 Construction of constitutive, stable expression of wild type TSC2 in    
TSC2
-/-
 MEFs using lentivirus infection 
2.13.3.1 DNA purification 
Purified plasmid DNA used for transfection must be free from contamination. 
Therefore, pLenti4/TO/V5-TSC2 obtained was purified by adding equal volume 
of phenol:chloroform:isoamyl alcohol 25:24:1 (#P3803, Sigma). The tube was 
then gently vortexed and subsequently spun for 5 minutes at highest speed (~16 
000 x g). The upper aqueous phase containing DNA was transferred cautiously 
into a new tube, followed by the addition of 2.5 X volume of 100% pure ethanol. 
Then, 10% of 10 M ammonium acetate was added and the suspension was gently 
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mixed. The tube was subsequently incubated overnight at -20°C. On the following 
day, the tube was spun in a microcentrifuge for 20 minutes at the highest speed 
(~16 000 x g). DNA pellet obtained was then added with 70% ethanol to wash the 
pellet, followed by centrifugation for 2 minutes at 16 000 x g. Supernatant was 
discarded gently and the DNA pellet was air-dried. Purified DNA was then 
dissolved in double distilled water and stored in -20°C for further usage. 
2.13.3.2 Lentivirus production in 293FT cells 
The expression plasmid needed for each transfection was 3 µg. For the generation 
of lentiviral stock, low passages of 293FT cells were seeded in 10 cm
3
 dishes in 
antibiotics-free medium and incubated overnight, with at least 90% confluency (6 
x 10
6
 cells) for transfection on the following day. DNA-Lipofectamine
TM 
2000 
complex was prepared, in which the first tube contained 9 µg of Virapower
TM
 
Packaging Mix, 3 µg of pLenti4-TSC2 in 1.5 ml of Opti-MEM
® 
I medium 
without serum. In another sterile tube, 36 µl of Lipofectamine
TM 
2000 was mixed 
into 1.5 ml of Opti-MEM
®
 I medium without serum. Both tubes were mixed 
gently and incubated for 5 minutes at room temperature. Then, both solutions 
were mixed together and further incubated for another 20 minutes. While DNA-
lipid complexes were forming, 293FT cells were trypsinised and and counted to 
form a density of 1.2 x 10
6
 cells/ ml in growth medium containing serum. The 
DNA-lipid complexes were added to a sterile 10 cm
3 
culture plate containing 5 ml 
of antibiotics-free growth medium with serum, followed by the addition of 5 ml of 
293FT cells (6 x 10
6 
total cells). After gentle mixing, the plate was placed in a 
CO2 incubator at 37°C. On the following day, medium was changed to DMEM 
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with additional 1 mM sodium pyruvate. The virus-containing supernatant was 
harvested 72 hours later into a 15 ml centrifuge tube and centrifuged at 3000 rpm, 
4°C for 5 minutes to pellet cell debris. Viral supernatants were pipette into 
cryovials in 1 ml aliquots and stored at -80°C.  





 MEFs were plated in a 10cm
3 
such that the cells would be 
50-60% confluent on the day of virus transfection. Lentiviral stock was filtered 
prior to cell infection. After removing culture medium from the plated cells, virus-
containing medium was added by gentle resuspension into the cells. Polybrene
® 
(#H9268) was additionally added to a final concentration of 6 µg/ml. The medium 
was removed on the following day (day 2) and cells were replaced with fresh 
complete medium. On day 3, cells were trypsinised, replated to reduce cell 
density and medium was replaced with Zeocin
TM
 (100 µg/ml) (#R250-01, 
Invitrogen) containing medium. Medium was changed every 2 to 3 days until 
about 2 weeks later, when Zeocin
TM
-resistant colonies could be identified. At 
least 30 colonies were selected, expanded and preserved. Clones of cells chosen 
were subsequently verified for reconstituted TSC2 expressions through 
immunoblotting and used for subsequent studies. 
2.14 Statistical analysis 
The image data were representatives from at least three repeated experiments. All 
numeric values were expressed as mean ± SD from at least three independent 
experiments. The p-value was calculated using Student’s t-test with p-values<0.05 












IMPAIRED AUTOPHAGY DUE TO CONSTITUTIVE mTOR 














Autophagy, or ‘self-eating’ is an catabolic process in which cytoplasmic 
constituents including macromolecules (such as proteins, glycogens, lipids and 
nucleotides) and organelles (such as mitochondria, peroxisomes and endoplasmic 
reticulum) are degraded by the hydrolytic enzymes in autolysosome and finally 
the recycling of the resulting macromolecules (Yang and Klionsky, 2010a). At 
present, the biological functions of autophagy have been well-studied. Autophagy 
is vital in maintaining cell and tissue homeostasis via clearing intracellular 
misfolded proteins and damaged organelles, in ageing prevention, in pathogen 
elimination, in cell death, and in tumour suppression (Mizushima, 2005; Yang and 
Klionsky, 2010a). Among them, one important aspect is that autophagy mediates 
cell survival under starvation conditions, in which cells recycle cytoplasmic 
constituents through lysosomal degradation to provide the essential nutrients for 
survival (Yang and Klionsky, 2010a). The cytoprotective roles of autophagy 
against death have also been showed in tumour growth under limited nutrients and 
oxygen conditions (Fung et al., 2008) as well as in drug-induced cell death in 
cancer cells (Amaravadi et al., 2007).  
Autophagy is a dynamic process that involves the following consecutive 
steps: 1) initiation, 2) nucleation, 3) elongation and 4) fusion and maturation 
processes. These processes are known to be controlled by a group of proteins 
encoded by Atg. For instance, the induction or initiation of autophagy is regulated 
via the ULK1/Atg1 complex downstream of mTORC1, while the nucleation 
process is mediated by the Beclin 1 and hVps34/class III PI3K complex (He and 
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Klionsky, 2009). In the membrane elongation and expansion step, a series of other 
Atgs are involved in two conjugation systems: Atg12-Atg5-Atg16 and LC3-PE 
(He and Klionsky, 2009). LC3 is largely cytosolic but exists as lipid-conjugated 
form and is localised to both sides of autophagosomes upon autophagy induction 
(Kabeya et al., 2000) and is widely used as an autophagy marker (He and 
Klionsky, 2009). 
mTOR integrates diverse signals from growth factor, energy and nutrients 
network to act as a central regulator. Upon stimulation of growth factors 
signaling, mTOR is activated via the well-established PI3K-AKT-TSC pathway 
(Inoki et al., 2002; Potter et al., 2002). TSC1 encodes hamartin (also known as 
TSC1) to form a heterodimeric functional complex with the gene product of 
TSC2, tuberin (known as TSC2) to act as GAP for Rheb. TSC2 stimulates the 
intrinsic GTP hydrolysis activity of Rheb by establishing the transition of Rheb 
from an active GTP bound to an inactive GDP-bound form (Garami et al., 2003; 
Zhang et al., 2003b). Upon binding to GTP, Rheb acts as a small GTPase directly 
activates mTORC1 (Long et al., 2005). On the other hand, amino acids can 
directly activate mTORC1 through Rag proteins binding to mTORC1 (Sancak et 
al., 2008). The activation of mTORC1 results in the phosphorylation of two 
downstream targets: S6K and 4EBP1 (eukaryotic translation-initiation factor 4E-
binding protein) to trigger ribosome biogenesis and protein translation (Burnett et 
al., 1998). In contrast to the well-studied mTORC1, the signaling pathways and 
functions of mTORC2 are still unclear. One important function of mTORC2 is to 
activate Akt by phosphorylation (Sarbassov et al., 2005). 
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mTORC1 is probably the most important upstream negative regulator of 
autophagy. Under nutrients-rich conditions, mTORC1 suppresses autophagy 
initiation by inhibiting the ULK1/Atg1 complex by phosphorylating Atg13 and 
ULK1/2. Activated ULKs further stimulates autophagy induction by the 
phosphorylation and activation of Atg13 and the scaffold protein FIP200 and 
ULK1 itself. In contrast, starvation or rapamycin treatment causes the 
dephosphorylation and activation of ULK1/2 complex (Hosokawa et al., 2009; 
Jung et al., 2009). 
Aberrant upregulation of mammalian target of rapamycin (mTOR) 
signaling pathway has been associated with various cancer signaling mechanisms. 
The loss of tumour suppressors such as PTEN, hamartin and tuberin, and STK11 
(serine/threonine kinase 11; also known as LKB1) that activates mTOR pathway 
are linked to cancer, including bladder, lung, ovarian, melanoma, brain, 
endometrial, and thyroid; as well as hamartoma syndromes, such as tuberous 
sclerosis, Peutz-Jeghers syndrome, and Cowden disease (Guertin and Sabatini, 
2005). TSC disease is a multisystem disease characterised by the formation of 
hamartomas in various organs (Crino et al., 2006). TSC disease is caused by 
autosomal dominant mutation in either TSC1 or TSC2, although patients with 
TSC2 mutations have more severe clinical findings than those with TSC1 
mutations (Sancak et al., 2005). Emerging evidence has showed that TSC-null 
cells, which are cells lacking either TSC1 or TSC2 and could not form a 
functional TSC1/2 complex, are more sensitive to cell death induced by various 
stimuli, as compared to its wild type counterparts. These stimuli include glucose 
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deprivation (Lee et al., 2007a), ER stress (Di Nardo et al., 2009; Kang et al., 
2011), bacterial stimulated-inflammation (Weichhart et al., 2008), DNA damage 
and TNFα stimulation (Ghosh et al., 2006). The high susceptibility of TSC-null 
cells to death were reported to be due to increased p53 translation (Lee et al., 
2007a), increased activation of Rheb to cause ER stress (Kang et al., 2011), lower 
NF-κB level (Ghosh et al., 2006), increased ER stress (Di Nardo et al., 2009; 
Ozcan et al., 2008), and defects in Akt activation (Huang et al., 2009a). 
In this study, we attempted to study the involvement of autophagy in the 





 cells are more susceptible to cell death induced by 
starvation and hypoxia. Second, we found that there is impaired basal and 
inducible autophagy in TSC2
-/-
 cells. Finally, we demonstrated that autophagy 
plays a pro-survival role and the impaired autophagy due to mTOR 
hyperactivation contributes to enhanced cell death of TSC2
-/-
 MEFs. Therefore, 
our findings reveal new insights into the complex relationships among mTOR, 




MEFs are hypersensitive to apoptosis induced by various cell 
death stimuli 
To explore the cell death sensitivity of TSC-
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Figure 3.1 Statistical quantifications for the susceptibility of TSC cells induced by 





 (TSC2 knockout) as well as the pair of TSC1
+/+
 (wild type, 
WT) and TSC1
-/-
 (TSC1 knockout) cells were collected after seeded overnight in 
full medium (DMEM). Cell lysates were used for western blotting and blotted for 
the indicated markers. Actin served as loading control. (B) Dotplot of propidium 
iodide (PI) live exclusion assay for quantification of viable and dead cells. The R1 
and R2 regions in the dotplot represent viable and dead cells, respectively for 
control TSC2
+/+ 





, WT, and TSC1
-/-
 MEFs were treated with control (full medium) or EBSS 
(Earle’s Balanced Salt Solution) (middle panel); and hypoxia (1% O2, 5% CO2, 
balance N2) or normoxia (control, 21% O2, 5% CO2) (right panel) for the 
indicated time points. The percentage of viable cells was measured with PI (5 





 MEFs were treated in EBSS as the indicated period of 
time. MTT stock (5 mg/ml) was added into the cells seeded in 96-well plates and 
results were analysed from optical absorbance obtained. All statistical data in all 
the figures are presented as means ± S.D of three independent experiments 
(**p<0.01, t-test). 
 
was more significant cell death in TSC-null
 
cells treated with starvation (with 
EBSS) and hypoxia, as quantified by PI exclusion test coupled with flow 
cytometry (Figure 3.1B) and MTT assay for starvation treatment (Figure 3.1C). 
The morphological changes as shown in Figure 3.2A were consistent with the PI 
exclusion test, showing more cell death in TSC2
-/-




Figure 3.2 TSC-null cells are more sensitive to cell death induced by starvation 
and hypoxia stimuli. (A) Morphological changes of MEFs with respective 
treatments (as described in Figure 3.1). Cells were examined and photographed 
with an inverted microscope (X 100). (B) Cell lysates were analysed by western 
blotting using antibodies specific to caspase 3 and PARP-1 cleavages. Tubulin 






or hypoxia. Moreover, to examine the nature of cell death, we detected two 
apoptotic markers, caspase 3 and PARP-1 cleavages using western blot. As shown 
in Figure 3.2B (middle and lower panel respectively), there were evident cleavage 
of caspase 3 and PARP-1 in TSC2
-/-
, but not in TSC2
+/+
. Similar results were 
found with other oxidative stimuli including H2O2, sodium nitroprusside, as well 
as with TNFα (Figure 3.3). Cycloheximide was added into TNFα treatment to 
induce typical apoptosis while the pan-caspase inhibitor zVAD was used to block 
apoptosis (Figure 3.3B). As expected, TSC-null cells are more sensitive to 
apoptosis induced by various stimuli. Such observations are indeed consistent 
with some earlier reports on cell death in TSC-null cells (Di Nardo et al., 2009; 






 MEFs are more sensitive to cell death induced by oxidative 
stress and TNFα stimuli. (A) Effects of hydrogen peroxide (H2O2) treatment on 
cell death in TSC2 MEFs (left panel). Cells were treated with H2O2 (0.5 mM) for 
16 hours. Effects of nitric oxide on cell death in TSC2 cells (right panel). Cells 
were treated with sodium nitroprusside (SNP, 0.5 mM) for the indicated time. (B, 
next page) Effects of TNFα on cell death in the cells. TSC2 MEFs were treated 
with TNFα (T, 10 ng/ml), with or without cycloheximide (C, 10 µM) and zVAD 
(Z, 20 µM) for 5 hours. Cell lysates were analysed by western blotting using 





3.2.2 Impaired basal and inducible autophagy in TSC2
-/- 
cells due to 
constitutive mTORC1 activation  
The loss of either TSC1 or TSC2 will lead to constitutive activation of 
mTORC1 (Garami et al., 2003).
 
Since mTORC1 negatively regulates autophagy 
(Jung et al., 2009), we postulate that hyperactivation of mTORC1 could thus limit 
autophagy in TSC2
-/-





 cells. As shown in Figure 3.4, there was high level of S6K 
(T389) phosphorylation in TSC2
-/-
 cells, indicating higher activity of mTORC1. 
Interestingly, LC3-II is found to be lower and p62 level is higher in untreated TSC2
-
/-
 cells comparing to TSC2
+/+
cells (Figure 3.4), suggesting the lower level of basal 
autophagy in TSC2
-/-
 cells. Next, we tested the autophagy level induced by 





 cells when cultured with EBSS within the first 2 hours, suggesting the 
suppression of mTORC1 activity by EBSS in TSC2
+/+
cells, while the mTORC1 
activity is not significantly affected in TSC2
-/-
 cells. In order to assess the level of 





Figure 3.4 Basal autophagy level is lower in TSC2
-/-
 cells. Cells were collected after 
incubated in fresh medium overnight without any treatment. Cell lysates were 
analysed with western blotting using indicated antibodies. 
 
 
autophagosome maturation and degradation via neutralizing the lysosomal pH 
(Mizushima et al., 2010; Shen and Codogno, 2011). Interestingly, the addition of 
CQ alone increased LC3-II level without affecting p-S6K, which suggests that the 
effect of CQ is independent of mTORC1 activity. Notably, EBSS induced 
significant increase of LC3-II, especially in the presence of CQ in TSC2
+/+
cells. In 
contrast, the changes of LC3-II in TSC2
-/-
 MEFs are much less evident, suggesting a 
lower level of autophagy induced by EBSS in TSC2
-/-
 cells (Figure 3.5A). 
Consistently, there was evident reduction of p62 protein level in wild type cells, but 
not in TSC2
-/-
 cells (Figure 3.5A). Similar patterns of both LC3-II and p62 were also 





Figure 3.5 Lower inducible autophagy levels in TSC2
-/-
 cells. (A) and (B) 
Induction of autophagy in TSC2 cells using EBSS. Cells were treated with EBSS 
in the presence or absence of chloroquine diphosphate (CQ, 10 µM) for the 
indicated period of time. Cell lysates were prepared for western blot for detection 
of various indicated markers. Actin and tubulin served as loading controls for the 
cell lysates.  
 
3.5B). Interestingly, in TSC2
-/-
 cells, starvation led to reduction of the p-S6K level 
in TSC2
-/-
 cells within the first 8 hours and then was restored from 12 hours 




and inducible autophagy in TSC2
-/-
 is impaired, possibly due to the constitutive 
activation of mTORC1.  
3.2.3 Suppression of autophagy sensitizes EBSS-induced cell death in 
TSC2
+/+
, but not in TSC2
-/-
 cells 
Here we used two experimental approaches to test if autophagy inhibition 
would have any impact on the cell death induced by EBSS in both type of cells. In 
our first approach, we used CQ to inhibit autophagy induced by starvation. As 
shown in Figure 3.6, the addition of CQ alone into fed cells did not induce any 
cell death. Notably, the addition of CQ was able to enhance cell death in cells 
treated under EBSS starvation. Interestingly, the death enhancing effect of CQ 
was much more evident in TSC2
+/+
as compared to TSC2
-/-
 cells. The percentage 
of cell death with CQ addition in starved TSC2
+/+
cells increased from 38.50% to 
50.34%, as compared to the slight increase from 58.13% to 64.58% in starved-
only TSC2
-/-
 cells (Figure 3.6B). Thus, these results suggest that (i) autophagy 
plays a pro-survival role in MEFs under starvation conditions; and (ii) CQ is less 
effective in TSC2
-/-
 cells due to the lower inducible autophagy level.   
Another approach used here was to knockdown Atg7, a key Atg in 
autophagosome expansion and completion by conjugating Atg12 to Atg5 
(Cecconi and Levine, 2008). As shown in Figure 3.7A, starvation led to a 
significant increase of LC3-II level in cells with control NS (non-specific) siRNA, 
while such changes were prevented in cells treated with Atg7 siRNA in TSC2
+/+
 
cells. As expected, the suppressive effect of Atg7 knockdown is much less evident 
in the TSC2
-/-






Figure 3.6 Autophagy inhibition with CQ sensitizes starved cells to death. (A) 
Morphological representative of cell death in TSC2 cells. Cells were treated in 
full medium or in EBSS, with or without CQ for 24 hours. CQ pretreatment was 
conducted in full medium for 2 hours and washed with 1X PBS prior to addition 
of full medium or EBSS in the presence or absence of CQ. Cells were examined 
and photographed with an inverted microscope (X 100). (B) PI live exclusion 
staining for cell death quantification. Cells were treated as in panel A and cell 
death was measured as described in Figure 3.1B and 3.2A. (C) Statistical 






Figure 3.7 Atg7 knockdown inhibits autophagy. (A) and (B) Effects of Atg7 




 cells were 
treated as described earlier in Figure 3.5. Cell lysates were subjected to western 











Figure 3.8 Autophagy inhibition with Atg7 knockdown sensitizes starved cells to 
death. Atg7 knockdown sensitizes TSC2
+/+
cells to cell death but not in TSC2
-/-
 
cells. (A) Morphological representative of TSC2 cells. Cells were treated as 
described in Figure 3.7, examined and photographed with an inverted microscope 
(X 100). (B) PI live exclusion staining for cell death quantification. Cell death 
was measured as described earlier in Figure 3.1B and 3.2A. (C) Statistical 
significance (
**




 cells increased the percentage of dead cells from 30.15% 
to 39.85%, whereas in starved TSC2
-/-
 cells, the percentage of dead cells in 
starved TSC2
-/-
 cells (56.86%) did not further increase upon Atg7 knockdown 
(54.92%). Consistently, the sensitization effect of Atg7 knockdown on cell death 
under starvation was much more significant in TSC2
+/+
 cells in comparison to 
TSC2
-/-








Since the suppression of autophagy is able to sensitize the TSC2
+/+
 cells to 
EBSS-induced cell death, suggesting a pro-survival function of autophagy under 
starvation, we next tested whether autophagy induction would increase cell 
survival of TSC2
-/-
 cells. We combined two approaches for autophagy activation 
in TSC2
-/-
 cells: treatment with rapamycin, a specific mTORC1 inhibitor, and 
raptor knockdown. First, we observed that rapamycin treatment or raptor 
knockdown in TSC2
-/-
 cells effectively suppressed mTOR activity, as evidenced 
by significant suppression of S6K phosphorylation (Figure 3.9). Interestingly, the 
4EBP1 (T37/46) phosphorylation (p-4EBP1) was found to be more resistant to 
rapamycin or raptor knockdown alone, while combination of both treatments led 
to a significant reduction of p-4EBP1 level (Figure 3.9). Consistently, either 
rapamycin or raptor knockdown was able to induce autophagy in TSC2
-/-
 cells 
cultured in either full medium or EBSS, based on increased LC3-II protein level 
with the addition of CQ, as observed in lane 3 and comparing lane 8 to lane 9. 
Although the addition of rapamycin into cells with raptor knockdown does not 
further enhance the autophagic flux (comparing lane 11 and 13), we did observe 
higher level of autophagic flux (LC3-II level) with combined treatment of 
rapamycin and raptor knockdown (lane 13) when comparing to rapamycin only 




Figure 3.9 Raptor siRNA knockdown in TSC2
-/-
 cells increases autophagy. TSC2
-
/-
 cells with control NS (non-specific) or raptor knockdowns were treated with full 
medium or EBSS in the presence or absence of CQ (10 µM) and rapamycin (10 
nM) for the indicated time. Cell lysates were collected and subjected to western 
blots for the indicated markers. 
 
Next, we examined cell death under the conditions described above. As 
shown in Figure 3.10B, rapamycin treatment alone failed to reduce the percentage  
of cell death induced by EBSS (percentage of cell death was 58.99% in starved 
TSC2
-/-
 as compared to 61.20% with rapamycin addition), whereas raptor 
knockdown offered moderate protection against EBSS-induced cell death 
(43.34%). Consistent with the degree of mTOR suppression and autophagy 
induction as shown in Figure 3.9, the combination of both rapamycin and raptor 
knockdown well protected TSC2
-/-
 MEFs against EBSS-induced cell death 
(percentage of cell death reduced from 61.2% to 29.99%). Such observations thus 
further support the notion that autophagy is an important pro-survival mechanism 








Figure 3.10 Autophagy induction through raptor knockdown rescues cell death in 
TSC2
-/- 
cells. (A) Morphological representatives of TSC2
-/-
 cells treated with full 
medium or EBSS, with or without rapamycin for 24 hours. Cells were examined 
and photographed under an inverted microscope (X 100). (B) PI live exclusion 
staining for cell death quantification. Cell death was measured as described 
earlier. (C) Statistical significance (
**
p<0.01, t-test) of respective treatments in (B) 




3.2.5 Nutrients supplementation protects against cell death in TSC2
+/+
cells, 
but enhances cell death in TSC2
-/-
 cells under starvation condition  
Here, in order to further establish the pro-survival function of autophagy 
in TSC2
-/-
 cells, we investigated whether nutrients supplementation will affect 
autophagy and cell death. Insulin-like growth factor-1 (IGF-1) together with 
leucine, an essential amino acid, is known to activate mTORC1 and suppress 
autophagy, via activation of the PI3K-Akt-TSC pathway (Meijer and Codogno, 
2009). In this study, the addition of IGF-1+leucine activates PI3K-Akt-mTORC1 
pathway, as seen by the phosphorylations of Akt (S473) and S6K (both shorter 
and longer exposures) in the TSC2
+/+
 MEFs (Figure 3.11). The absence of Akt 
phosphorylation (p-Akt) in TSC2
-/-
 MEFs in response to IGF-1+leucine is 
believed to be due to the negative feedback loop between activated S6K on IGF 
receptor signaling (Huang et al., 2009a). Similar to the earlier observations, EBSS 
starvation caused slight reduction of p-S6K level in TSC2
-/-
 cells, while the 
addition of IGF-1+leucine restored its original level.  
The supplementation of nutrients also affects autophagy induced by EBSS 
in both type of cells. As shown in Figure 3.11, the addition of IGF-1+leucine 





MEFs, although in the level of autophagy in TSC2
-/-
 MEFs was much lower, 
being consistent with earlier observations in Figure 3.5. Intriguingly, the addition 
of IGF-1+leucine had opposite effects on EBSS-induced cell death in these two 
cell types: it almost completely abolished caspase 3 cleavage in TSC2
+/+
 MEFs, 
while enhanced caspase 3 cleavage in TSC2
-/-




Figure 3.11 Effect of IGF-1+Leu (insulin growth factor-1 and leucine) on 




 cells were 
starved in EBSS for two hours, followed by the addition of IGF-1 (200 nM) + Leu 
(0.2 mg/ml) for the indicated time. Cell lysates were subjected to western blotting 
for the markers. Respective lane intensity of LC3-II and caspase 3 cleavage were 
quantified using Kodak Imaging Software as fold change to control. 
 
 
(lane 8, Figure 3.11). Similar results were observed when cell death was 
determined by cell morphological changes (Figure 3.12A) and PI live exclusion 
staining (Figure 3.12B). Therefore, data from this part of our study further support 
the notion that autophagy plays a vital function in maintaining cell survival under 
starvation conditions, especially in TSC2
-/-










Figure 3.12 Nutrients supplementation further sensitizes TSC2
-/-
 cells to cell 
death. (A) Morphological representatives of cells treated as in Figure 3.11 for the 
indicated time. Cells were examined and photographed under an inverted 
microscope (X 100). (B) PI live exclusion assay for cell death quantification. Cell 
death was quantified using PI as described earlier. (C) Statistical significance 
(
**







It has been well established that the dysfunction of TSC leads to 
constitutive activation of mTORC1, a process implicated in various pathological 
conditions including cancer (Inoki and Guan, 2009). On the other hand, the TSC-
mTOR signaling axis is also known to be a key negative regulator of autophagy, 
directly upstream of the Atg1/ULK complex (He and Klionsky, 2009). Cells with 
TSC deficiency have been found to be hypersensitive to various cell death stimuli, 
such as TNFα (Ghosh et al., 2006), glucose deprivation (Lee et al., 2007a) and ER 
stress (Di Nardo et al., 2009; Kang et al., 2011). At present, it has not been 
systematically studied whether autophagy is involved in the hypersensitive nature 
of the TSC-deficient cells to cell death. In this study, we provide evidence 
suggesting that the constitutive activation of mTORC1 impaired autophagy (both 
basal and inducible), which then contributes to the hypersensitivity of the TSC2
-/-
 
cells to stress-induced apoptosis. Our findings thus shed new lights onto the 
intricate relationship among the TSC-mTOR signaling pathway, autophagy and 
cell death.  
mTORC1 activation is known to suppress autophagy via targeting the 
ULK1-Atg13-FIP200 complex (He and Klionsky, 2009; Hosokawa et al., 2009; 
Jung et al., 2009). Therefore, the constitutive activation of mTORC1 in TSC2
-/-
 
cells is expected to lead to suppression of autophagy. In this study, we found that 
the basal level of autophagy in TSC2
-/-
 was lower than the wild type cells, shown 
by the lower LC3-II and higher p62 protein level (Figure 3.4). More importantly, 




cells in comparison to the wild-type cells (Figure 3.5). It has been reported that 
mTORC1 activity in TSC2
-/-
 cells is rather refractory to starvation (Smith et al., 
2005). Consistently, we only observed partial reduction of p-S6K level in TSC2
-/-
 
cells after EBSS exposure (Figure 3.5A) and the p-S6K level was largely restored 
to the basal level with prolonged EBSS treatment (for 12 hours, Figure 3.5B). In 
contrast, culturing in EBSS completely abolished p-S6K in TSC2
+/+
 cells (Figure 
3.5). Consistently, starvation (in EBSS) is more effective for the induction of 
autophagy in TSC2
+/+
 cells (Figure 3.5). Moreover, rapamycin or raptor 
knockdown was able to enhance autophagic flux in TSC2
-/-
 cells (Figure 3.9), 
suggesting that the basic autophagy machinery is not defective in TSC2
-/-
 cells. 
Therefore, it is believed that it is the constitutive activation of mTORC1 that leads 
to autophagy suppression in TSC2
-/-
 cells. 
In this study, we examined the function of autophagy in cell death under 
starvation via several approaches. On one hand, suppression autophagy by CQ or 
Atg7 knockdown was able to enhance cell death, which is much more effective in 
TSC2
+/+
 cells than the TSC2
-/-
 cells (Figure 3.6 and 3.8). Such data could be 
understood as the autophagy level was already low in TSC2
-/-
 and further 
suppression will only give rise to less significant effect. On the other hand, 
activation of autophagy by rapamycin and raptor knockdown was effective in 
protecting starvation-induced cell death in TSC2
-/-
 cells (Figure 3.10). Rapamycin 
specifically inhibits mTORC1 via the formation of immunophilin FKBP12-
rapamycin complex that allosterically interrupts the FRB (FKBP12-rapamycin 
binding) domain of mTOR (Choi et al., 1996). It is also known that some of the 
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mTOR activity is insensitive to rapamycin, such as the phosphorylation of 4EBP1 
at T37 and T46 sites (Gingras et al., 1999; Wang et al., 2005). 
 It is interesting to note that combination of raptor knockdown and 
rapamycin could offer more effective protection against starvation-induced cell 
death than rapamycin or raptor knockdown alone (Figure 3.10). Such findings are 
generally consistent with a very recent report on ER stress-mediated apoptosis in 
TSC2
-/-
 cells (Kang et al., 2011). In their study, rapamycin effectively blocked 
apoptosis in glucose-deprived TSC2
-/-
 cells, but not in ER-stress induced cells. 
Similarly, raptor knockdown rescues ER-stress induced cell death (Kang et al., 
2011). One possible explanation is that there are rapamycin-insensitive functions 
of mTOR which may mediate the resistance to cell death. In fact, rapamycin was 
able to completely abolish p-S6K, while only partly reduce p-4EBP1 (Figure 3.9). 
Similar trend in p-4EBP1 was found for the effect of raptor knockdown, while the 
combination of these two approaches led to more evident suppression of p-4EBP1 
(Figure 3.9). It is thus believed that either rapamycin or raptor knockdown alone 
are insufficient to block all mTORC1 functions. Moreover, since the induction of 
autophagy by the combination of rapamycin and raptor knockdown was not 
proportional to the blockage of mTORC1 activity and protection against cell 
death, it is possible that not all mTOR-related functions on cell death are mediated 
via autophagy. 
One interesting observation in this study is that EBSS is able to induce cell 
death, while there is no obvious cell death induced by rapamycin or raptor 
knockdown, although all these treatments can block the mTORC1 function. There 
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are several possible explanations. First, only very low concentration of rapamycin 
(10 nM) was used in this study. It is well known that higher concentration of 
rapamycin is capable of inducing cell death in certain cancer cell lines (Guertin 
and Sabatini, 2005). Second, it has been reported that EBSS is able to induce cell 
death (apoptosis) via multiple mechanisms, such as oxidative stress (Scherz-
Shouval et al., 2007). Third, Akt is no longer activated in EBSS-treated cells 
(Figure 3.11). As Akt activation plays an important role in maintaining cell 
survival and preventing apoptosis (Franke et al., 2003), it is possible that the 
different Akt activation status contributes differently to cell death/survival under 
different treatments as described above. 
Another intriguing observation from this study is that nutrient 




 cells: In EBSS-
starved cells, addition of IGF-1+leucine was able to reduce cell death in 
TSC2
+/+
cells, but aggravate cell death in TSC2
-/-
 cells (Figure 3.11 and 3.12). An 
earlier study has shown that starvation is able to elicit a p53-dependent apoptosis 
pathway in cells with TSC deficiency and hyperactivation of mTORC1 (Lee et al., 
2007a). Since the TSC2 cells used in our study are p53 deficient (Zhang et al., 
2003a), the apoptotic pathway is likely to be p53-independent. In TSC2
+/+
 cells, 
supplementation of IGF-1+leucine leads to evident activation of Akt, a well-
established pro-survival molecule to block apoptosis via multiple pathways 
(Franke et al., 2003). Theoretically, nutrient supplementation (IGF-1+leucine) is 
able to elicit two pathways that are able to affect the cell fate: (i) activation of the 
Akt for cell survival (Franke et al., 2003), and (ii) suppression of autophagy for 
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cell death (He and Klionsky, 2009). 





 cells to EBSS-induced apoptosis. Therefore, it is believed that in 
TSC2
+/+
 cells, the Akt activation induced by nutrient supplementation plays a 
more dominant role in protecting against cell death. Conversely, in TSC2
-/-
 cells, 
nutrient supplementation fails to activate Akt due to the negative feedback from 
activated S6K on IRS-1, an essential component of insulin receptor (Harrington et 
al., 2004). Rather it was able to further enhance mTORC1 activation and reduce 
autophagy, leading to increased susceptibility of TSC2
-/-
 cells to starvation-
induced cell death. Such findings are generally consistent with our previous report 
in which the activation of PI3K-Akt-mTOR pathway suppresses autophagy and 
promotes cell death via necrosis (Wu et al., 2009).  
AMPK is another critical mediator upstream of mTOR in modulation of 
autophagy (Meijer and Codogno, 2007; Papandreou et al., 2008). In this study, we 
did not study the role of AMPK as it was widely believed that involvement of 
AMPK in autophagy was mainly via its effect on TSC2 to suppress mTOR 
(Gwinn et al., 2008; Inoki et al., 2003b). However, several very recent reports 
have discovered the new functions of AMPK on autophagy, including its direct 
effect on the ULK1 complex (Egan et al., 2011; Kim et al., 2011). Therefore, it 
would be important to investigate the involvement of AMPK in the suppressed 
autophagy level in TSC2
-/-
 cells in future. 
Despite the general belief that autophagy is a pro-survival mechanism 
under starvation condition (Yang and Klionsky, 2010a), at present whether 
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autophagy is involved in the hypersensitivity of TSC2
-/-
 cells to cell death stimuli 
is not clear. An earlier report examined the role of autophagy in cell death 
induced by glucose deprivation in TSC2
-/-
 cells (Choo et al., 2010). In their study, 
rapamycin was found to be highly effective in protecting cell death induced by 
glucose deprivation. Although rapamycin is able to induce autophagy in TSC2
-/-
 
cells, suppression of such autophagy failed to affect the protective effect of 
rapamycin, thus it is concluded that autophagy is not involved in the protective 
effect of rapamycin (Choo et al., 2010). Unfortunately, the authors did not 





 cells, and whether such autophagy contributes to the different 
susceptibility of both cells to cell death under glucose deprivation. Another 
possible reason for such discrepancies is the different nature of starvation used. In 
our study, EBSS contains a considerable amount of glucose (1 g/L), while it is 
completely deprived of amino acids and growth factors in their study. It remains 
to be further investigated whether these two forms of starvation engage 
autophagy’s pro-survival function differently in TSC2-/- cells.   
Taken together, data from our study provide the first evidence showing the 
importance of autophagy in mediating the survival of cells with deficiency of TSC 
function. As shown in Figure 3.13, the constitutive activation of mTOR leads to 
suppression of autophagy, which serves as an important pro-survival mechanism 
in response to starvation. Suppression of autophagy by CQ or Atg7 knockdown 
enhances the cells to starvation-induced apoptosis while rapamycin and raptor 
knockdown would protect cells via suppression of mTOR activation and 
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subsequent induction of autophagy. Such findings shed new lights onto the 
intricate relationship among the TSC-mTOR signaling pathway, autophagy and 
cell death. More importantly, our results may provide clues for developing 




Figure 3.13 The involvement of TSC in the regulation of autophagy and cell 
death. In the absence of TSC, constitutive mTORC1 activation suppresses 


















TSC PROTEIN PROMOTES OXIDATIVE STRESS-MEDIATED JNK 




















4.1  Introduction 
Oxidative stress is defined as the elevated production of reactive oxygen 
species (ROS), due to insufficient antioxidant mechanism for the defense against 
the production of ROS during cellular processes (Halliwell and Cross, 1994; Sies, 
1997). At present, oxidative stress has been extensively studied and it is known to 
be closely implicated in human diseases such as neurodegeneration, cancer, 
autoimmune diseases and ageing, through damage to DNA, lipids and proteins 
(Weinberg and Chandel, 2009). Hydrogen peroxide (H2O2) is a common ROS 
produced in cells as a byproduct of oxidative metabolism. Despite the presence of 
antioxidant enzymes and other non-enzymatic antioxidants that rapidly detoxify 
ROS in cells, a perturbed cellular aerobic metabolism may lead to ROS 
accumulation, and subsequently causes cellular injury (Weinberg and Chandel, 
2009). On the other hand, ROS are known to be important signaling molecules 
and mediate several signaling cascades that are closely involved in numerous 
physiological and pathological processes (D'Autreaux and Toledano, 2007; 
Gamaley and Klyubin, 1999; Thannickal and Fanburg, 2000).  
Among them, the c-Jun-N-terminal kinase (JNK) signaling is one of the 
key pathways elicited by ROS (Shen and Liu, 2006; Torres, 2003). JNK has been 
extensively studied and its activation is mediated through the three-tiered 
signaling modules, initiated from the upstream mitogen-activated protein kinase 
kinase kinase (also known as MAPKKK, MKKK or MAP3K), to MAPKK 
(MAP2K or MKK) and subsequently to MAPK (Marshall, 1994). At least 14 
MAP3Ks have been found to activate JNK, including apoptosis signal-regulating 
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kinase 1 (ASK1), while the direct upstream of JNK are MKK4 and MKK7 (Seki 
et al., 2012). Meanwhile, JNKs are dephosphorylated by MAPK phosphatases 
(MKPs), which are dual-specificity phosphatases (Keyse, 2008). The most 
effective substrate of JNK is c-Jun, which is a member of the nuclear 
transcriptional factor AP-1, together with other JNK substrates such as JunB, 
JunD, and Fos (Karin and Gallagher, 2005).  
At present there is evidence suggesting the crosstalks between the JNK 
and mTOR signaling pathways. It has been previously reported that JNK is 
required for the feedback inhibition of the insulin signaling cascade of IRS-1 
(Aguirre et al., 2000; Hilder et al., 2003; Lee et al., 2003), which lies upstream of 
the PI3K-Akt-mTOR pathway (Cohen, 2006). The absence of JNK1 resulted in 
significant improvements of insulin sensitivity as well as enhancement in insulin 
receptor signaling capacity in obese mice models (Hirosumi et al., 2002). JNK is 
also responsible for raptor phosphorylation to stimulate mTORC1 in intestinal 
tumour cells (Fujishita et al., 2011) as well as during osmotic stress (Kwak et al., 
2012). However, up to date little is known whether the TSC-mTORC1 pathway 
has any functional effect on the JNK signaling pathway mediated by various 
stress factors. 
Despite numerous studies have indicated that TSC-null cells are more 
susceptible to various cell death inducers, the function of TSC in oxidative-stress 
response remains elusive. In this study, we first found that JNK activation was 
impaired in both TSC1- and TSC2- deficient cells. We also found that mTORC1 
activity, autophagy and upstream MAP3K-MAP2K signaling were not involved 
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in the impaired JNK regulation observed in TSC-deficient cells. Interestingly, 
TSC2
-/-
 cells have a significantly lower tyrosine phosphorylation with H2O2 
treatment, and this possibly correlated with the significantly higher MKP-1 
mRNA level observed in the TSC2
-/-
 cells. Importantly, we found that TSC2 was 
co-immunoprecipitated with MKP-1, indicating a possible functional impact of 
TSC2 protein on MKP-1. Finally, we provided evidence suggesting that JNK 
impairment promoted necrotic cell death in TSC2
-/- 
cells. We thus propose a novel 
role of TSC in regulating oxidative stress-mediated JNK signaling pathway via 
MKP-1.  
4.2  Results 
4.2.1  Activation of JNK is impaired in TSC-null MEFs 
In order to test whether the TSC-mTORC1 signaling pathway has any 
functional impact on JNK activation under stress, we first explored H2O2-induced 
JNK activation in TSC2-null (TSC2
-/-
) and TSC1-null (TSC1
-/-
) MEFs. 
Interestingly, dose- and time-dependent treatments of H2O2 showed abrogated 
JNK activation in TSC2
-/-
 (Figure 4.1A and 4.1B, respectively) as compared to its 
corresponding wild type (TSC2
+/+
) cells. Moreover, there was reduced p-c-Jun, a 
downstream substrate of JNK (Seki et al., 2012). Since JNK signaling is also 
activated in response to other stress stimuli such as TNFα, ultraviolet (UV) 
radiation and nitric oxide (Karin and Gallagher, 2005), we asked if JNK signaling 
is also reduced with these stimuli in TSC2
-/-
 cells. Consistently, we found that the 
JNK activation was much reduced in TSC2
-/-
 cells stimulated with TNFα, UV and 






cells are impaired in oxidative stress-induced JNK activation. 





mouse embryonic fibroblasts (MEFs) were treated with different doses of H2O2 
(0, 0.1, 0.25, 0.5, 1 and 2 mM, respectively) as indicated for 1 hour. (B) Time-
dependent effect of H2O2. The TSC2 cells were treated with of H2O2 (0.5 mM) for 
the indicated period of time. Subsequently, cell lysates were collected and western 








MEFs have weakened JNK signaling activation induced by 
other stimuli. (A) Effect of pro-inflammatory cytokines and ultraviolet (UV) 




 MEFs were treated with TNFα (10 
ng/ml) and UV for the indicated time. (B) Effect of nitric oxide in TSC2 cells. 
The nitric oxide donor, sodium nitroprusside (SNP) of different doses was used to 
stimulate the cells as indicated for 1 hour. Cell lysates were collected after 
designated treatments and western blotting was performed for the indicated 
markers. Actin served as loading control. 
 
Similar results were also observed in TSC1
-/-
 cells treated with H2O2 (Figure 4.3), 













 MEFs were treated with different doses of H2O2 as 
indicated for 1 hour. After treatment, cell lysates were collected for western 






 MEFs have reduced JNK activation induced by other stimuli. 
(A) Effect of pro-inflammatory cytokines in TSC1 cells. The WT and TSC1
-/-
 
cells were treated with TNFα (10 ng/ ml) for the indicated time. (B) Effect of 
nitric oxide inducer in TSC1 cells. The MEFs were treated with different doses of 
SNP as described in Figure 4.2B. Cell lysates were collected. Subsequently, 





our study thus demonstrate that deficiency of TSC protein impairs JNK activation 
in response to stress factors.  
4.2.2  TSC2 protein is involved in the JNK signaling pathway 
In order to confirm the role of TSC protein in JNK signaling, we then 
assessed the effects of TSC2 siRNA knockdown in TSC2
+/+
 cells on H2O2–
mediated JNK activation. As expected, TSC2 knockdown reduced JNK activation 
(Figure 4.5). To further determine the relevance of TSC2 toJNK signaling, we 
used the following three different approaches to reconstitute TSC2 expression in 
TSC2
-/-
 MEFs. First, we transiently over-expressed TSC2 in TSC2
-/-
 cells and 
then treated with H2O2. As shown in Figure 4.6, we found that the 
phosphorylation of JNK (p-JNK) is restored partially in transfected cells. The 
concurrent reduction of the p-S6K and p-4EBP1 level indicated the restoration of 
TSC complex function.  
Second, we generated clones with stable reconstitution of TSC2 into 
TSC2
-/-
 cells. As shown in Figure 4.7A, although the TSC2 level was rather low, 
we observed a reduced p-S6K, indicating the functionality of TSC2 in suppressing 
mTORC1 in TSC2
-/-
 cells. Clones #4, #9, #10, and #11 were then further utilised 
to examine H2O2-induced JNK signaling. As shown in Figures 4.7B and 4.7C, 
respectively, clone #9 and #10 indeed showed significant restoration of p-JNK, 
indicating the role of TSC2 or TSC complex in the regulation H2O2-mediated 
JNK activation. Third, we took advantage of existing stable reconstituted MEFs 
(Huang et al., 2008), which were labeled as TSC2
-/-(+/+)
 with pairing reconstituted 
Empty Vector, TSC2
-/-(EV)
 cells as control (Figure 4.8A). The identity of the  
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Figure 4.5 TSC2 knockdown impairs JNK phosphorylation. Non-specific (NS) 
siRNA that served as control or TSC2 siRNA knockdown in TSC2
+/+
 cells was 
performed. After 48 hours, cells were treated with H2O2 (0.5 mM) for the 
indicated time. TSC2
-/-
 cells were treated simultaneously. Cell lysates were 





Figure 4.6 Overexpression of TSC2 restores JNK activation. TSC2
-/-
 cells were 
transfected with a control vector or with the plasmid containing TSC2 gene 
(pLenti4-TSC2). After 48 hours transfection, the cells (including TSC2
+/+
 cells) 
were treated with 0.5 mM of H2O2 as the indicated time. The collected cell lysates 
were subsequently used for immunoblotting. Actin served as loading control. All 




Figure 4.7 Reconstitution of TSC2 increases activation of oxidative stress-induced 





 (lane 1) and TSC2
-/-
 (lane 2) cells served as controls respectively, while 
lane 3 was a transient expression of pLenti4-TSC2 plasmid in TSC2
-/-
 cells for 48 
hours. The clones labeled #1 to #4, and #9 to #15 in the subsequent lanes (lane 4 
to 14) were stable cell lines of TSC2
-/-
 MEFs reconstituted with TSC2 (labeled as 
TSC2
-/-(+/+)
. (B) and (C) Selection of positive clones for H2O2 treatment. The 
clones (labeled as #4, #9, #10, and #11) were further treated with H2O2 (0.5 mM) 
for the indicated time to examine the TSC2 reconstitution effect on JNK 
activation. Cell lysates were collected and subsequently used for western blotting. 







Figure 4.8 JNK activation is restored in TSC2-reconstituted stable cell line. (A) 







 (Huang et al., 2009a). The lysates of the TSC2 reconstituted 
cells were collected after overnight incubation in full medium. (B) TSC2 




as well as cells in panel A were treated for the indicated time with H2O2 (0.5 
mM). Cell lysates were then analysed with western blot for the indicated markers. 
Actin was used as a loading control. 
 
 
reconstituted cells was confirmed by the presence of TSC2 protein and the 
reduced p-S6K and p-4EBP1 level (Figure 4.8A). Consistently, H2O2-induced 
JNK activation was significantly higher in the reconstituted TSC2
-/-(+/+)
 as 
compared to the TSC2
-/-(EV)





 MEFs used in this study, showed in the same western 
blot (Figure 4.8B). Taken together, these data clearly demonstrate that TSC2 is an 








As the earlier part of this thesis showed that TSC2
-/-
 cells have a lower 
basal and inducible autophagy level (Figure 3.4 and 3.5), we sought to determine 
if lower autophagy plays a role in the impaired JNK activation in TSC2
-/-
 cells. 
We first utilised choloroquine (CQ) to block lysosomal function and autophagy. 
As shown in Figure 4.9A and 4.9B, respectively, CQ had no effect on JNK 





Increased levels of LC3-II and p62 served as autophagic flux markers, as 
described earlier. Next, we used another autophagy inhibitor- wortmannin, which 
is known to block autophagy via suppression of PI3K Class III (Arcaro and 
Wymann, 1993; Wu et al., 2010). As shown in Figure 4.10, wortmannin markedly 





suggesting that suppression of autophagy fails to have any impact on JNK 
activation. To further rule out the involvement of autophagy in JNK activation, 
we treated WT MEFs and Atg7
-/-
 MEFs with H2O2 and SNP. Atg7 acts as E1-like 
enzyme that is required for the conjugation phosphatidylethanolamine (PE) to 
LC3-I to form LC3-II protein (Mizushima et al., 2011). As expected, Atg7
-/-
 
MEFs were marked with absence of LC3-II and elevated level of p62 protein 
(Figure 4.11A). Interestingly, we observed a slightly increased level of JNK 
activation in Atg7
-/-
 MEFs treated with H2O2 (Figure 4.11B) and SNP (Figure 
4.11C). Therefore, it is believed that the impaired JNK activation observed in 
TSC2
-/-




Figure 4.9 Inhibition of autophagy with chloroquine does not inhibit JNK 





 MEFs were treated with H2O2 (0.5 mM) or SNP (0.5 mM) with or without 
CQ (10 µM) for the indicated period of time. CQ was pretreated 1 hour prior to 








Figure 4.10 Inhibition of autophagy with wortmannin alters JNK signaling. H2O2 
(0.5 mM) was added with or without wortmannin (Wort, 100 nM) for the 
indicated time. Wortmannin was pretreated for 1 hour prior to the addition of 
H2O2. Cell lysates were collected and western blotting was performed using the 
indicated antibodies. The reduction of JNK signaling was observed using shorter 
exposure (SE) or longer exposure (LE) of imaging system to compare the effect 










 MEFS. The cell lysates were collected after overnight 
incubation in full medium. (B) (next page) Dose-dependent effect of H2O2 in Atg7 
cells. The Atg7 cells were treated with different doses of H2O2 as described earlier 
for 1 hour. (C) (next page) Effect of nitric oxide in Atg7 cells. Atg7 cells were 
treated with SNP (0.5 mM) with or without CQ, as described earlier in Figure 
4.9B. Cell lysates were collected and subsequently analysed with western blotting 










4.2.4 Impaired JNK activation in TSC2
-/-
 cells is not associated with 
constitutively active mTORC1 
As TSC2
-/-
 cells have higher basal mTORC1 activity (Jaeschke et al., 
2002), we next investigated the role of mTORC1 signaling in H2O2-induced JNK 
activation using various inhibitors of the PI3K-Akt-mTORC1 pathway, including 




rapamycin, and PP242) were able to effectively abolish the aberrant mTORC1 
activity in TSC2
-/-





 MEFs (Figure 4.12A-4.12C). Interestingly, all the three inhibitors failed 










 MEFs, being consistent with the earlier reports (Li et al., 
2010; Smith et al., 2005). Such data thus indicate that hypersensitivity of 




As raptor is the regulatory subunit of mTORC1 (Chi, 2012), we next took 





As shown in Figure 4.13A, the successful knockdown of raptor significantly 
reduced the mTORC1 activity in TSC2
+/+
 cells, evidenced by the reduction of p-
S6K and an increase of p-Akt. Similarly in TSC2
-/-
 cells, raptor knockdown 
inhibited the constitutive mTORC1 activity (Figure 4.13B). However, raptor 
knockdown did not cast any effect on JNK activation in both type of cells. Taken 
together, it is believed that the impaired JNK activation in TSC2
-/-
 cells is not 
associated with the constitutively activated mTORC1.  




In this part of our study, we attempted to examine and compare the 




 cells. H2O2 is 




Figure 4.12 JNK impairment in TSC2
-/-
 cells is not due to PI3K-Akt-mTORC1 
pathway. (A) PI3K inhibitor does not affect JNK signaling. TSC2 MEFs were 
treated with H2O2 (0.5 mM) with or without PI3K-Akt inhibitor, LY294002 (10 
µM) for the indicated time. The mTORC1 inhibitors, (B) Rapamycin or (C) 
PP242 does not further upregulate JNK signaling in TSC2
-/-
 cells. Rapamycin (10 
nM) or PP242 (1 µM) were added respectively into the cells, with or without 
H2O2 (0.5 mM) for 1 hour. Pretreatment with respective inhibitors for 1 hour was 
performed prior to the addition of H2O2. Cells were lysed and cell lysates were 








Figure 4.13 Raptor knockdown does not affect JNK signaling. (A) Effect of raptor 
knockdown in TSC2
+/+ 
cells. Non-specific (NS) siRNA that served as control or 
raptor siRNA knockdown in TSC2
+/+
 cells was performed. After 48 hours, cells 
were treated with H2O2 (0.5 mM) for the indicated time. (B) Effect of raptor 
knockdown in TSC2
-/-
 cells. Similarly as described in panel A, knockdown of NS 
or raptor was performed in TSC2
-/-
 cells. The pair of TSC2 cells were treated 
simultaneously with respective cells of siRNA-knockdown in both panels. Cell 
lysates were subsequently analysed with western blotting for the indicated 
markers. Tubulin served as loading control. 
 
MAPKKK (MAP3K), MAPKK (MAP2K) and MAPK (Chang and Karin, 2001; 




(ASK1), a MAP3K, which is a key upstream kinase in response to H2O2; while 
the activated ASK1 will then phosphorylate and activate MKK4 and MKK7, the 
two key MAP2K for JNK activation (Liu et al., 2007). As shown in Figure 4.14, 





 cells, suggesting that the impaired JNK activation in TSC2
-/-
 
cells is unlikely caused by defective upstream kinases. In addition, we also 
examined the changes of the other two MAPK pathways: p38 and ERK. 
Interestingly, there were no evident differences in the phosphorylation level of 
MKK3/MKK6 and p38 between these two types of cells when treated with H2O2 
(Figure 4.14). 
However, there was a reduction in both ERK (p-ERK Thr202/Tyr204) and 
a slight downregulation of MKK4 at T261 (p-MKK4 Thr261) phosphorylation 
level in TSC2
-/-
 cells when compared to TSC2
+/+
 cells (Figure 4.14). These 
observations suggested that the upstream regulation of MAPK is unlikely to be 
the main mechanism responsible for the impaired JNK activation in TSC2
-/-
 cells. 
Due to the unavailability of a good antibody, we were thus limited in obtaining a 
functional immunoblotting for MKK7 phosphorylation. However, we have 
performed an overexpression study using JNKK2 (also known as MKK7)-JNK1 
plasmid that displays constitutive JNK activation (Zheng et al., 1999), which will 
be discussed in the next section (Figure 4.18). 
4.2.6 TSC2
-/-
 cells have a significantly lower level of tyrosine 
phosphorylation  











 cells were treated with H2O2 
(0.5 mM) for 1 hour. Cell lysates were collected and western blotting was 
performed for the indicated antibodies. Actin was the loading control. 
 
and threonine residues, we asked if the either of these two signaling is affected in 
TSC2
-/-
 cells. We first examined the tyrosine and threonine phosphorylation states 
in TSC2 cells treated with H2O2. We observed a significant decrease of tyrosine 
phosphorylation in TSC2
-/-
 cells in response to H2O2, while the phosphorylated 
threonine level was also slightly reduced, but to a much lesser extent (Figure 
4.15A). Next, we used okadaic acid (OA), a general serine/threonine phosphatase 
inhibitor (Garcia et al., 2002) and sodium orthovanadate (Na3VO4), which is a 
general tyrosine phosphatase inhibitor (Kim et al., 1999) to inhibit phosphatases 




Figure 4.15 Tyrosine phosphorylation activity is significantly lower in TSC2
-/-
 
MEFs. (A) Tyrosine phosphorylation is impaired in TSC2
-/-
 cells. The pair of 
TSC2
 
MEFs were treated with H2O2 (0.5 mM) for 1 hour. (B) Effect of tyrosine 
and serine/threonine phosphatase inhibitors. TSC2 MEFs
 
were treated with 





, 100 µM), or both for 1 hour. Western blotting was subsequently 
performed with the collected cell lysates to blot for the indicated markers. Actin 





tyrosine and threonine, respectively, in TSC2
-/-
 cell with the addition of these two 
inhibitors (Figure 4.15B). 
We next tested if protein phosphatases are involved in the impaired JNK 
activation in TSC2
-/-
 cells. Results showed that while OA had not much effect on 
p-JNK level in the TSC2
-/-
 cells, the addition of orthovanadate significantly 
restored the JNK signaling in TSC2
-/-
 cells in response to H2O2 (Figure 4.16A). 
Such observations thus suggest that the impaired JNK activation in TSC2-null 
cells is likely to be caused by a higher activity of tyrosine phosphatases. Similar 
trend was observed when cells were treated with both TNFα and UV (Figure 
4.16B and 4.16C, respectively).  





restoration activity of JNK signaling seemed to be observed in the three panels of 
Figure 4.16. In panel A, the JNK restoration of H2O2+Na3VO4 treatment was 
significantly higher in TSC2
-/-
 MEFs while less effect was observed in TSC2
+/+
 
cells whereas in both panel B and C (Figure 4.16), the effect of orthovanadate 
phosphatase inhibitor was significantly higher in the TSC2
+/+
 MEFs. One possible 
reason for this observation is that the MKPs that were involved could possibly be 
highly expressed and activated in response to H2O2 in the TSC2-deficient cells. 
Moreover, it is also noteworthy to note that the treatment of H2O2 was longer (1 
hour) while the TNFα and UV treatments were shorter, at a 20 minutes time point. 
It is thus possible that in cells with functional TSC, the deactivation of MKPs 
involved may have already taken place at the longer time point.  




Figure 4.16 Tyrosine phosphatase inhibitors restored JNK activation in the TSC2
-
/-










, 100 µM), or both for 1 hour prior to the addition 
of H2O2 (0.5 mM) as indicated. (B) Effect of phosphatase inhibitors on TNFα. 
The MEF cells were treated with TNFα (10 ng/ml) as described in panel A for 20 
minutes. (C) Effect of phosphatase inhibitors on UV radiation. Cells were radiated 
with UV as described in panel A for 20 minutes. Subsequently, western blot was 
performed using cell lysates and immunoblotted for the indicated markers. Actin 






H2O2-mediated JNK activation, we utilised the stable TSC2-reconstituted cells. As 
expected, reconstitution of TSC2 markedly reduced the tyrosine phosphorylation 
level in response to H2O2 when compared to their corresponding counterparts. 
Meanwhile, no evidence difference was found for threonine phosphorylation 
(Figure 4.17), suggesting the possibility that TSC2 protein specifically affects 
tyrosine phosphorylation. To further strengthen our hypothesis, we utilised the 
plasmid expressing a constitutive active level of JNK, 3HA-JNKK2-JNK1 that 
contains the JNKK2-JNK1 fusion protein (Zheng et al., 1999) and examined the 
tyrosine phosphorylation states in response to H2O2. Consistently, we found that 
the immunoprecipitated JNKK2-JNK1 in TSC2
-/-
 cells had a much lower tyrosine 
phosphorylation level as compared to the counterpart in the wild type cells 
(Figure 4.18), further implying a TSC-mediated role in tyrosine phosphatase 
activity. 
4.2.7 TSC2 regulates MKP-1 expression 
Having the earlier observations that the H2O2-induced tyrosine 
phosphorylation was poorly activated in TSC2
-/-
 cells, we next sought to 
determine if the MAPK phosphatases (MKPs) are involved in the impairment of 
the JNK signaling in TSC2
-/-
 cells under oxidative stress. JNK is 
dephosphorylated by MKPs, a group of specialised phosphatases acting 
specifically on tyrosine and threonine residues for MAPK (Karin and Gallagher, 
2005). The important MKPs that regulate JNK activity include MKPs-1, -3, -5 
and -7 (Hirsch and Stork, 1997; Kamata et al., 2005; Masuda et al., 2001; 




Figure 4.17 Tyrosine phosphatase inhibitor significantly upregulates tyrosine 









 were treated with sodium orthovanadate 
(Na3VO4, 100 µM), or both for 1 hour prior to the addition of H2O2 (0.5 mM). 





Figure 4.18 Immunoprecipitated phospho-tyrosine is lower in TSC2
-/-
 cells 





 MEFs, respectively were transfected with empty vector (pcDNA) or HA-
JNKK2-JNK1 plasmid. After transfected for 48 hours, the cells were treated with 
H2O2 (0.5 mM) for 1 hour. The total phosphorylated-tyrosine immunoprecipitated 
(IP) with anti-HA antibody was immunoblotted (IB) by western blot. Other 
markers in the total cell lysates (TCL) was similarly obtained from western 
blotting. 
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although it was reported that MKP-3 is more specific for ERK deactivation 
(Bermudez et al., 2011; Keyse, 2008). Thus, we examined the changes of MKP-
1,-3, -5 and -7 mRNA levels in H2O2-treated cells. We noticed that MKP-1 
mRNA level was upregulated significantly in TSC2
-/-
 cells when compared to the 
TSC2
+/+
 cells (Figure 4.19). 
 
 







cells were treated with H2O2 (0.5 mM, 1 hour) and then the total RNA of all 
indicated samples were isolated. RNA was reverse-transcribed to cDNA using 
PCR, followed by real-time PCR (RT-PCR) amplification. The MKPs data 
obtained from RT-PCR were expressed as folds relative to respective control. 





. Statistical significance (*p<0.05, t-test) of MKP-1 level in respective 
treatments was indicated in the bar chart. 
 
We further studied the interaction of TSC2 to MKP-1 by performing co-
immunoprecipitation assay. In TSC2
+/+
 MEFs that were transfected with Flag-
MKP-1, there was an increased binding of TSC2 to MKP-1 in response to H2O2 
treatment (Figure 4.20). Interestingly, while there was an increase of TSC2 
protein, a substantial amount of MKP-1 protein level was reduced in the treated 






Figure 4.20 TSC2 binds to MKP-1. TSC2
+/+
 MEFs was transfected with Flag-
MKP-1 for 48 hours, followed by treatment of H2O2 (0.5 mM) for 1 hour. The 
total TSC2 immunoprecipitated (IP) with anti-Flag antibody was immunoblotted 
(IB) by western blot. Other markers in the total cell lysates (TCL) were similarly 
obtained from western blotting. Actin was the loading control. 
 
together, data from this part of our study suggest that TSC2 protein regulates at 
least one of the MKPs (MKP-1) via protein-protein interaction. Absence of TSC2 
may lead to higher expression of MKP-1 which then impairs JNK activation in 
the TSC2
-/-
 cells.  
4.2.8 JNK impairment sensitizes TSC2
-/-
 cells to necrosis 
To investigate the physiological and pathological relevance of the TSC2-
MKP1-JNK signaling pathway identified above, we further tested whether JNK 
impairment in TSC2
-/-
 cells contributes to the susceptibility of TSC2
-/-
 cells to 
stress-mediated cell death. We found that the specific JNK inhibitor, SP600125, 
failed to protect TSC2
-/-
 cells against H2O2-induced cell death (Figure 4.21A). 







Figure 4.21 H2O2-induced cell death in TSC2
-/-
 MEFs. (A) JNK inhibitor, 
SP600125 does not protect TSC2
-/-
 cells from H2O2-induced cell death. TSC2 
cells were treated with H2O2 (0.5 mM) with or without JNK inhibitor with 
SP600125 (20 µM). (B) Necroptosis inhibitor, necrostatin-1 protected TSC2
-/- 
from H2O2-induced cell death. Cells were treated as in panel A with or without 
necrostatin-1 (30 µM) for 24 hours. Pictures were examined and photographed at 






Meanwhile, it has been reported previously that JNK is able to promote 
necrotic cell death under oxidative stress (Zhang et al., 2007). Thus, we further 
investigated H2O2-induced cell death using necrostatin-1 (Nec-1), a specific 
necrosis inhibitor via suppression of RIP1 (Degterev et al., 2008). Surprisingly, 
treatment with Nec-1 effectively protected TSC2
-/-
 against H2O2-induced cell 
death, evidenced by the morphological changes (Figure 4.21B) and cell viability 
determined by the PI-exclusion test (Figure 4.22B). Such observations thus 
indicate that H2O2 mainly induces necroptotic cell death in TSC2
-/-
 cells. 





H2O2 which was not affected by the addition of Nec-1, suggesting the possibility 
that both apoptosis and necrosis co-exist in H2O2-treated TSC2
-/-
 cells. Taken 
together, these data suggest that H2O2-induced necrosis in TSC2
-/-
 cells are 






Figure 4.22 H2O2 induces apoptotic and necrotic cell deaths in TSC2
-/-
 MEFs. (A) 
Apoptotic cells is present in TSC2
-/- 
treated with H2O2 and necroptosis inhibitor. 
TSC2
-/-
 MEFS were added with or without necrostatin-1 (Nec-1, 30 µM) in H2O2 
(0.5 mM) -treated cells for the indicated period of time. Cell lysates were 
subsequently used for western blotting to blot for the indicated antibodies. 
Caspase 3 cleavage was still observed in necrostatin-1 treated cells, blotted for 
shorter exposure (SE) or longer exposure (LE) with imaging system. Actin was 
the loading control. (B) PI live exclusion staining for cell death quantification. 
The cells were treated as described in (A) for 24 hours. The percentage of viable 
cells was then measured with PI (5 µg/ml) using flow cytometry. All statistical 
data in all the figures are presented as means ± S.D of three independent 
experiments (**p<0.01, t-test). 
 
 
4.3  Discussion 
In this part of our study, we demonstrate that TSC protein possesses 
additional functions in mediating stress responses via regulation of JNK signaling 
and cell death. We provide evidence showing that TSC2 protein and the 
TSC1/TSC2 complex are able to promote oxidative stress-mediated JNK 
activation via engaging MKP-1. In cells deficient of TSC2 or TSC1, the JNK 
activation is impaired due to up-regulation of MKP-1, a process we found 
independent of mTORC1 activity. Our findings thus expand the functional scope 
of TSC and provide a novel link connecting TSC proteins to JNK signaling in 
B 
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mediating oxidative stress and cell death. 
TSC1 forms a heterodimer with TSC2 protein to negatively regulate 
downstream mTORC1 activity (van Slegtenhorst et al., 1998). Thus, in TSC1- or 
TSC2-deficient cells, the absence of TSC protein complex would lead to 
constitutive activation of mTORC1 (Jaeschke et al., 2002; Kwiatkowski et al., 
2002), which is supported by our data as shown in Figure 3.1A. One key finding 
in our study was the impairment of JNK activation observed in both types of 
MEFs, which were either deficient of TSC1 or TSC2, despite of the various 
stimuli used (H2O2, TNFα, UV radiation and SNP) (Figure 4.1-4.4), thus strongly 
suggesting that the functional TSC1/TSC2 complex is involved in the activation 
of JNK signaling. Moreover, a recent study has shown that p53 is involved in 
stimulating JNK activity under stress (Gowda et al., 2012). The TSC1 and TSC2 
MEFs cells used in our study were known to be p53 positive and negative, 
respectively (Kwiatkowski et al., 2002; Zhang et al., 2003a). As both TSC1- and 
TSC2-deficient cells showed similar trends with reduced JNK activation when 
stimulated (respective Figure 4.1, 4.2, 4.3, and 4.4), thus our study thus suggests 
that p53 is unlikely to play an important role in JNK activation observed in these 
cells. 
Another profound observation from our study was the independent roles of 
mTORC1 hyperactivation, autophagy and upstream MAP3K-MAP2K in the 
impaired JNK signaling of TSC2
-/-
 cells. In Chapter 3, the hypersensitivity of 
TSC2
-/-
 MEFs to various cell death stimuli was associated with a lower autophagy 
level, which was mainly due to the suppression of autophagy by aberrant 
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mTORC1 activity. However, in this study, we found that neither mTORC1 nor 
autophagy was involved in the impaired JNK activation in TSC2
-/-
 MEFs (Figure 
4.9-4.13). Such data could be understood as mTORC1 plays a major role in 
suppressing autophagy during the autophagy induction process (Ganley et al., 
2009; Hosokawa et al., 2009; Jung et al., 2009) whereas the activation of JNK 
during starvation leads to JNK-mediated Bcl-2 phosphorylation that subsequently 
releases Beclin 1 for the nucleation complex formation is mTOR-independent 
(Mehrpour et al., 2010; Wei et al., 2008).  
Consistently, the JNK activation in autophagy deficient Atg7
-/-
 MEFs 
seemed stronger than the Atg7
+/+
 MEFs (Figure 4.11B and 4.11C). It is currently 
unknown if autophagy deficiency may induce higher JNK activation, as JNK is 
known to be activated during starvation to release Beclin 1 in promoting 
autophagy process (Wei et al., 2008). One possible explanation is, the ROS level 
in autophagy deficient cells may be higher and consequently, further promote 
JNK activation. Notably, it was previously reported that autophagy deficient plant 
have a higher oxidative stress level (Xiong et al., 2007). Moreover, the extent of 





MEFs when the Class III PI3K autophagy inhibitor, wortmannin (Arcaro and 
Wymann, 1993) was used (shown in Figure 4.10). Thus, these data indicate that 
JNK impairment signaling in TSC2
-/-
 cells is autophagy-independent whereas the 
autophagy impairment (shown in Chapter 3) was largely attributed to the 
mTORC1 hyperactivity. 
The oxidative stress-mediated JNK signaling is activated through a three-
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tier cascade; initializing from upstream MAP3K such as ASK1 to MAP2K 
(MKK4, MKK7) and subsequently to MAPK (JNK). Notably, despite the 
significant JNK deficiency in TSC2
-/-
 cells in response to oxidative stress, the 
upstream MAPK kinases including ASK1 and MKK4 were not perturbed in 
TSC2
-/-
 cells (Figure 4.14).  
Another profound observation that we have obtained from our studies was 
the significant reduction of tyrosine phosphorylation observed in TSC2-null cells 
(Figure 4.15A). During oxidative stress, tyrosine phosphorylation-dependent 
signal transduction takes place involving the large protein tyrosine phosphatase 
(PTP) superfamily, which comprises of these groups of enzymes: i) classical 
PTPs, ii) dual specificity PTPs and iii) low molecular weight PTPs (Andersen et 
al., 2001). Tyrosine phosphorylation plays a key role in the regulation of various 
processes such as cell to cell communication, cell transformation, regulation of 
gene transcription, mRNA processing, transportation of molecules in cells; in 
which it is implied in numerous cellular processes such as embryogenesis, tissue 
homeostasis, organ development and immunity. Meanwhile, tyrosine 
phosphorylation abnormalities have been associated with immune deficiency as 
well as in cancer (Alonso et al., 2004; Ullrich and Schlessinger, 1990).  
The MKPs deactivate the MAPK signaling by dephosphorylating 
threonine and tyrosine at the TXY motif of the kinase activation loop (Davis, 
2000). Elevated MKPs expression, such as MKP-1, have been shown to aid the 
oncogenic transformation by suppressing apoptotic consequences in response to 
oncogenic or genotoxic stress (Small et al., 2007; Wang et al., 2007a). In the 
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manifestations of TSC disease, benign tumours are formed in multiple organs 
(Gomez, 1991; van Slegtenhorst et al., 1997). In our study, we found that the 
expression of MKP-1 was higher in TSC2
-/-
 cells (Figure 4.19). It is thus possible 
that in the absence of TSC, the MKP-1 expression is elevated and therefore, leads 
to tumours progression as seen in TSC disease-manifestated pathologies. 
Moreover, in agreement that JNK may also be dephosphorylated by dual-
specificity MKPs (Karin and Gallagher, 2005), our data have also shown that TSC 
may regulate the MKPs (Figure 4.19 and 4.20). 
Increased expression of MKP-1 is also found in patients with multiple 
sclerosis (Eljaschewitsch et al., 2006) and major depressive disorders (Duric et al., 
2010). Moreover, elevated MKP-1 expression is also seen in certain cancers, such 
as in non-small cell lung cancer (Vicent et al., 2004) while high expression of 
MKP-1 confers drug resistance in melanoma as well as in glioblastoma (Kundu et 
al., 2010; Yu et al., 2012). Contradictorily, the loss of MKP-1 may also promote 
tumour metastasis and cell proliferation, such as seen in non-small cell lung 
cancer, prostate, colon, and bladder cancer (Loda et al., 1996; Tai et al., 2010). 
Moreover, MKP-1 induction is reduced in cells of severe asthmatics conditions 
(Bhavsar et al., 2008) and is essential for proper regulation of innate immunity 
(Zhang et al., 2009c). Therefore, MKP-1 seems to be a potential target for 
therapeutic purposes for various diseases, through the manipulation of its activity 
by using either specific inhibitors or inducers (Doddareddy et al., 2012). 
Notably, in our study, we found that an interaction has existed between 
TSC2 and MKP-1 during oxidative stress. As shown in Figure 4.19, the mRNA 
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expression was higher in TSC2
-/-
 cells treated with H2O2 whereas a drop of 
mRNA level occurred in TSC2
+/+
 cells. Interestingly, more TSC2 protein was 
found to be bound to MKP-1 while a decreased of MKP-1 protein level was 
observed in oxidative stress-stimulated MEFs (Figure 4.20). These results 
possibly indicate that TSC suppresses MKP-1 both at the transcriptional level as 
well as the protein level, possibly by promoting its degradation. In agreement that 
MKP-1 is regulated in multiple contexts, earlier studies have shown that the 
transcriptional activity of MKP-1 is induced by various extracellular stimuli 
(Keyse, 1995, 1999), and while its stability is promoted through acetylation (Cao 
et al., 2008), the MKP-1 interaction with other MAPKs members is also able to 
enhance its catalytic activity (Hutter et al., 2000; Slack et al., 2001). Thus, these 
clearly indicate that TSC-mediated regulation of MKP-1 may involve these 
mechanisms. 
On the other hand, MKP-1 protein has a half-life of about 1 hour and is 
targeted for degradation through the proteasome pathway for its inactivation 
(Brondello et al., 1999; Roth Flach and Bennett, 2010). Accordingly, as shown in 
Figure 4.16A, the addition of phosphatase inhibitors failed to further restore JNK 
activation in TSC2
+/+
 cells, while a significant difference was observed in TSC2
-/-
. 
These imply that the degradation of MKP-1 may be affected due to the absence of 
a functional TSC.  
While it is well known that activation of JNK from ROS stimuli is linked 
to apoptosis (Hampton and Orrenius, 1998) as well as necrosis (Shen and Pervaiz, 
2006; Vanden Berghe et al., 2010), we are interested to explore whether the 
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impaired JNK activation in TSC2
-/-
 cells is functionally associated with ROS-
mediated cell death. Interestingly, data from our study have revealed that the 
oxidative stress-mediated JNK activation had mainly promoted necroptotic cell 
death in TSC2
-/-
 cells, as such cell death was effectively protected by Nec-1 
(Figure 4.21 and 4.22). This suggests that the TSC-deficient cells may undergo 
necroptotic cell death during oxidative stress, although apoptotic cell death was 
also present, as indicated by the cleaved caspase 3 (Figure 4.22A).  
In this study, we have also observed an insignificant difference of p38 
activation in response to H2O2 in the TSC2 cells. Although it is generally known 
that MKP-1 may also regulate p38 (Roth Flach and Bennett, 2010), data from our 
study (Figure 4.14) has suggested that MKP-1 does not target p38 in our system. 
Meanwhile, we have also noted a downregulation of ERK and MKK4 (T261) 
phosphorylation status (Figure 4.14). It was previously reported that phosphatases 
such as protein phosphatase type 5 (PP5) could downregulate MKK4 (T261) 
independent of p38 and p-ERK (Zhou et al., 2004). As such, the regulation of 
other types of phosphatases by TSC1/TSC2 complex remains to be established. 
Higher phosphatase activities may lead to other cognitive complications. 
Two recent studies have found that an elevated alkaline phosphatase activity is 
observed in Alzheimer’s disease patients (Kellett et al., 2011; Vardy et al., 2012). 
Moreover, Protein Tyrosine Phosphatase Nonreceptor Type 5 was found to be 
involved in stress-mediated cognitive functions of psychopathology (Yang et al., 
2012). Notably, TSC disease patients are also known to suffer from neurological 
disorders (Budde and Gaedeke, 2012). Thus, it would be interesting to know if the 
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deregulated phosphatase activity observed in this study may be accounted for the 
neurological disorders implicated in TSC disease.  
Although it is not known on how exactly TSC mediates MKP-1 
degradation, nevertheless data from our study strongly indicate that TSC is a key 
mediator of MKP-1 activity. It is also currently unknown if the elevated MKP-1 
expression is associated with TSC-related pathologies, but as MKP-1 plays a 
diverse role in both the pathological and physiological functions (Doddareddy et 
al., 2012), this approach may have potential therapeutic implications in TSC-
related pathologies. Collectively, our study has thus revealed a novel role of TSC 
in promoting stress-mediated JNK signaling via suppression of MKP-1, and its 
implications in cell death, as illustrated in Figure 4.23. 
 
 
Figure 4.23 The regulation of TSC1/TSC2 complex in oxidative stress and cell 
death. In the presence of TSC protein, the MKP-1 activity is negatively regulated 
to activate JNK activity. Depending on the extent of stimuli, activated JNK may 
induce to apoptosis or necrosis. In TSC-null cells, the MKP-1 activity is high, 




























Dysfunctional TSC, either due to its mutated TSC1 or TSC2 genes, leads 
to constitutive activation of mTORC1 that eventually causes numerous 
pathological conditions, including tumour formation in multiple organs, such as 
brain, kidneys, lung, heart and skin (Inoki and Guan, 2009). Presently, no 
effective systemic treatment is available for TSC-related disease (Budde and 
Gaedeke, 2012), in spite of the disastrous outcomes in TSC disease 
manifestations. 
Meanwhile, autophagy is an evolutionary conserved mechanism in 
eukaryotes that maintains cytoplasmic homeostasis and enables cells to meet 
energy requirements under starvation, as well as to prolong survival under stress 
conditions (Rubinsztein et al., 2012). The mTORC1, a major cellular growth 
controller, is known to inhibit autophagy through inhibition of ULK1/2 complex 
and initiation of autophagy process (Rubinsztein et al., 2012). Hyperactivation of 
mTORC1 has always been linked to cancers and thus, extensive research has been 
performed on mTORC1 as a therapeutic target in cancer and several other 
diseases (Zoncu et al., 2011).  
On the other hand, JNK is known to regulate cell death (apoptosis and/or 
necrosis) or cell survival, depending on the nature of the stimuli, the cellular 
extent and the periodic activation of JNK signaling (Weston and Davis, 2007). 
Among various stimuli, ROS and oxidative stress are particularly important for 
JNK activation (Torres, 2003). Notably, ROS, such as H2O2 has long been 
implicated in numerous diseases, including neurodegeneration, cancer, 
autoimmune diseases and ageing, DNA damage, lipids and proteins (Weinberg 
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and Chandel, 2009). Therefore, the role of JNK in mediating cell stress is 
indispensable in determining the final outcome of the cell’s fate. 
At present, the TSC-null cells are known to be more susceptible to various 
cell death stimuli, such as TNFα (Ghosh et al., 2006), glucose deprivation (Lee et 
al., 2007), and ER stress (Di Nardo et al., 2009; Kang et al., 2011). Despite the 
hypersensitivity of the TSC-null cells to various stimuli, the underlying 
mechanisms whether autophagy is involved has not been studied systematically.  
Meanwhile, JNK is known to affect the TSC-mTORC1 signaling pathway 
via phosphorylation of raptor in a familial adenomatous polyposis model as well 
as during osmotic stress (Fujishita et al., 2011; Kwak et al., 2012). However, up to 
date, little is known whether the TSC-mTORC1 would affect JNK activation 
pathway under stress conditions. 
Therefore, the main objective of this study is to investigate the regulatory 
roles of TSC in cellular stress response by focusing on autophagy, JNK signaling 
and cell death. By using multiple approaches, we have: (i) identified the role of 
TSC in autophagy under starvation conditions and (ii) revealed the role of TSC in 
JNK signaling in response to oxidative stress. Data from this study thus provided 
new insights in the functional roles of TSC in autophagy, JNK signaling and cell 
death regulation.  
5.1   TSC-deficiency impairs autophagy and sensitizes cells to cell death 
 The TSC-null cells have been reported to be highly susceptible to various 
cell death stimuli due to various mechanisms, including increased p53 translation 
(Lee et al., 2007), increased activation of Rheb to ER stress (Kang et al., 2011), 
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lower NF-κB level (Ghosh et al., 2006), increased ER stress (Di Nardo et al., 
2009; Ozcan et al., 2008), and defects in Akt activation (Huang et al., 2009). 
However, it is unknown if autophagy plays an important role in the sensitization 
of these cells to cell death. Therefore, in Chapter 3, we systematically investigated 
the role of autophagy in this process. Firstly, we compared the extent of cell death 




 MEFs treated with various cell 
death stimuli (Figures 3.1, 3.2 and 3.3). We then examined the basal and inducible 
autophagy levels through autophagy flux studies, using starvation as an inducer of 
autophagy. Interestingly, the autophagy level in TSC2
-/-
 cells was low, along with 
an elevated mTORC1 activity (Figures 3.4 and 3.5). Moreover, suppression of 
autophagy by chloroquine or Atg7 knockdown was found only effective in 
sensitizing cell death in the TSC2
+/+
, but not the TSC2
-/-
 cells (Figures 3.6 and 
3.8), indicating that TSC2-deficient cells have an impaired autophagy, thus 
resulting these cells to be more susceptible to various cell death stimuli. 
 The notion that TSC2 deficiency causes defective autophagy, which has a 
pro-survival role, was further evidenced when TSC2
-/-
 cells were rescued during 
autophagy activation through raptor knockdown and rapamycin (Figures 3.9 and 
3.10). All these data clearly demonstrate that the pro-survival role of autophagy is 
important in cells that lack TSC.  
 Moreover, another remarkable observation was that supplementation of 




 cells (Figure 3.11 
and 3.12). In general, nutrient supplementation may elicit two outcomes: 1) 
activates Akt pathway that thus suppresses apoptosis via multiple mechanisms 
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(Franke et al., 2003), or 2) blocks autophagy via activation of Akt-mTORC1 
pathway and subsequently promotes cell death (He and Klionsky, 2009; Wu et al., 





 MEFs could possibly be due to the 
different Akt status in both types of the cells. In TSC2
+/+
 cells, nutrients 
supplementation rescues the cells from EBSS-induced starvation via activation of 
Akt; whereas in TSC2
-/-
 cells, the Akt level is already low due to the negative 
feedback from activated S6K on IRS-1 (Harrington et al., 2004). On the other 
hand, in TSC2
-/-
 MEFs, the activated Akt further increases mTORC1 activity thus 
leading to suppression of autophagy that finally enhances cell death. 
Autophagy is well-known for its pro-survival role via recycling amino 
acid pool under starvation conditions (Mizushima, 2007). For example, Atg3, 
Atg5, and Atg7 knockout mice undergo neonatal lethality due to deficiency in 
maintaining amino acid pool (Komatsu et al., 2005; Kuma et al., 2004; Sou et al., 
2008). As autophagy is negatively regulated by mTORC1 through the 
phosphorylation of ULK1, ULK2 and Atg13 and a direct interaction of raptor to 
ULK1 (Ganley et al., 2009; Hosokawa et al., 2009; Jung et al., 2009), whereas 
under starvation conditions, deactivated mTORC1 dissociates from this 
complexes that leads to the induction of autophagy (Ganley et al., 2009; 
Hosokawa et al., 2009; Jung et al., 2009), it is understandable that the role of 
mTORC1 in mediating autophagy is indispensable. Moreover, as TSC1 and TSC2 
proteins form a functional complex and integrate various upstream signals to 
represses mTORC1 (Laplante and Sabatini, 2012), it is thus intriguing to know 
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that TSC does play a key role in the regulation of autophagy in response to stress 
and starvation conditions. Therefore, data from our study clearly demonstrate that 
TSC is indeed an important factor that mediates mTORC1 and autophagy for cell 
survival when cells are undergoing stress conditions, such as starvation.  
Our data are in fact, supported by several recent studies. For instance, the 
combination of treatments with mTORC1 and autophagy inhibition in TSC2-null 
xenograft tumours has led to synergised therapeutic efficacy (Parkhitko et al., 
2011), thus suggesting that both autophagy and mTORC1 may be the therapeutic 
targets in TSC-related malignancy. In addition, another recent study has also 
implicated the role of TSC in autophagy and neurology (McMahon et al., 2012). 
Consistent with our results, they have showed that autophagy is suppressed in the 
brain tissues of TSC patients. They also observed seizures in TSC1 and PTEN 
knockout mice, respectively, in which both have aberrant mTORC1 activation. 
Meanwhile, they also performed Atg7 conditional deletion, in which seizures were 
promoted; thus indicating a link of TSC, mTORC1 and autophagy to 
epileptogenesis and neurology (McMahon et al., 2012).  
It is important to note that since autophagy is a key mediator for cell 
survival, the importance of autophagy may be much implicated for the therapeutic 
benefits of TSC-related pathologies. For example, in TSC patients, the 
suppression of mTORC1 using mTOR inhibitors may cause the induction of 
autophagy, which may further enhance cell survival or tumour development as 
autophagy protects the cells from cell death induced by chemotherapeutic agents. 
In fact, current clinical trials for the treatment of TSC disease are targeting 
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mTOR-kinase inhibitors (Budde and Gaedeke, 2012). However, it has also been 
reported that the benign tumours seems to proliferate again when the 
administration of mTORC1-targeting drugs is stopped (Bissler et al., 2008). This 
may possibly indicate that the mTORC1-inhibitory drugs may activate the pro-
survival role of autophagy that thus promotes the progression of tumour growth. 
Therefore, caution must be taken during the designation of treatments for TSC- or 
mTOR-related diseases. 
Taken together, we provide evidence demonstrating a novel function of 
TSC in control of cell death in response to nutritional stress/starvation via 
suppression of mTORC1 and promotion of autophagy. Cells deficient of TSC are 
thus susceptible to cell death due to impaired autophagy, which is known to be an 
important pro-survival mechanisms against stress-mediated cell death.  
5.2  TSC promotes JNK activation via downregulation of tyrosine 
phosphatase  
At present, there is evidence indicating the crosstalk between mTORC1 
and JNK signaling pathway. On one hand, JNK is known to phosphorylate and 
negatively regulation the function of IRS-1, which lies upstream of Akt-mTORC1 
pathway (Aguirre et al., 2000; Hilder et al., 2003; Lee et al., 2003). On the other 
hand, JNK is involved in phosphorylating raptor to promote mTORC1 activity in 
intestinal tumour cells (Fujishita et al., 2011) and during osmotic stress (Kwak et 
al., 2012). However, to the best of our knowledge, so far there is no clear 
evidence whether the TSC-mTORC1 pathway has any regulatory effect on JNK 
signaling in response to oxidative stress. Therefore, in Chapter 4, we have 
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expanded the scope of TSC function and examined the role of TSC in oxidative 
stress-mediated JNK signaling and cell death. 
One key finding from this part of our study is impairment of JNK 
signaling was observed in TSC-null cells induced with various stress stimuli 
(Figures 4.1-4.4). We first found that the deficient JNK activation in TSC2
-/-
 
MEFs in response to oxidative stress was not associated with the hyperactivity of 
mTORC1, low autophagy, or impairment of the upstream JNK signaling (Figure 
4.9-4.14). It is known that mTORC1 suppresses autophagy through the 
phosphorylation of ULK1 complex (Ganley et al., 2009; Hosokawa et al., 2009; 
Jung et al., 2009). On the other hand, the autophagy signaling involving JNK-
mediated Bcl-2 phosphorylation seems to be mTORC1-independent (Mehrpour et 
al., 2010; Wei et al., 2008). Thus, it is understood that the impairment of JNK 
regulation in TSC2
-/-
 MEFs was not associated with its autophagy deficiency. 
Remarkably, we found that TSC2
-/-
 MEFs had a significantly reduced 
tyrosine phosphorylation in response to H2O2 (Figure 4.15A), and a general 
tyrosine phosphatase inhibitor, sodium orthovanate was able to restore JNK 
activation (Figure 4.16). In fact, tyrosine phosphorylation is a key signaling event 
that plays a critical role in many physiological processes such as embryogenesis, 
tissue homeostasis, organ development and immunity, whereas abnormalities of 
tyrosine phosphorylation have been associated with immune deficiency and 
cancer (Alonso et al., 2004; Ullrich and Schlessinger, 1990). Thus, it remains to 
be further investigated whether the impaired JNK activation and the reduced 
tyrosine phosphorylation is causatively associated with the pathology manifested 
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in in TSC disease.  
 In search of the molecular mechanisms underlying the impaired JNK 
activation in TSC2
-/-
 MEFs, we first excluded the possibility that it is caused by 
the deficiency in the activation of upstream kinases such as ASK1 and MKK4 
(Figure 4.14). We then attempted to establish the role of protein phosphatases. 
MKP-1 is one of the key phosphatases in the regulation of JNK signaling (Hirsch 
and Stork, 1997; Kamata et al., 2005). One important finding is that there is a 
significantly higher mRNA level of MKP-1 in TSC2
-/-
 MEFs comparing to the 
TSC2
+/+
 MEFs (Figure 4.19). Interestingly, from the protein-protein interaction 
study, MKP-1 was found to bind to TSC2, with an increased binding of TSC2 and 
a decreased level of MKP-1 protein level were observed in H2O2-treated TSC2
+/+
 
MEFs (Figure 4.20). These data thus indicate the possibility that TSC might 
mediate the MKP-1 function via transcriptional down-regulation and through 
protein-protein interaction to mediate its degradation. In the absence of TSC, 
these functions are probably perturbed, thus leading to enhanced MKP-1 activity 
and subsequently causes impaired JNK activation. However, the underlying 
mechanism on how TSC regulates MKP-1 needs to be further elucidated.  
 Data from this study have thus indicated that TSC plays an additional role 
which is independent of the mTORC1 regulation, in mediating MKP-1 activity. 
At present, MKP-1 serves as a potential target for therapeutic therapies as it plays 
a diverse role in both physiological and pathological processes (Doddareddy et 
al., 2012). Elevated MKP-1 expression is linked to drug resistance in melanoma, 
glioblastoma and breast cancer (Kundu et al., 2010; Small et al., 2007; Yu et al., 
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2012), while its overexpression is seen in non-small cell lung cancer (Vicent et 
al., 2004). Although there are also reported studies that the loss of MKP-1 may 
promote metastasis and cell proliferation in non-small cell lung cancer, prostate, 
colon, and bladder cancer (Loda et al., 1996; Tai et al., 2010), nevertheless, MKP-
1 appears to be an important therapeutic target in these cancers (Doddareddy et 
al., 2012). Therefore, data from this study provide useful insights for establishing 
the role of MKP-1 in TSC-related pathologies. 
5.3  Conclusions 
 In this thesis, we have systematically investigated the roles of TSC in 
mediating stress-mediated cellular responses by focusing on autophagy, JNK and 
cell death. This study consisted of mainly two parts: (i) investigation on the role 
of TSC in regulation of autophagy and cell death under starvation and, (ii) 
examination on the role of TSC in JNK signaling and cell death under oxidative 
stress. The main findings are: 
1. Impaired autophagy due to constitutive mTOR activation sensitizes TSC2-
null cells to cell death under stress 
i. TSC2-/- cells have lower basal and inducible autophagy level due to 
constitutive mTORC1 activation 
ii. Suppression of autophagy failed to sensitize TSC2-/- cells to cell 
death due to low autophagy level 
iii. Activation of autophagy with starvation in TSC2-/- cells protected 
cells from death 




cells, but enhances cell death in TSC2
-/-
 cells under 
starvation condition  
2. TSC promotes JNK activation via downregulation of MKP-1  
i. Activation of JNK signaling in response to ROS and other stimuli 
is impaired in TSC2
-/-
 MEFs 
ii. TSC2-/- cells have a significantly lower tyrosine phosphorylation 
activity 
iii. TSC binds to MKP-1 and regulates its expression 
iv. JNK impairment sensitizes TSC2-/- cells to necrosis 
Taken together, we have demonstrated the crucial role of TSC in 
autophagy, JNK signaling and cell death regulation. The main findings from this 
study are illustrated in Figure 5.1. We believe that data from this study will 
contribute to the current literature for the function of TSC, particularly in control 
of autophagy, JNK activation and cell death, which provide a foundation for 
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